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ABSTRACT
OLIGODENDROCYTE RESPONSES
AFTER SPINAL CORD INJURY
George Z. Wei
April 27, 2021

Recent studies demonstrate that neuroprotection strategies targeting the
proteostasis network and components of its effector signaling pathways improve cell
survival and motor recovery outcomes in several models of neuronal injury and
degeneration. However, the individual contributions of these signaling pathways to the
pathogenesis of spinal cord injury (SCI), white matter damage, and motor recovery have
not yet been determined. Here, I explored the role of the HIF prolyl hydroxylase domain
proteins (PHD/EGLN), effectors that can modulate stress responses activated by the
proteostasis network, on motor function recovery after SCI. Furthermore, I identified
previously unknown candidate mechanisms in an unbiased manner that may regulate
oligodendrocyte death and survival in the context of SCI using RiboTag technology.
Chapter one presents background information on the SCI pathogenesis, the types
of cell death involved in SCI, oligodendrocytes function and death, the proteostasis
network as a global target for neuroprotection in SCI, and finally introduces tools that can
be used to study OL-specific translatomes after SCI. Chapter two examines the effects of
HIF PHD/EGLN inhibition on a mouse model of moderate T9 contusive SCI.
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Pharmacological inhibition of PHDs using adaptaquin moderately lowers acute induction
of activating transcription (Atf4) and C/EBP homologous protein (Chop/Ddit3) mRNAs
and prevents the acute decline of oligodendrocyte (OL) lineage mRNAs, but does not
improve long-term recovery of hindlimb locomotion or increase chronic white matter
sparing. Furthermore, conditional genetic ablation of all three PHD isoenzymes in OLs
did not affect Atf4, Chop or OL mRNAs expression levels, locomotor recovery, and white
matter sparing after SCI.
Chapter three uses RiboTag technology to study the translatome of OLs at
different time points after SCI. Using mouse genetics, I tagged ribosomes specifically in
OLs, and immuno-purified mRNA associated ribosomal complexes. I identified genes
that were upregulated in OLs with a maximum increase at 2 days post-injury (dpi). Genes
that may induce oxidative stress (Chac1, Steap3), inhibit survival signaling kinases
(Spred3, Spry4, Parvb), and directly contribute to OL death (Runx1) were highly
upregulated after SCI. Potential pro-survival genes include Sphk1, Aldh18a1, and Gdnf.
My results show that SCI activates multiple signaling pathways that may affect
locomotor recovery, cellular homeostasis, and survival. Although PHDs are involved in
modulating responses involved in the proteostasis network, PHD inhibition and/or
deletion alone is not sufficient to protect white matter after SCI. These observations are
in contrast to those from various CNS injury models with primary effects on the grey
matter. PHD inhibitors are currently used in 27 clinical trials treating anemia, and
currently show potential for neuroprotection in stroke. I show that PHDs may not be
suitable targets to improve outcomes in traumatic CNS pathologies that involve acute
white matter injury. Finally, I show using RiboTag technology that OLs upregulate genes
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that may increase oxidative stress and inactivate survival signaling that may collectively
contribute to cell death after SCI. Taken together, the work established in this dissertation
shows limited involvement of the PHD-ATF4-CHOP pathway in SCI, and identifies
novel candidate mediators of OL death/survival after SCI.
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CHAPTER 1
INTRODUCTION

SCI Incidence and Pathology
Traumatic spinal cord injury (SCI) is a debilitating injury to the central nervous
system (CNS) which leads to severe neurological impairments. It is the second leading
cause of paralysis, only behind stroke, in the United States (Stats about Paralysis.
www.christopherreeve.org/living-with-paralysis/stats-about-paralysis). Each year
>17,000 people (50 cases per one million individuals) in the U.S. suffer a traumatic SCI,
with male cases (80%) vastly outnumbering female cases (20%) (National Spinal Cord
Injury Statistical Center, Facts and Figures at a Glance. Birmingham, AL: University of
Alabama at Birmingham, 2016.). The average age at the time of SCI follows a bimodal
distribution with the one peak occurring between 15-29 years old and the second peak at
>50 years old. Injury to the cervical spine level is most common (~60%), followed by
thoracic (32%), and lumbosacral (9%). Finally, automobile traffic accidents remain the
leading cause of SCI (38%), followed by falls (30%), acts of violence (14%), and finally
sports related injuries (9%). The estimated direct cost for patients with SCI is estimated
to be at $1.5–4.6 million over their lifetime (National Spinal Cord Injury Statistical
Center, Facts and Figures at a Glance. Birmingham, AL: University of Alabama at
Birmingham, 2016.). Finally, SCI has far reaching and devastating social and
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psychological sequela for the patient which drastically decreases the quality of life for the
affected patient. Injury to the spinal cord disrupts the spinal circuitry that connects the
brain to muscle/sensory systems and leads to many complications including loss of motor
control. According to the American Spinal Injury Association (ASIA), patients in
approximately 55% of SCI cases have varying degrees of motor or sensory activity below
the level of injury, while in the remaining 45% there is a complete lack of motor or
sensory activity in the S4-5 segments (https://asia-spinalinjury.org/isncsci-2019-revisionreleased/). These symptoms can be directly attributed to effects of SCI on motor
neuroaxis. Currently, there is no acute therapeutic modality that has proved to be
substantively efficacious in enhancing motor function recovery.
The pathophysiology of SCI is thought to be biphasic and can be divided into a
primary injury and secondary injury cascade that progresses hours to months post-SCI
(Fig. 1). The initial spinal cord contusion (primary injury) is caused by the mechanical
insult to the vertebral column which can compress or transect the spinal cord tissue
resulting in immediate death of all impacted CNS cell types, disruption of blood vessels
and cellular membranes, accumulation of neurotransmitters, and demyelination (Almad et
al., 2011; Oyinbo, 2011). Secondary injury, characterized by a prolonged temporal
progression of cellular death, follows the initial injury and spreads rostral and/or caudal
to the initial focal SCI lesion (Almad et al., 2011). For instance, Wallerian degeneration
of axons contributes to prolonged oligodendrocyte (OL) apoptosis over the course of days
or weeks that may result in chronic demyelination (Beattie et al., 2000; Crowe et al.,
1997; Shuman et al., 1997; Warden et al., 2001). However, mechanisms mediating OLdeath are understudied, but thought to be mediated by inflammatory cytokines (Beattie et
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al., 2002a; Beattie, 2004; Casha et al., 2005; Shuman et al., 1997) and/or loss of survival
signals from intact axons (Barres et al., 1999). Death of OLs and other cells can also
occur though several mechanisms in response to disruptions in protein homeostasis (the
proteostasis network) which are induced by hypoxia, bioenergetic failure, excitotoxicity,
oxidative stress, and neuro-inflammation (Dumont et al., 2001; Myers et al., 2019; Ohri
et al., 2013; Ohri et al., 2020b; Ohri et al., 2012; Ohri et al., 2011; Ohri et al., 2014; Park
et al., 2004; Saraswat Ohri et al., 2018a; Saraswat Ohri et al., 2020). For instance,
disruption of the neuro-vasculature results in the ischemia and the hemorrhage with
extravagated blood components are directly cytotoxic in the CNS (Robinson et al., 2009;
Sahinkaya et al., 2014). While ischemia has effects on both the gray matter and the white
matter, the re-establishment of blood flow can lead to reperfusion injuries which are
characterized by the formation of free radicals that generate oxidative damage to lipids
and membranes that further elicit an inflammatory response (Jia et al., 2012). Disruption
of the blood spinal cord barrier is an important pathogenic event in the secondary injury
cascade and is a major mechanism behind the activation of the neuro-inflammatory
response after SCI (Hausmann, 2003; Whetstone et al., 2003; Zhang et al., 2012b). The
inflammatory response occurs within hours of the injury with polymorphic nuclear cells
infiltrating first, followed then by macrophages (Pukos et al., 2019). Tumor necrosis
factor α (TNF-α) levels, although not fully understood, rise within an hour after SCI and
have neuroprotective properties, but also induce edema and enhance leukocyte migration
(Sharma et al., 2003; Yune et al., 2003). Finally, these cascades of injuries culminate in
the formation of a glial scar that is comprised of multiple cellular and extracellular
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components that may further limit tissue repair and recovery after SCI (Yuan et al.,
2013).
The mechanisms of secondary injury affect multiple neural cell types and are
closely interwoven together in a self-propagating cycle that collectively contributes to a
toxic environment that promotes prolonged cellular death, demyelination of surviving
axons, and inhibition axonal regeneration that ultimately result in neurological
impairment (Oyinbo, 2011). Therefore, understanding the various types of death cell that
occur after SCI may be of paramount importance when developing neuroprotective
therapeutics that are based on targeted mechanisms.
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Figure 1. Injury progression after SCI
This diagram illustrates the different events after SCI and is divided into phases. In the
acute time points, there is bleeding, as well as glutamate release. Neurons die
immediately, while OL death is prolonged and lasts until the subacute time period. In the
subacute time monocyte and macrophages infiltrate and activate.
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Types of cell death involved in SCI
Traumatic SCI is a complex pathology characterized by a dynamic timedependent injury cascade with distinct molecular changes occurring at different stages of
injury that may result in death of various cells types that ultimately contribute to
functional deficits. The balance between cell survival, proliferation, differentiation, and
death is a critical parameter in the maintenance of organismal homeostasis. After SCI,
various cytotoxic events including hypoxia, hemorrhage, bioenergetics failure, oxidative
stress, endoplasmic reticulum (ER) stress, and neuroinflammation contribute to
secondary injury (Pukos et al., 2019) . Importantly, these events occur at different time
points with varying duration of insult, and therefore may differentially contribute to cell
death. For instance, hemorrhage, oxidative stress, and excitotoxicity may contribute to
acute phase cell death as compared to immune cell infiltration, expression of pro-death
cytokines, and Wallerian degeneration that occur in the subacute phase (Pukos et al.,
2019). Here, I briefly touch upon a few, but not limited to, types of cellular death that
occur after SCI (Fig. 2).
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Figure 2. Types of Cell death
Diagram illustrating the different classification of cell death type and major mediators
that initiates death
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Apoptosis is perhaps one of the best characterized forms of programmed cell
death and involved a series of well-regulated events that result in morphological and
molecular changes that include cell shrinkage, membrane blebbing, and DNA
fragmentation (Coleman et al., 2001). The three major signaling pathways that mediate
apoptotic death are the granzyme/perforin pathway, the extrinsic pathways involving
death receptors, and the intrinsic pathway involving the mitochondria. The intrinsic
pathway can be initiated by a variety of stressors like DNA damage, ER stress,
replication stress, and oxidative stress (Coleman et al., 2001). A key stage for intrinsic
apoptosis is the permeabilization of the mitochondrial outer membrane which is regulated
by theBCL2family of proteins (Coleman et al., 2001). Bcl-2 antagonist/killer 1 (BAK)
and Bcl-2 associated X (BAX) are two key pro-apoptotic members of the Bcl-2 proteins
that have the ability to create pores in the outer mitochondrial membrane (Chipuk et al.,
2006). Other pro-apoptotic members of the BCL2 family of proteins (those that contain a
single BH3 domain) include BCL2 binding component 3 (PUMA), BCL2 like 11 (BIM),
phorbol-12-myristate-13-acetate-induced protein 1 (NOXA), BH3-only harakiri (HRK),
and BH3 interacting domain death agonist (BID) can collectively interact with BAX
and/or BAK to initiate mitochondrial permeability (Elmore, 2007; Inohara et al., 1997).
Increased mitochondrial permeability promotes the release of cytochrome c, second
mitochondria-derived activator of caspase (SMAC), apoptosis inducing factor (AIF), and
high temperature requirement protein-A2 (Omi/HTRA2) (Elmore, 2007). Cytochrome c
can bind to apoptotic protease activating factor-1 (APAF1) to activate Procaspase-9.
Caspase-9 cleaves Procaspase-3 to form active Caspase-3 that cleaves DNA
fragmentation factor Inhibitor of Caspase-Activated Dnase (ICAD) to stimulate the
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DNase activity resulting in DNA fragmentation (Elmore, 2007). In the receptor mediated
extrinsic pathway, death receptors play a critical role in transmitting apoptotic signals by
specific ligands such as Fas and TNF receptor-1 (TNFR1) (Elmore, 2007). The Fas
Ligand (FasL) ligand binds, causes oligomerization of the receptor and through of a
series of steps activate Procaspase-8 that results in the activation of Caspase-3 and -7 that
results in apoptosis (Elmore, 2007). Importantly, apoptotic cell death in both neurons and
OLs can be observed in spinal cords obtained from deceased patients after SCI using
DNA fragmentation and caspase activation assay (Emery et al., 1998).
Autophagic cell death represents starvation response and may occur in
conjunction with other forms of cellular death like apoptosis, ferroptosis, and necroptosis
(Glick et al., 2010). It is characterized by membrane blebbing, depletion of cytoplasm
organelles, and swelling of intracellular vesicles in the absence of chromatin
condensation. It functions to degrade long-lived proteins, cytoplasmic components, and
organelles for lysosomal pathway degradation (Glick et al., 2010). Authophagy is
regulated by unc-52-like kinase (ULK), Atg 13, and FIP200 under the control of
mammalian target of rapamycin complex 1 (mTORC1) (Glick et al., 2010). For instance
authophagy can be initiated when mTORC1 is inhibited using rapamycin which results in
phosphorylation and activation of Atg13 and FIP200 (Glick et al., 2010). This leads to
the elongation of the phagophore around products marked for degradation. Atg12, Atg5,
Atg16L complex and LC3 then assists in the formation of the autophagosome (Glick et
al., 2010). LC3 is then cleaved, conjugated to phosphatidylethanolamine to form LC3-II,
and remain associated with the autophagosome until lysosomal fusion. Several studies
have shown changes in markers of autophagy after SCI (Sekiguchi et al., 2012, Kanno et
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al., 2011, Tanabe et al., 2011, Hao et al., 2013). The role of autophagy is currently
protective after SCI. Autophagy marker increases after SCI, and therefore reflects
inhibition rather than its activation (Lipinski et al., 2015). For instance, deletion of
autophagic gene Atg5 in oligodendrocytes exacerbates and correlates with worse
functional recovery after SCI and greater myelin loss suggesting that autophagy serves as
protective response in OLs (Ohri et al., 2018). Moreover, autophagy reduces neuronal
damage by inhibition of apoptosis after SCI (Tang et al., 2014).
Necrosis is a form of non-programmed cell death that can be caused by toxins,
infections, ischemia and trauma that ultimately results in cell membrane rupture, loss of
intracellular organelles, and degraded DNA (D'Arcy, 2019). Importantly, this process is
energy independent and does not exhibit condensation of chromatin, which is a hall mark
observed in apoptosis. Instead, damage to the cell perturbs its function and causes
swelling that result in cell membrane rupture and leaking of cellular components into
surrounding areas which may result in further inflammation or damage (D'Arcy, 2019).
Necrosis has been shown to occur after SCI (Beattie et al., 2002c). Myelotomy that
remove necrotic tissue were functionally beneficial in dogs (Ducker et al., 1971; Hu et
al., 2015).
Necroptosis is a form as programmed necrosis that is characterized by the
activation of receptor-interacting protein kinases (RIPKs) and is similar with the necrotic
morphology in sharing membrane rupture and organelle loss (Frank et al., 2019).
Necroptosis can be triggered by toll-like receptors (TLRs), death receptors (DRs), and
cytosolic DNA (indicative of viral infection). RIPK3 is first activated by RIPK1 and
subsequently phosphorylates mixed lineage kinase domain-like protein (MLKL) to
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induce MLKL oligomerization (Frank et al., 2019). Oligomerized MLKL then inserts into
cellular membranes permeabilizing them and ultimately resulting in cell death. Notably,
after SCI, RIPK1, RIPK3, and MLKL have been shown to rapidly accumulate due to
lysosomal dysfunction, and rapamycin treatment to stimulate lysosomal function
attenuated cell death (Liu et al., 2018). After SCI, necroptosis inhibitors promotes cell
protection and function recovery (Kanno et al., 2015; Rojas-Rivera et al., 2017; Wang et
al., 2017; Wang et al., 2019; Wang et al., 2014; Wang et al., 2018).
Ferroptosis is a form of iron-dependent cell death and is characterized
morphologically as appearing to be normal without cell membrane defects and the
absence of chromatin condensation (Dixon et al., 2012). Free iron can generate oxidative
stress by reacting with lipids to form lipid peroxidation products. The glutathionedependent antioxidant defense system involves the Xc- transporter which brings cysteine
into the cell that is then converted into cysteine and used for glutathione synthesis (Dixon
et al., 2012). The glutathione peroxidase 4 (GPX4) then uses glutathione to protect cells
against membrane lipid peroxidation (Dixon et al., 2012). Defects or depletion in system
Xc-, GPX4, and glutathione synthesis can lead to excessive lipid peroxide accumulation
and initiate ferroptosis (Dixon et al., 2012). Studies have shown that treatment with
molecular inhibitors of ferroptosis can improve motor function recovery in rodents after
SCI (Feng et al., 2019, Zhang et al., 2019).
Pyroptosis is a form of programmed cell death that is characterized by chromatin
condensation, membrane permeabilization and fragmentation (Bergsbaken et al., 2009). It
is triggered by processes related to the innate immunity such as pathogen invasion
(Bergsbaken et al., 2009). After encountering a pathogen, a inflammasome is formed to
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induce inflammation and pyroptosis (Xue et al., 2019). Pyroptosis has been shown to
involve activation of human and mouse caspase-1, human caspase-4 and caspase-5, or
mouse caspase-11, and is often initiated in response to pro-inflammatory sections IL-1β
and IL18 (Bergsbaken et al., 2009; Man et al., 2017). After SCI, P2X4 receptors
influence inflammasome activation (de Rivero Vaccari et al., 2012). Importantly, P2X(4)
knock-out mice have impaired inflammasome signaling associated with decreased levels
of IL-1β and reduced neutrophil/macrophage infiltration resulting in significant
improvements in functional recovery (de Rivero Vaccari et al., 2012).
Neutrophil extracellular trap-associated cell death (NETosis) is a form of cell
death that commonly occurs in immune cells like neutrophils that encounter pathogens,
although exact molecular mechanisms are still unknown (de Bont et al., 2019). However,
it is thought that NADPH oxidases generate intracellular ROS that triggers the release of
neutrophil elastase (NE) and myeloperoxidase from granules (de Bont et al., 2019).
Elastases then catalyze the proteolysis of F-actin and promote histone degradation (de
Bont et al., 2019). This ultimately leads to cell death and the extrusion of chromatin
fibers mixed with cytoplasmic components known as the neutrophil extracellular trap
(NET). After SCI, neutrophil elastase has been shown to be released at the injury site and
disrupt vascular endothelium (Kumar et al., 2018). In the same study, sivelstat, a
neutrophil elastase inhibitor, attenuated levels of inflammatory cytokines, reduced glial
formation, increased blood vessel formation, and improved locomotor recovery after SCI
(Kumar et al., 2018).
Taken together, traumatic SCI is complex pathology associated with a variety of
different stressors that induce distinct molecular changes in the CNS that collectively
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result in cell death. The balance between cell survival and death is a critical parameter in
the maintenance of homeostasis and function recovery following SCI. Importantly, in the
rodent mid-thoracic contusive SCI models, white matter loss and not neuronal loss, is the
principal driver of impaired hindlimb motor function suggesting that reducing OL loss
and/or protecting axonal integrity by attenuating secondary injury cascades improves
hindlimb locomotor functional recovery (Hadi et al., 2000; Magnuson et al., 2005;
Magnuson et al., 1999).
Oligodendrocytes
Oligodendrocytes: Function
Oligodendrocytes (OLs) are a type of glial cell found in the CNS that
differentiates from oligodendrocyte precursor cells (OPCs) and perform several
functions. Non-myelinating functions of OLs include a supportive, immunomodulatory,
and regulatory role for neurons, including the secretion of neurotrophic factors such as
glial- and brain-derived neurotrophic factor (GDNF and BDNF) which supports axonal
functionality and modulate neurite outgrowth (Simons et al., 2015; Wilkins et al., 2003).
However, OLs are also the main myelin forming cells in the CNS and have a number of
processes that contacts segments of axons and wraps them in concentric layers of
membrane to form the myelin sheath that insulates axons and potentiates fast axonal
conduction (Bradl et al., 2010). The sheath is comprised of lipids (70% dry weight) and
several different proteins, but myelin basic protein (MBP, 30%) and proteolipid protein
(PLP, 50%) make up approximately 80% of the total protein fraction (Baumann et al.,
2001; Duncan et al., 2016; Gudz et al., 2002). These proteins are synthesized by
ribosomes located on the rough endoplasmic reticulum (RER), while the lipid
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components of myelin are synthesized in the smooth ER. It has been estimated that a
single OL can synthesize as much as 20×105 µm2 in surface area of myelin making it one
of the most prolific membrane producing cells, but also placing a substantial burden on
the ER of myelinating OLs (Pfeiffer et al., 1993). The myelinated axons contain gaps
between myelin segments, the nodes of Ranvier, which allow for faster propagation of
action potentials through the axon by salutatory conduction. The formation of myelin
requires an elevated metabolism that is coupled to a high protein translation capacity
along with increased demand for iron which serves as a cofactor for enzymes involved in
making essential components of myelin such as cholesterol and glycolipid (Lin et al.,
2009). Moreover, in the rodent CNS, OLs accumulate highest levels of iron and that the
highest period of iron uptake coincides with demand for peak myelination (Connor et al.,
1996; Morath et al., 2001; Taylor et al., 1990). While essential for these cellular
processes, iron can be highly reactive by generating oxidative radicals that directly
damage proteins, lipids, and DNA (Koskenkorva-Frank et al., 2013). Despite the
requirement for high iron concentrations, OLs are more readily damaged by free radicals
than other glial cells due to lower production of glutathione (Thorburne et al., 1996).
Collectively, these unique OL characteristics make them particularly sensitive to
oxidative and metabolic stressors. Indeed, loss of OLs has been implicated in contributing
to several CNS diseases such as Pelizaeus-Merzbacher disease, multiple sclerosis,
Alzheimer’s disease, cerebral palsy, stroke, and SCI (Goldman et al., 2015; Lucchinetti et
al., 2000; Nasrabady et al., 2018; Nobuta et al., 2019).
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OL-specific death and dysfunction in disease
Multiple sclerosis (MS) is a chronic multifocal neuro-inflammatory disorder that
causes functional deficits in walking, vison, and cognition. It is characterized by immune
cell infiltration that induces demyelination, causing axonal damage and loss of neuronal
synapses (Ghasemi et al., 2017). Specifically, the inflammatory and immune systems
attack components of myelin or OLs resulting in OL death (Cudrici et al., 2006). In early
MS lesions, OPCs accumulate while OLs are still detected (Boyd et al., 2013). However,
as the lesion progresses chronically, both OPC and OL numbers drop. Despite the loss in
OPC/OLs numbers, they are still detected in chronic demyelinated lesions, indicating that
deficiencies may occur in OPC maturation and/or OL remyelination (Caprariello et al.,
2012). These deficiencies have been hypothesized to be caused by the elevated levels of
inflammatory mediators such as immune cytokines and reactive oxygen species that
contribute to an inflammatory environment which leads to the activation of cellular stress
responses (Peferoen et al., 2014). Although previous therapies targeted the immune
response, more recently studies show the therapeutic potential of modulating OL stress
response that regulates the proteostasis network such as the unfolded protein response
(UPR) (Naughton et al., 2016; Peferoen et al., 2014).
Pelizaeus-Merzbacher disease (PMD) is an X-linked leukodystrophy that is
caused by mutations in proteolipid protein 1 (PLP1) and the inability to form functional
myelin (Gencic et al., 1989). The clinical presentations of PMD range and is thought to
be dependent on the mutation in PLP1, however severe mutations can result in
developmental delay and lethality (Hoffman-Zacharska et al., 2013). Some PMDassociated mutant PLP proteins accumulate in the ER lumen, which causes ER stress and
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UPR activation resulting in death of OLs (Inoue, 2017). Recent studies suggest that
targeting the ferroptosis may be therapeutically beneficial. Nobuta and colleagues
showed that PLP1 mutations can cause iron-induced OL death that may be rescued by
iron chelators or lipophilic antioxidants (Nobuta et al., 2019). However, they also showed
that certain PLP1 mutations, namely exon 6 deletion mutations that have more
upregulation of the UPR when compared to other mutants cannot be rescued by iron
chelation, suggesting that various PLP1 mutations have different mechanisms of
cytotoxicity.
Myelin breakdown has also been implicated in neurodegenerative diseases such as
AD. The white matter of patients with AD shows an increase of beta-amyloid
accumulation along with decreases in MBP, PLP, and OLs indicating a role for white
matter degeneration and impaired cortical processing (Desai et al., 2010). Indeed, betaamyloid aggregates induce death of OLs in vitro (Lee et al., 2004). Moreover, diffusion
tensor imaging (DTI) MRI detected disturbances to myelin integrity as evidenced by
white matter hyper-intensities in AD patients (Heo et al., 2009).
Finally, in SCI, OLs undergo several modes of cell death, including necrosis and
apoptosis. In the rodent SCI model, neuron and OL numbers decrease immediately. By 7
dpi, OLs at the injury site are reduced by 93% (McTigue et al., 2001). However, OLs
continuously die over nearly 3 weeks post-injury which further contributes to the loss of
myelin and impede axonal function (Pukos et al., 2019). Numerous factors contribute to
mechanisms of OL loss including immediate excitotoxicity, disruption of the proteostasis
network, ischemia, and oxidative stress associated with reactive oxygen species (ROS)
formation generated from reperfusion (Anthes et al., 1996; Benton et al., 2011;
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Fassbender et al., 2011; Pukos et al., 2019; Wallace et al., 1986). Oxidative stress can
damage ceramides which are a family of waxy lipid molecules involved in the formation
of sphingosine and used in cellular membranes (Novgorodov et al., 2018). Ceramides are
released by sphingomyelinase activity and can activate pro-apoptotic signaling cascades
that lead to OL death (German et al., 2006). Interestingly, ceramides accompanied by
ROS accumulation induce death that did not exhibit apoptotic characteristics, and perhaps
mediated by ferroptosis (Yang et al., 2016). In addition to ischemia, Ca2+ influx, and
secretions from inflammatory cells have been show to play a role (Shultz et al., 2017).
Infiltrating mononuclear (macrophages, neutrophils) cells peak at early time points within
the lesion and secrete products including free radicals and pro-inflammatory cytokine
such as TNFα and interleukin-1α (IL-1α), IL-1β, and IL-6 which stay elevated for several
days after injury (Jurewicz et al., 2005; Nakamura et al., 2005; Sato et al., 2012; Ulndreaj
et al., 2016). TNFα induces OL death by acting through TNF receptor p55 (TNFR-p55)
(Jurewicz et al., 2005). Upon ligand binding, apoptosis-inducing factor (AIF) translocates
from mitochondria translocates to the nucleus triggering cell death (Jurewicz et al.,
2005). Disruption of AIF prevents this TNFα-induced cell death in human OLs (Jurewicz
et al., 2005). Macrophages and neutrophils also generate ROS causing further oxidative
damage. Furthermore, OLs express AMPA-type glutamate receptors (Gallo et al., 1996),
NMDA-type glutamate receptors (Salter et al., 2005), and the ATP receptor P2X7
(Matute et al., 2007) making them vulnerable to glutamate and ATP-induced
excitotoxicity. Compromised blood-spinal cord barrier leaks components of blood into
the CNS which can induce apoptosis and inhibit OPC proliferation (Sahinkaya et al.,
2014; Zhang et al., 2012b). Finally, OLs may also initiate apoptotic mechanisms through
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FAS and p75 receptor activation (Beattie et al., 2002b). After SCI, OLs that express p75
receptor bind proNGF and activate apoptosis (Beattie et al., 2002). In the same study,
p75-/- mice that underwent SCI had a 33% reduction in apoptotic OLs. The mechanisms
of OL death after a complex injury like contusive SCI are diverse multiple, but several
studies have shown that preventing OL death-induced demyelination and/or promoting
remyelination represents a key therapeutic avenue in treating acute SCI (Dong et al.,
2003). Importantly, therapeutic effects of any pharmacological treatment on OPCs/OLs
responses can extend to all cell types undergoing these similar responses. Targeting the
proteostasis network and its effector signaling pathways is a potential global therapeutic
approach to facilitate neuroprotection in acute SCI.
The Proteostasis Network: A global target for neuroprotection in SCI
The proteostasis network is comprised of all the elements that are necessary to
maintain biologically functional and relevant levels of protein within a cell (Fig 3.). Its
effectors include chaperone proteins which help to ensure that newly synthesized proteins
are folded correctly to their final native conformation at precise times as dictated by
cellular demands (Hartl et al., 2011). Additionally, the proteostasis network removes the
accumulation of misfolded or cytotoxic aggregated proteins through either the ubiquitin
proteasome system (UPS) or autophagy. The UPS is a highly regulated proteolytic
system that controls intracellular protein degradation and turnover through a series of
concerted actions by enzymes that link ubiquitin to targeted proteins. The UPS degrades
90% of all cellular proteins (Shen et al., 2013). Aging and cellular stress responses can
disrupt proteostasis resulting in an increase of protein misfolding, aggregation, and
degradation (Kurtishi et al., 2019). To counteract these types of stresses, the cell utilizes
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key stress response pathways that are integral to proteostasis network: the heat shock
response (HSR), endoplasmic reticulum stress response (ERSR), integrated stress
response (ISR), and the unfolded protein response (UPR) which collectively determines if
cellular homeostasis is restored or apoptosis is initiated (Costa-Mattioli et al., 2020).
Importantly, proteostasis is critical for normal maintenance of the nervous system and its
dysregulation may contribute to several different neurodegenerative pathologies as
mentioned above (Lottes et al., 2020). Notably, it also represents a major pathway in
mediating secondary injury after SCI (Fig. 4.). Because it is a system that all cells utilize
globally, understanding the contribution of each component of the proteostasis network to
cell death is critical when designing a rational therapeutic strategy. Such strategies should
consider the potential deleterious consequences of proteostasis interventions on
inflammation as studies have shown that manipulation of the ISR can lead to enhanced
inflammasome activation which may potentially cause more damages (de Rivero Vaccari
et al., 2012; Ravindran et al., 2016). Neuroprotective strategies that target global
responses such as the proteostasis network after SCI will likely prevent and limit the
progression of secondary injury induced neural cell death on all cell types undergoing
these responses after SCI and therefore may reduce neurological impairment.
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Figure 3. Proteostasis Network and Stress Response Pathways.
The proteostasis network promotes the folding of newly synthesized proteins.
Chaperones are involved to help proteins fold into final conformational form. Misfolded
or protein aggregation is removed through the proteasome system or though autophagy
by proteolytic degradation. Disruptions in proteostasis network can lead to the activation
of stress response pathways that maintain homeostasis or initiate cell death (Figure from
Whittemore, Saraswat Ohri, Forston, Wei, Hetman, unpublished)
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Figure 4. Stress responses activated after SCI.
Cellular stress after SCI ER stress, nutrient deprivation, and oxidative stress all lead to
elevated phosphorylation of eIF2α through the PERK, PKR, GCN2, and HRI kinases,
respectively. Phosphorylation of eIF2α inhibits global translation of most mRNAs and
results in a decline of protein synthesis. The translation of the transcription factor ATF4
is increased. The HIF-PHDs can directly stimulate ATF4 activity independent of eIF2α
phosphorylation (Figure from Whittemore, Saraswat Ohri, Forston, Wei, Hetman,
unpublished).
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Heat shock response (HSR)
The HSR is triggered when cells are exposed to stresses such as oxidation, heavy
metals, ischemia, inflammation, infection, and sudden increases in temperatures that
interfere with protein homeostasis (Richter et al., 2010a). Cells respond rapidly through a
collective group of heat shock transcription factors that bind to promoter regions of
various heat shock genes that encode for the heat shock proteins (HSP), molecular
chaperones, and other effectors involved in the proteostasis network (Morimoto et al.,
1997). For instance, heat shock factor 1 (HSF1) is a well-known transcription factor
whose function is regulated by HSP90 and HSP70 (Craig, 1985). While it is known to
upregulate production of HSP molecular chaperone proteins that assist in folding,
refolding, or degrading misfolded proteins, HSF 1 has diverse mechanisms that can
modulate the ERSR, UPS, autophagy, cellular differentiation, survival, and apoptosis .
The endoplasmic reticulum stress response (ERSR)
The endoplasmic reticulum (ER) is key component of the proteostasis network
and performs a variety of different cellular functions that include the synthesis, folding,
and maturation of proteins before they form components of cellular membranes or are
excreted extracellularly. Additionally, the ER lumen serves as a storage site for cellular
calcium (Ashby et al., 2001). The ER can further be divided into the rough ER and
smooth ER. Proteins that are synthesized by ribosomes studded on the cytosolic surface
of the rough ER are modified and folded inside the ER lumen. The cytosolic surface of
the smooth ER is the site of cholesterol, lipids, and steroid synthesis. The protein folding
capacity of the ER is dependent on cell type and cellular function. When protein demand
exceeds folding capacity, unfolded or misfolded proteins that accumulate in the ER

22

lumen cause ER stress that triggers the ER stress response (ERSR) (Hetz, 2012).
Examples of pathophysiological process that can induce ER stress include ischemia,
reperfusion injury, and viral infections (Dara et al., 2011). The ERSR is comprised of
both a transcriptional and translational response that attempts to alleviate ER stress by
increasing folding capacity, inhibiting general protein translation, and degrading
misfolded proteins (Ron, 2002). The transcriptional upregulation of ER components and
chaperones proteins help facilitate protein folding and is described as the UPR (Schroder
et al., 2005). The UPR signaling pathways regulate and monitor protein folding capacity
within the ER to minimize improperly folded forms, and degrade cytotoxic misfolded
proteins (Ron, 2002). Unfolded or misfolded proteins that accumulate in the ER lumen
are detected by UPR sensors endoribonuclease inositol-requiring enzyme 1-α (IRE1α),
protein kinase RNA-like endoplasmic reticulum kinase (PERK) and activating
transcription factor 6 (ATF6α), and partly requires the assistance of ER chaperone protein
GRP78 (Safra et al., 2013). In the absence of ER stressed conditions, GRP78 binds to the
luminal domains of the three sensors and prevents their activation (Chen et al., 2013b).
When misfolded proteins begin to accumulate, GRP78 dissociates from the UPR sensors
and preferentially binds to regions within the misfolded proteins (Gardner et al., 2013).
This allows for IRE1α and PERK to dimerize and become active through
autophosphorylation. Following autophosphorylation, IRE1α undergoes a conformational
change that activates an RNase domain that excises a 26 nucleotide segment of X-Box
binding protein 1 (Xbp1) mRNA that shifts the reading frame (XBP1 splicing) and
generates the XBP1s transcription factor which activates genes involved in protein
folding and secretion (Lee et al., 2003). Although initially, IRE1 promotes restoration of
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homeostasis, in the presence of persistent ER stress IRE1 can directly activate the proapoptotic ASK1-JNK signaling cascade and shift from favoring homeostasis to the
induction of cell death (Brown et al., 2016). Finally, in the presence of ER stress, the
transcription factor ATF6α is cleaved by site-1 protease (S1P) and site-2 protease (S2),
exported from the ER and translocated to the nucleus to activate adaptive programs
including genes that help eliminate misfolded or unassembled proteins from the ER (Lee
et al., 2002). Activated PERK phosphorylates eukaryotic initiation factor 2 α (eIF2α)
which transiently inhibits global cellular synthesis of de novo proteins by transiently
pausing mRNA translation in an attempt to reduce extra protein load the ER needs to
process (Teske et al., 2011). Additionally, peIF2α increases translation of ATF4, which
enhances chaperone protein synthesis but also stimulates expression of the pro-death
transcription factor C/EBP Homologous Protein (CHOP) and growth-arrest DNA damage
gene 34 (GADD34) which contains a protein phosphatase 1 (PP1) and provides negative
feedback in PERK-eIF2α axis through GADD-mediated dephosphorylation of eIF2α
(Marciniak et al., 2004; Ohoka et al., 2005; Teske et al., 2011). The ultimate biological
aim of the ERSR is to restore proteostasis, but if chronic ER stress fails to resolve,
persistent activation of the ERSR results in cellular death through various mechanisms
some of which well-characterized, and others currently unknown (Johnson et al., 2011).
In Atf6-/- mice, there was no enhanced recovery after contusive SCI (Saraswat Ohri et al.,
2018b). Moreover, in Xbp1-NestinCre mice, there was worse locomotor recovery after a
T12 hemisection SCI (Valenzuela et al., 2012). Likewise, Plp‐creERT2+/+:Xbp1fl/fl mice
that have OL/OPC-specific deletion of Xbp1 also show a reduced locomotor recovery and
less spared white matter after contusive thoracic SCI (Ohri et al., 2020a). SCI injured
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mice treated with salubrinal, a pharmacological agent that disrupts GADD34 (R15A, ERstress induced) and CReP (R15B, a constitutive homolog of GADD34) interactions with
protein phosphatase 1c (PP1c) therefore prevents dephosphorylation of peIF2α, acutely
(0, 24, and 48 hours post-SCI) show increases in the level of peIF2α and decreases the
levels of ATF4, GADD34, and BiP protein in the injury epicenter (Ohri et al., 2013).
Transient with salubrinal treatment attenuates OL loss, enhances hindlimb locomotor
function, and white matter damage in the epicenter, yet global genetic deletion of
GADD34 using Ppp1r15a/Gadd34-/- mice shows no effects on behavioral recovery (Ohri
et al., 2014). Similarly, treatment with guanabenz, inhibitor of ER-stress induced
GADD34 (R15A) and not CreP (R15B), does not affect functional recovery after SCI
(Ohri et al., 2014). Salubrinal disrupts PP1c binding of either regulator (Choy et al.,
2015). This suggests temporally and/or substrate specific inhibition of pS51-eIF2α
dephosphorylation may be required to reduce SCI-associated white matter damage.
Integrated Stress Response (ISR)
The Integrated Stress Response (ISR) is a conserved translational and
transcriptional signaling program that is activated in response to a various stress stimuli
such as amino acid deprivation, hypoxia, glucose deprivation, oxidative damage, viral
infection, and ER stress (Fig. 5). The four independent stress sensing kinases (PERK,
PKR, HRI, GCN2) involved in ISR signaling all converge on phosphorylation of eIF2α
which, as detailed above, causes global attenuation protein synthesis, but allows for the
translation of specific genes that aid in cell survival and recovery such as ATF4 (PakosZebrucka et al., 2016). PERK is predominately activated by ER stress, but also by
hypoxia-ischemia, oxidative stress, and oxygen-glucose deprivation (Pakos-Zebrucka et
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al., 2016). When unfolded or misfolded proteins begin to accumulate in the ER lumen,
glucose-regulated protein (GRP78) dissociates from PERK resulting in
autophosphorylation and activation (Wang et al., 2009a). PKR is mainly activated in the
presence of double stranded RNA which usually indicates a viral infection, but can also
be activated by oxidative stress, ER stress, and bacterial infections (Pakos-Zebrucka et
al., 2016). In the presence of double stranded viral RNA, PRK dimerizes which results in
autophosphorylaton and activation of its kinase activity to phosphorylate eIF2α leading to
a shutdown of global protein synthesis in an attempt to inhibit viral protein synthesis
(Pakos-Zebrucka et al., 2016). The exact mechanism by which HRI is activated is not
well defined, although it seems to play a major role in regulating erythrocyte globin
protein levels in the presence of an iron deficiency (Chen, 2014). In the presence of
heme, a component needed for the production of hemoglobin, HRI kinase activity is
inhibited, but when heme is absent, HRI forms a dimer and becomes active (Zhang et al.,
2019). Other stress stimuli including oxidative stress, osmotic stress, heat shock,
cytosolic protein aggregates during inflammasome formation, and proteasome inhibition
also activate HRI (Zhang et al., 2019). Finally, the GCN2 kinase is activated in response
to amino acid starvation, glucose deprivation, and UV irradiation (Pakos-Zebrucka et al.,
2016). Although these kinases are activated by distinct pathophysiological stimuli, they
can all be activated by oxidative stress. Furthermore, the various signals from each
response can differentially summate and converge on key signaling molecules or
pathways allowing for a fine tuned control on cellular response to stresses. In general, the
ISR is considered to be a pro-survival response, however if stresses are prolonged or
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severe enough to devastate the adaptive capacity of the ISR response, ISR may trigger
cell death (Pakos-Zebrucka et al., 2016).
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Figure 5. The Integrated Stress Response.
The PKR, PERK, GCN2 and HRI kinases react to various forms of stresses and increase
peIF2α. This leads to the inhibition of GEF activity of eIF2B and therefore, mRNA
translation initiation. Although there is inhibition on global mRNA translation, the
increased levels of peIF2α facilitate the translation of select mRNAs containing that
contain uORFs in their 5′UTR, such as mRNA for Atf4 that plays a key role in
determining cell fate. peIF2α is negatively regulated by the CreP/PP1 phosphatase and
GADD34/PP1 phosphatase complexes. (modified from Pakos-Zebrucka et al., 2016)
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Activating transcription factor 4 (ATF4)
The ISR and ERSR contain overlapping signaling pathways that converge to
transiently phosphorylate eIF2α and upregulate expression of ATF4. ATF4 modulates
several signaling pathways including oxidative stress, inflammation, autophagy, and
translation. The outcome on cellular fate can be either pro-survival or pro-death,
dependent on the severity of stress, the duration of eIF2a phosphorylation, and translation
of ATF4 (Han et al., 2013; Pihan et al., 2017). ATF4 is a transcription factor that belongs
to the cAMP response element-binding protein (CREB)-2 family of proteins. It regulates
gene transcriptional programs that are influenced upon interactions with its various
partners and is tightly regulated at the transcriptional, translational, and post-translational
level as it plays a major role determining cell fate in response to stress (Blais et al., 2004).
In response to stress, cells inhibit protein synthesis by phosphorylating eIF2α (Harding et
al., 2003). However, despite the transient pause of protein synthesis there is an increase in
protein levels of ATF4 that is modulated by translational control (Vattem et al., 2004).
Atf4 mRNA contains two upstream open reading frames (uORF) (Vattem et al., 2004).
uORF1 is a positive-acting element, while uORF2 is an inhibitory element that blocks
ATF4 expression (Vattem et al., 2004). Under homeostatic conditions, uORF1 facilitates
ribosomal scanning and re-initiates at uORF2 that is out-of-frame and overlaps with the
coding sequence of ATF4 (Vattem et al., 2004). Thus, ATF4 is not synthesized.
However, when eIF2α is phosphorylated under conditions of stress, the accompanied
reduction in levels of eIF2-GTP prolongs the duration required for scanning ribosomes to
reinitiate translation, and allows ribosomes to scan past uORF2 (Vattem et al., 2004).
This allows re-initiation at the ATF4 coding region and the synthesis of ATF4 under
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conditions of stress. ATF4 protein stability and activity can further be regulated as it
contains multiple sites for post-translational modification that includes ubiquitination,
phosphorylation, hydroxylation, SUMOylation, and acetylation (Wortel et al., 2017). For
instance, HIF-PHDs hydroxylate proline residues located in the ATF4 protein sequence
and regulate its activity (Koditz et al., 2007). ATF4 plays several important roles in
regulating neural plasticity, mitochondrial stress, basal metabolic processes such as
glucose homeostasis and energy expenditure, and is a key transcription factor during
activation of stress responses (Vattem et al., 2004). In response to stress, ATF4 facilitates
transcriptional upregulation of gene programs that are involved in the restoration of
cellular homeostasis including components of anti-oxidant defense systems, nutrient
uptake, and amino acid synthesis and translation (Vattem et al., 2004). Additionally,
ATF4 can regulate mitochondrial stress by activating cytoprotective genes that reprogram
cellular metabolism via the ISR that results in the attenuation of mitochondrial function,
mitochondrial ribosomal proteins, and inhibition of mitochondrial translation (Quiros et
al., 2017). In global Atf4-/- mice that received a lateral hemisection SCI, there was worse
functional recovery (Valenzuela et al., 2012). This may be attributed to dependence of the
hemisection lesion on plasticity for recovery, and suggests ATF4’s role as a positive
regulator of neural plasticity (Chen et al., 2003; Corona et al., 2018).
C/EBP homologous protein (CHOP)
ATF4 induces additional transcription factors like CHOP/DDIT3 which can
induce apoptosis (Rozpedek et al., 2016). While ATF4 itself can promote cellular death
by activating pro-apoptotic BCL-2 family member PMAIP1B, one of the best
characterized mechanisms of ATF4-induced cell death is through activation of CHOP
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(Galehdar et al., 2010). CHOP is a 29 kD protein that belongs to the family of
CCAAT/enhancer binding proteins (C/EBPs) and is involved in the regulation of genes
that control proliferation, differentiation, and metabolism (Yoneshima et al., 2016). It is
comprised an N-terminal transcriptional activation domain and a C-terminal basic-leucine
zipper (bZIP) domain. In ER stress, CHOP can function both as a transcriptional
repressor and activator. It selectively enhances expression BAK and BAX, pro-apoptotic
members of BCL2, which can result in the release of apoptotic molecules like
cytochrome c (Cyt-C) and AIF (Hu et al., 2018; McCullough et al., 2001). Deletion of the
bZIP domain demonstrates a critical role in CHOP-induced apoptosis (Ubeda et al.,
1999). However, CHOP-deficient cells are only partially resistant to ER stress-induced
cell death (Song et al., 2008). Moreover, CHOP overexpression alone is insufficient to
induce cell death (Oyadomari et al., 2004; Song et al., 2008; Southwood et al., 2016). In
the moderate mid-thoracic contusive SCI model, global Chop-/- mice exhibited decreases
in acute expression levels of ERSR effector mRNAs (Xbp1, Atf4, Gadd34, and BiP) in
the injury epicenter (Ohri et al., 2011). More importantly, at 6 week post-SCI, CHOP
deletion attenuates OL apoptosis and leads to an improvement in hind limb locomotor
accompanied by an increase of white matter sparing (WMS) at the epicenter (Ohri et al.,
2011). Likewise, treatment with valproic acid, an ER stress and pan HDAC inhibitor,
reduces CHOP induction, OL, and myelin loss in the injury epicenter after SCI resulting
in greater functional recovery (Penas et al., 2011). However, in a severe thoracic
contusive SCI model, the same global Chop-/- mice did not have any enhanced functional
recovery, suggesting that additional unidentified mediators of secondary tissue damage
maybe involved in such injury or that the secondary injury cascade contributions after
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severe injury are diminutive (Ohri et al., 2012). CHOP mediated cell-death is thought to
occur through several mechanisms. For instance, CHOP expression of pro-death genes
including BH3-only members of the BCL-2 family members, BCL2L11, and BBC3, and
DR5 contributes to cell death under ER stress conditions (Li et al., 2014). CHOP can also
cooperate and form interactions with other transcription factors including ATF4 to further
stimulate the preferential expression of ATF3, GADD34, Trib3, and ER-associated
protein synthesis that can lead to additional oxidative stress and mitochondrial damage
(Ohoka et al., 2005). CHOP and ATF4 together can regulate expression of 218 genes,
while ATF4 alone regulates expression of 254 genes (Pitale et al., 2017). TRB3, an
intracellular pseudokinase, is upregulated by ATF4-CHOP when cells are under hypoxia
and ER stress conditions (Rozpedek et al., 2016). TRB3 expression inhibits the antiapoptotic activity of AKT, and increases activation of caspase-3 (Eyers et al., 2017).
Expression of CHOP increases ERO1α, an ER reductase that catalyzes the oxidation of
protein disulfide isomerase (PDI), causes a highly oxidized environment within the ER
resulting in the production of ROS (Muller et al., 2013). The production of ROS within
the ER activates a cascade of events serves as positive feedback and further increases
CHOP transcription which ultimately results in cell death (Muller et al., 2013; Rozpedek
et al., 2016). Finally, ATF4/CHOP-mediated increase in protein synthesis leads to
excessive generation of reactive oxygen species (ROS) in the ER that can damage
mitochondria and lead to mitochondrial permeabilization induced cell death (Rozpedek et
al., 2016).
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Hypoxia-inducible factor prolyl hydroxylases (HIF-PHDs)
The HIF-PHD proteins are iron-dependent dioxygenases and exist in three
isoforms: PHD1 (EGLN1), PHD2 (EGLN2), and PHD3 (EGLN3). They are a class of
metalloenzymes oxygen sensors that hydroxylate proline residues of the hypoxiainducible factor 1α (HIF-1α) to stimulate its proteasomal degradation under normoxic
conditions (Ratcliffe et al., 1998; Semenza, 2001). Under hypoxic conditions, PHDs are
inactive so that HIF-1α accumulates and activates adaptive genes that protect against
hypoxia (Semenza, 2001, 2007). Furthermore, they are transcriptionally upregulated by
HIF-1 and are required for feedback inhibition during persistent hypoxia (Ratcliffe et al.,
1998; Semenza, 2001, 2007). The PHDs may also function as a sensor in cellular
metabolism of iron (Nandal et al., 2011). Because proline hydroxylation requires the
decarboxylation of 2-oxoglutarate, PHDs are inhibited by high concentrations of Krebs
cycle intermediates (Ratcliffe et al., 1998; Semenza, 2001, 2007, 2012). The poly (rC)
binding protein 1 (PCBP1) functions as an iron chaperone by transferring iron from
ferritin and delivering it to the PHDs (Nandal et al., 2011). Under conditions of iron
deficiency, loss of PCBP1 leads to diminished hydroxylation of HIF1 and
downregulation of HIF target genes (Nandal et al., 2011). However, under conditions of
iron deficiency followed by incubation of PCBP1 loaded with iron, PHD activity was
restored, suggesting that PCBP1 is able to mediate changes in iron levels into PHD
activity (Nandal et al., 2011). Therefore in conditions of iron overload, free iron is
scavenged by PCBP1 complexes where it then loads the PHDs thereby increasing its
hydroxylation activity (Nandal et al., 2011). Although PHDs are best characterized for
their ability to hydroxylate HIF-1α (Fong et al., 2008), they have also been shown to
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target other proteins such as nuclear factor kappa-light-chain-enhancer of activated B
cells (NF-κB) (D'Ignazio et al., 2016), mitogen-activated protein kinase 6 (MAPK6)
(Strowitzki et al., 2019), nuclear factor kappa-light-chain-enhancer of activated B cells
p100 (NF-κB2/p52) (D'Ignazio et al., 2016), and ATF4 (Cummins et al., 2006). Recent
studies have shown that some HIF-PHD isoforms can hydroxylate ATF4 directly on
prolines (P156, P162, P164, P167, and P174) (Karuppagounder et al., 2016). In neurons,
proline-to-alanine mutations in ATF4 prevent proline hydroxylation and reduce ATF4dependent cell death (Karuppagounder et al., 2016). Pharmacological PHD inhibition
using adaptaquin (AQ) or genetic deletion of the Egln1-3 genes protect neurons from
oxidative death due to blood lysis-derived free iron and improves functional outcome
after experimental intracerebral hemorrhage (ICH) (Karuppagounder et al., 2016).
Moreover, in models of Parkinson's disease, PHD inhibition by AQ directly suppressed
Atf4 and/or Chop mRNA as well as the induction of pro-death Trib3 mRNA (Aime et al.,
2020). Those beneficial effects appear to be mediated by attenuation of the ATF4-driven
cytotoxic gene expression program that is activated in neurons under oxidative stress
(Aime et al., 2020; Karuppagounder et al., 2016). One possible explanation is that
inhibition of proline hydroxylation functions to reduce ATF4 transcriptional activity, and
prevents ATF4 from being recruited to the promoters of pro-death genes such as Trib3 or
Chop in response to oxidative stress (Aime et al., 2020; Karuppagounder et al., 2016).
Furthermore, the extent of protection of neurons by AQ in individual mice correlated
strongly with the improvement of motor function (Karuppagounder et al., 2016).
Importantly, these studies demonstrate that ATF4 activity can be upregulated by the
PHDs independent of the mediators involved in the proteostasis network after ICH and
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represents a potential target for neuroprotection. However, PHD inhibitors have not been
evaluated for their therapeutic potential in protecting white matter against acute injuries
such as thoracic contusive SCI where the ATF4 target gene Chop also plays a major
pathogenic role. Furthermore, the role of PHDs in ATF4-CHOP activation after SCI is
unknown.
OL-specific translatomic gene expression after SCI
Recent studies demonstrate the involvement of the ERSR in OLs after SCI
(Matsuyama et al., 2014; Ohri et al., 2013; Ohri et al., 2011; Saraswat Ohri et al., 2021;
Valenzuela et al., 2012). The ERSR employs extensive translational regulation and
several of its effector mechanisms are controlled by master transcription factors (TFs)
including ATF4, CHOP, XBP1, ATF6 and HSF (Han et al., 2013). Manipulation of the
ERSR-associated translational regulation as well as the ERSR-regulated transcription
factor CHOP affects both white matter loss and locomotor outcome of SCI (Ohri et al.,
2011). Taken together, although it is likely that there are unidentified transcriptional and
translational programs that regulate OL responses, little is known about the OL gene
expression in the setting of SCI.
Previous transcriptomic studies using homogenized fragments of whole spinal
cord provide unprecedented and unbiased systematic knowledge about global
transcriptional responses after SCI (Chen et al., 2013a; Li et al., 2019b). However, the
various cellular compositions of the spinal cord that undergoes pathological insult after
SCI limit cell-specific interpretation of such gene expression data and confound
mechanistic insight on OL-specific injury responses. Furthermore, there is no
consideration for the extensive post-transcriptional regulation of gene expression that is
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employed in cells that are under stress. For instance, SCI induces altered expression of
thousands of mRNAs in the contused spinal cord, but a much smaller number of proteins
were affected (Chen et al., 2013a; Li et al., 2019b; Squair et al., 2018). Therefore, an
unbiased transcriptome-wide approach of OLs in the setting of SCI may provide direct
insight of key unknown mechanisms and drivers of OL injury responses that can be
targeted to reduce white matter damage and/or facilitate its repair. As detailed further
below, the RiboTag methodology can be utilized to immunoprecipitate and capture cellspecific hemagglutinin (HA)-tagged ribosome-associated mRNA complexes in tissues
consisting of different cell types.
Mechanisms of translational regulation
The ribosome serves as the site of translation and produces proteins that are
needed for cell function and survival (Genuth et al., 2018). Gene expression of a cell is
regulated at the epigenetic, transcriptional, translational, and post-translational levels
(Genuth et al., 2018). Although transcriptional mechanisms can control gene expression
through master regulars such as transcription factors and alternative splicing, the
processes are complex and slow. Translation control is a rapid and highly dynamic
process that can be regulated by cell responses to stress (Hershey et al., 2012). For
instance, under conditions of nutrient deficiency such as a lack of amino acid or glucose
availability, the cell’s primary response is to regulate overall protein synthesis which
through a series of cascading reactions, can reduce ATP use nearly 50% and conserve
energy for other critical tasks (Rolfe et al., 1997). However, certain genes during
increased cellular stress can resist translational inhibition through different mechanisms
such as decreased reliance on ribosomal initiating proteins and upstream open reading
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frames (Holcik et al., 2000; Richter et al., 2010b; Spriggs et al., 2010). Translation plays
a critical role in responding to exogenous and endogenous stressors by selectively
enhancing and targeting the production of proteins that exert protective functions. The
structural composition of genes influences how the mechanisms of translational control
are accomplished (Hershey et al., 2012). During translation, ribosomal initiation is
considered to be the rate-limiting step of protein synthesis, which means that in
m7G(5')ppp(5')A cap-dependent ribosomal translation initiation, the critical step of 5’ cap
recognition of the ribosome with the help of initiation factors is a target for translation
regulation (Hershey et al., 2012). Translational regulation of initiation involves the
phosphorylation of subunits in initiation factors that induce changes in conformation that
affect its ability to recognize mRNA (Hershey et al., 2012). For instance, cap-mediated
inhibition can be mediated through phosphorylation of the initiation factor eIF4F
complex (eIF4E, eIF4A, RNA helicase, eIF4G) (Hershey et al., 2012). Under normal
conditions, 4EBPs are phosphorylated and lowers affinity to bind to eIF4E, but under
stress, 4EBPs become dephosphorylated and bind eIF4E, which reduces the complex’s
ability to bind to the mRNA and diminishes cap-dependent translation initiation.(Carroll
et al., 2006). Stress-induced phosphorylation of the eIF2α decreases GDP-GTP exchange
and alters formation of the initiation complex, thereby transiently pausing translation
(Clemens, 2004). Translational elongation can also be inhibited and controlled through
phosphorylation of eukaryotic elongation factor 2 (eEF2) (Hershey et al., 2012). It is
targeted by multiple growth-related regulatory pathways triggered by stressors like
hypoxia and starvation.
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mRNA concentrations and protein abundance correlate significantly, however the
variation in mRNA expression only accounts for ∼25-30% of the variation in protein
abundance for human Daoy medulloblastoma cell line (Vogel et al., 2010). Similarly,
another study shows gene-to-gene changes in protein synthesis rates contributes to ~55%
of final protein levels, whiles mRNA abundance contributes ~40% (Schwanhausser et al.,
2011). Additionally, only a fraction of total mRNAs produced in a cell are actively being
translated. This is especially true when the proteostasis stress responses are activated,
such that specific genes that launch adaptive responses are selectively and preferentially
translated. Ribosome concentrations are in excess to mRNAs levels with a total of 2 x 105
ribosomes (von der Haar, 2008; Warner, 1999) and 6 x 104 mRNAs (Zenklusen et al.,
2008) estimated to be in a cell at any one time. Ribosome occupancy (mRNA engaged in
translation) among expressed genes ranges from 41% to 84% (Lackner et al., 2007;
Picard et al., 2012) suggesting that 20% to 60% (gene dependent) of total gene-specific
mRNA transcripts are freely diffusing and not bound to ribosomes. Using ribosome
profiling of the 2,300 total genes in the Lactococcus lactis genome, 1948 genes were
expressed at mRNA level, while ribosomes were associated to 1619 genes, demonstrating
that 83% of genes expressed have ribosomes bound (Picard et al., 2012). Furthermore,
during oxidative stress in Saccharomyces cerevisiae, only 15% of genes involved in the
translational response showed changes at the mRNA levels (Shenton et al., 2006). In cells
that require rapid induction for function such as cells of the immune system that produce
cytokines and chemokines to mediate the inflammatory response, transcriptional and
post-transcriptional controls are tightly regulated (Schott et al., 2014). In macrophages
(one of the first lines of defense against infections) stimulated with LPS
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(lipopolysaccharide), 34.4% of translationally up-regulated mRNAs accounted for 7.8%
of total mRNA pool (Schott et al., 2014). Additionally, this response is so potent that
genes that are transcriptionally upregulated >3,000 fold, can still be inhibited as
demonstrated by the lack of protein product detection (Schott et al., 2014). Furthermore,
after LPS stimulation, nearly 40% of genes exhibit a change in translation efficiency
using ribosome profiling combined with RNA-Seq (Ribo-Seq), suggesting that immune
cells like macrophages extensively use translational regulatory networks to shift from
homeostatic responses and synthesize proteins that are critical to launching the
inflammatory response in conditions of stress (Zhang et al., 2017).
The mTOR (mammalian target of rapamycin) pathway is a good example of a
translational regulatory network that enhances translation and involves two distinct
serine/threonine kinases: mTORC1 affects growth, proliferation, protein synthesis and
metabolism, while mTORC2 targets cellular survival (Carroll et al., 2006). mTORC1 can
directly modulate protein synthesis through interactions with eIF4G, eIF4E, eIF4A
helicase, and ribosomal s6 kinase (S6K1) (Holz et al., 2005). For instance, mTORC1 may
activate S6 kinase that phosphorylates PDCD4, an eIF4a binding protein, which triggers
its ubiquitination by E3 ubiquitin ligase and subsequent degradation, and therefore
increasing eIF4a activity. S6K1 can also regulate translation initiation by phosphorylating
the cap binding complex component eIF4B at S422 (Shahbazian et al., 2006). Finally,
S6K1 can phosphorylate translation initiation factor 4B (eIF4B) which recruits eIF4B to
eukaryotic initiation factor 4A (eIF4A) at the translation initiation complex to function as
a cofactor of eIF4A that ultimately enhances processivity. The MAPK-ERK pathway and
the RAS-RAF pathway can also target eIF4 through kinases MNK1 and MNK2
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(Shahbazian et al., 2006). MNK1/2 can phosphorylate Ser209 on eIF4E, and increase
translation of selective survival-related genes (Wendel et al., 2007).
The ISR serves as another pathway that can modulate translation through
phosphorylation of eIF2 and eIF2α and its network of kinases and phosphatases (PakosZebrucka et al., 2016). Nutrient deprivation, viral infection, iron deficiency, and ER
stress can cause GCN2, PKR, HRI and PERK to phosphorylate eIF2α and trigger an
adaptive response that preferentially translates ATF4, while decreasing relative global
translation (Pakos-Zebrucka et al., 2016). The dysregulation of these networks that
regulate translation is common to different pathologies involving oxidative stress,
ischemia, aberrant cellular proliferation, and protein expression in multiple cells types
(Costa-Mattioli et al., 2020). Therefore, the proteostasis network and its signaling
pathways represents potential global therapeutic target (Oakes, 2017). However, little is
known about the OL-specific post-transcriptional regulation of gene expression in the
spinal cord that occurs under SCI stress. While it is likely that both transcriptional and
translational reprogramming regulate critical components of the injury response in a cell
type-specific manner, previous studies of spinal cord transcriptomics or translatomics
only provide a global view of spinal cord tissue response to injury (Zhang et al., 2020).
Limitations in bulk RNAseq after spinal cord injury
RNA sequencing and microarrays are usually two high-throughput methods that
are utilized for identifying genome-wide mRNA transcripts (Kukurba et al., 2015). These
methods offer an unprecedented insight and information about changes in the
transcriptome and cellular processes. Microarrays can offer information about the relative
expression of thousands of defined genes that are detected by chosen probes fixed to an
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array matrix chip that bind and hybridize to complementary sequences in the mRNAs of
target genes (Kukurba et al., 2015). However, the hybridization-based detection has poor
sensitivity, low specificity, and a limited dynamic range. RNA-seq determines sequences
of all RNA fragments in a sample and is therefore is truly non-biased and highly
quantitative (Evans et al., 2018). This method is able to detect sequence variations
including single nucleotide polymorphisms (SNPs), alternative splicing, and non-coding
miRNAs. RNA-seq using next-generation sequencing (NGS) by Illumina allows for short
reads in parallel rather than individual fragments of DNA and uses the sequencing by
synthesis method (Evans et al., 2018). A full description of how RNAseq is performed
can be found in the Illumina handbook
(https://support.illumina.com/content/dam/illuminasupport/documents/documentation/chemistry_documentation/samplepreps_truseq/truseqstranded-total-rna-workflow/truseq-stranded-total-rna-workflow-reference1000000040499-00.pdf). Briefly, isolated RNA is first reverse transcribed to produce
cDNA, which is then fragmented using enzyme digestion or mechanical shearing.
Fragments of 200 base pairs in size are recommended (Wang et al., 2009b). After
fragmentation, a poly-A tail is ligated at the 3’ end, while a phosphate group is attached
at the 5’ end, which contributes to cDNA stability and facilitates ligation of adapters that
are used in sequencing. These adapters may contain short barcode sequences so that
several samples can be sequenced on the same flow cell. After adapter ligation, cDNA
libraries undergo an amplification process that uses the adapter sequences as primers in a
PCR reaction so that products with ligated adapters are enriched (Head et al., 2014). In
the sequencing by synthesis method, the adapters bind to complementary
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oligonucleotides that are fixed to the flow cell. Every fragment that is captured undergoes
a process called bridge amplification, while adapters at the unbound end of the fragments
bind to nearby oligonucleotides that are complementary (Head et al., 2014). A parallel
strand is synthesized and this process is repeated so that identical fragments clusters are
formed in a process known clonal amplification (Wang et al., 2009b). Reverse strands are
washed from the flow cell leaving behind the forward strands so that a primer can attach
to the adapter primer biding site. Polymerase adds a single fluorescently labeled dNTP to
the DNA strand. Since each of the four bases are labeled with a unique fluorescent label,
a detector then images the flow cell and can identify the dNTP that is incorporated by
wavelength of light emitted by the fluorophore, after laser excitation. The number of base
pairs sequenced from a DNA fragment determines the read length and is directly
correlated to the number of cycles, while the number of clusters determines the number
of reads. These metrics are then input into base-calling algorithms to determine the
accuracy of the read. NGS pipeline produces raw data in the form of millions of reads of
nucleotides 50-200 nucleotides in length along with an associated quality score (Wang et
al., 2009b). Low quality reads are then removed in a quality control step using FastQC so
that reads can better align to a selected genome in the next set. Genome alignment
accounts for introns that are removed during mature mRNA synthesis and can performed
using RNAseq aligners such as TopHat2 or STAR. Finally, the aligned reads can be
quantified using HTSeq or Cufflinks prior to downstream analysis of differentially
expressed genes between samples using DESeq2 or cuffdiff. Prior RNASeq studies that
evaluate differentially expressed genes after SCI utilized total tissue homogenates, and
therefore report global mRNA changes that occur (Chen et al., 2013a; Li et al., 2019b;
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Shi et al., 2017). However, in those experiments, genes identified were overrepresented
with functions that are involved with the inflammatory response after SCI (Chen et al.,
2013a; Li et al., 2019b; Shi et al., 2017). For instance, biological processes (BP)
associated with the immune response, neutrophil chemotaxis, innate immune response,
regulation of cell proliferation, and positive regulation of cell migration dominate the top
groups of GO (gene ontology) enrichments after SCI (Chen et al., 2013a; Li et al., 2019b;
Shi et al., 2017). These genes are likely due to the massive influx of immune system cells
after SCI, and can therefore obscure the detection of critical responses in various other
cell types that undergo significant cell death post injury.
RiboTag allows for OL-specific translatome profiling after SCI
There are several methods for studying the translatome (King et al., 2016).
Polysome profiling using sucrose density-gradient methods separated mRNAs that were
associated to polysomes from free RNA and ribosomal subunits by mass and density.
This fractionation method also separated out polysomes by the number of bound
ribosomes per mRNA and allowed for direct determination of translation efficiencies
(Panda et al., 2017). Recent techniques for polysome profiling include translating
ribosome affinity purification (TRAP) and RiboTag. Both are based on affinity
purification of genetically labeled ribosomes (Heiman et al., 2014; Sanz et al., 2019).
Tags are introduced to core ribosomal proteins such as EGFP to RPL10a, in TRAP or HA
to RPL22, in RiboTag. This allows for the effective selection of mRNAs undergoing
translation from a cellular homogenate (Heiman et al., 2008). Furthermore, by using celltype specific promoters, these methods can be utilized to drive expression of tagged
ribosomal proteins in specific cell populations of transgenic animals and avoid the
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possible contamination issues that plagued fractionation techniques caused by polysome
bound mRNA complexes that were also generated from spatially touching cells in
complex tissues (Haimon et al., 2018). These mRNA-associated tagged ribosome
complexes can then be immunoprecipitated using magnetic beads coated in antibodies
against the anti-EGFP or anti-HA antibodies so that mRNAs can be selectively isolated
and coupled together with RNA-Seq. Comparison of purified immuno-precipitated
mRNA (IP) to input RNA (IN), which is comprised of both bound and unbound mRNAs
enables measuring of ribosome bound mRNA enrichment and can identify cell specific
translational gene expression (Ramanathan et al., 2019). Indeed, such an approach was
utilized to study gene expression changes in OLs during remyelination that revealed
cholesterol homeostasis a therapeutic target in a MS model (Itoh et al., 2018). Another
study using RiboTag labeled macrophages and showed that lipid catabolic pathways
could be therapeutically targeted after SCI (Zhu et al., 2017). However, there are
currently no studies that look at OL-specific responses in the setting of SCI. Therefore,
the RiboTag can be applied to study SCI-mediated gene expression in OPC/OLs (Fig. 6).
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Figure 6. Schematic of RiboTag SCI mouse model and experimental workflow.
An illustration that highlights RiboTag technology. A RiboTag mouse is crossed to a Cre
mouse under the control of the Plp1 promoter. Oligodendrocytes that express Cre
recombinase will delete WT exon 4 so that HA-tagged exon 4 is now expressed.
Translating mRNA ribosome complexes are extracted from the spinal cord homogenate
and immunoprecipitated using anti-HA antibodies and magnetic beads. After overnight
incubation, magnetic beads are washed with a high salt buffer; RNAs are then purified
and used in RNA-Seq analysis.
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CHAPTER 2
HYPOXIA-INDUCIBLE FACTOR PROLYL HYDROXYLASE DOMAIN (PHD)
INHIBITION AFTER CONTUSIVE SPINAL CORD INJURY DOES NOT IMPROVE
LOCOMOTOR RECOVERY

Introduction
The pathophysiology of spinal cord injury (SCI) consists of a primary injury
phase which occurs as the direct result of mechanical insult to the spinal cord and a
secondary injury phase that involves multiple pathophysiological mechanisms including
inflammation, vascular disruption, blood hemorrhage and ischemia. These mechanisms
further exacerbate the initial injury and lead to greater functional loss (Ahuja et al., 2017;
O'Shea et al., 2017). The proteostasis network includes all proteins with a role in protein
synthesis, folding, disaggregation, or degradation (Labbadia et al., 2015). Integral to
proteostasis are the heat shock response (HSR), the endoplasmic reticulum stress
response (ERSR), the integrated stress response (ISR), and the unfolded protein response
(UPR) pathways which further attempt to restore cellular homeostasis and if unsuccessful
initiate apoptosis and cell death. We and others have shown that the ERSR is activated
acutely after SCI (Ohri et al., 2013; Ohri et al., 2020b; Ohri et al., 2012; Ohri et al., 2011;
Penas et al., 2007; Valenzuela et al., 2012). The ERSR initially promotes cell survival by
reducing global protein synthesis and upregulating chaperones that assist in protein
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folding. However, excessive or sustained ER stress that cannot be resolved initiates
cellular death and contributes to the secondary injury cascade (Lin et al., 2008; Ohri et
al., 2011; Ohri et al., 2014; Penas et al., 2007). Interventions that target or alleviate the
ERSR after SCI reduce oligodendrocyte (OL) death, protect white matter, and improve
locomotor recovery (Myers et al., 2019; Ohri et al., 2013; Ohri et al., 2012; Ohri et al.,
2011; Valenzuela et al., 2012).
The ERSR drives expression of activating transcription factor 4 (ATF4) and its
target and partner CCAAT-enhancer-binding protein homologous protein
(CHOP/DDIT3). Upon activation of the ERSR, these transcription factors (TFs) drive a
gene expression program that supports amino acid and protein synthesis in an attempt to
restore ER homeostasis. However, if ER stress is unresolved, ATF4/CHOP-mediated
gene expression becomes cytotoxic by causing ER protein overload, ER-induced
oxidative stress, mitochondrial damage, and ultimately apoptosis (Han et al., 2013).
The HIF prolyl hydroxylase domain proteins PHD1/EGLN1, PHD2/EGLN2, and
PHD3/EGLN3, encoded by the Egln1, Egln2, and Egln3 genes, are a class of
metalloenzymes oxygen sensors that, under normoxic conditions, hydroxylate proline
residues of hypoxia-inducible factor 1α (HIF-1α) to stimulate its proteasomal degradation
(Fong et al., 2008). Under hypoxic conditions, PHDs are inactive so that HIF-1α
accumulates and activates adaptive genes that protect against hypoxia. However,
pharmacological PHD inhibition using adaptaquin (AQ) or genetic deletion of the Egln13 genes protect neurons from oxidative death due to blood lysis-derived free iron and
improves functional outcome after experimental intracerebral hemorrhage (ICH)
(Karuppagounder et al., 2016). Those beneficial effects appear to be mediated by
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attenuation of the ATF4-driven cytotoxic gene expression program that is activated in
neurons under oxidative stress (Karuppagounder et al., 2016). PHD-mediated
hydroxylation of several ATF4 proline residues is a likely mechanism that promotes
cytotoxic activity of ATF4 (Karuppagounder et al., 2016).
Recent studies further demonstrate the protective role of pharmacological PHD
inhibition by reducing ATF4-CHOP-mediated neuronal death and protecting against
oxidative damage in models of neurodegeneration including Parkinson's and Alzheimer's
disease (Aime et al., 2020; Li et al., 2019a; Li et al., 2016; Neitemeier et al., 2016;
Niatsetskaya et al., 2010), where neuronal loss is paramount. However, PHD inhibitors
have not been evaluated for their therapeutic potential in protecting white matter against
acute injuries such as thoracic contusive SCI where the ATF4 target gene Chop plays a
major pathogenic role (Ohri et al., 2011). Furthermore, the role of PHDs in ATF4-CHOP
activation after SCI is unknown. The current study was undertaken to determine the
contributions of PHDs to ATF4-CHOP activation and white matter loss after SCI.
Materials and Methods
Animals
All animal procedures were approved by the University of Louisville Institutional
Animal Care and Use Committee and the Institutional Biosafety Committee, in
accordance with guidelines from the Public Health Service Policy on Humane Care and
Use of Laboratory Animals, Guide for the Care and Use of Laboratory Animals (Institute
of Laboratory Animal Resources, National Research Council, 1996), and strictly adhered
to NIH guidelines on use of experimental animals. AQ experiments were performed on
wild type (WT) 8-10 week-old C57BL/6 female mice (Envigo, Indianapolis, IN) fed a
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standard ad libitum chow and housed under 12h dark/light cycle. Females are
predominantly used in rodent SCI literature due to lower incidence of post-operative
complications and, therefore, have better survival as compared to males (Stewart et al.,
2020). Moreover, while sex-specific drug effects are possible, locomotor recovery in SCI
rodents is not significantly affected by sex (Fukutoku et al., 2020; Luchetti et al., 2010;
Walker et al., 2019). Therefore, AQ studies were performed in females to reduce the
animal number needed for adequately powered data. Plp-creERT2 (proteolipid protein)
(Plp-cre-B6.Cg-Tg (Plp1-Cre/ERT) 3Pop/J; catalog #5975) and Egln1/2/3fl/fl (Egln2tm2Fong
Egln1tm2Fong Egln3tm2Fong/J; Stock No: 028097) mice were acquired from The Jackson
Laboratory (Bar Harbor, ME). Those lines were crossed to generate experimental
subjects (Egln1/2/3fl/fl:Plp-CreERT2), which, due to limited availability of animals with the
desired genotype, included both males and females. Those mice were treated with
tamoxifen to induce Egln1/2/3 knockout primarily in CNS myelinating OLs (Doerflinger
et al., 2003; Fuss et al., 2001; Wight et al., 1993) (see the Drug treatments paragraph for
more details). Controls included male and female Egln1/2/3fl/fl:Plp-CreERT2 that were
treated with vehicle and WT mice that were treated with tamoxifen. Importantly, PLP is
expressed earlier than myelin basic protein (MBP) during development, beginning during
embryonic life and at early developmental stages of OPC differentiation (Mallon et al.,
2002; Wight et al., 1993), so in tamoxifen-induced Egln1/2/3fl/fl:Plp-CreERT2 mice, some
OPC recombination may be expected as well. Sex unbalanced groups emerged in studies
using Egln1/2/3fl/fl:Plp-CreERT2 mice due to limited availability of males of comparable
age and peri- and/or post-operative loss of animals (Table 1 for more details).
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Spinal cord injury
Prior to surgery, mice were anesthetized using an intraperitoneal injection of 0.4
mg/g body weight Avertin (2,2,2-tribromoethanol in 0.02 ml of 1.25% 2-methyl-2butanol in saline, Sigma-Aldrich, St. Louis, MO). The back of the mice was shaved and
disinfected using a 4% chlorohexidine solution. Lacri-Lube ophthalmic ointment
(Allergen, Madison, NJ) was used to prevent drying of the eyes. A dorsal laminectomy
was done at the T9 vertebrae and positioned under the Infinite Horizons (IH) Impactor as
previously described (Ohri et al., 2011; Scheff et al., 2003). A moderate contusion injury
(50 kdyn force/400–600 μm displacement) was delivered and mice were immediately
placed onto a temperature-controlled 37°C heating pad until sternal time. Mice were
administered buprenorphine twice daily for the following 2 days. Gentamycin (50 mg/kg;
Boehringer Ingelheim, Ridgefield, CT) was administered subcutaneously to reduce
infection. Controls included sham animals that received T9 laminectomy only. All
surgeries were performed without knowledge of a group assignment or genotype. For
each study, surgeries for all groups were performed on the same day or two consecutive
days with random sequence of animals from various groups/genotypes.
Drug treatments
Tamoxifen was dissolved in corn oil (Sigma, C8267) at 20 mg/mL and
administered intraperitoneally (1 mg/day) beginning 21 days prior to SCI and continuing
for 8 consecutive days as previously described (Ohri et al., 2018). Adaptaquin (AQ),
obtained from Dr. Rajiv Ratan and Dr. Saravanan Karuppagounder (Burke Neurological
Institute, Weill Medical College of Cornell University), was dissolved in a solution of
0.03% DMSO and olive oil. Fresh aliquots were prepared daily for treatment. AQ was
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administered by intraperitoneal injections (0.1 cc/injection 30 mg/kg) first, within 1 hour
after SCI, and then, daily for either 3 days (the experiment to collect tissues at 3 days post
injury; the last AQ injection administered 2h before euthanasia) or 7 days (the experiment
to determine effects of AQ on locomotor recovery) of treatment. The AQ dosing was
based on the previous ICH study which confirmed blood-brain barrier penetration and
anti-ATF4 activity in the brain (Karuppagounder et al., 2016). Proton nuclear magnetic
resonance spectroscopy (1H NMR) was used to confirm the molecular integrity of AQ
(Fig. 9).
Behavioral Assessment
Animals were habituated to human interaction and handling twice a day for 5
consecutive days, 1 week prior to SCI/Sham. Baseline Basso Mouse Scale (BMS)
locomotor scores were obtained prior to injury for every individual animal and weekly
following SCI for 6 weeks (Basso et al., 2006; Ohri et al., 2011). Raters were trained by
Dr. Basso and colleagues at the Ohio State University and were blinded to the animal
genotype and treatment groups. The order of animal analysis was random.
RNA extraction and analysis
Total RNA was extracted from spinal cord tissue at the injury epicenter (5 mm
segment spanning the injury site) using Trizol (Invitrogen) according to the
manufacturer’s guidelines. RNA was quantified by ultraviolet spectroscopy
(NanoDrop2000, Thermo Scientific, Waltham, MA). cDNA synthesis was performed
with random hexamers using 500 ng of total RNA using the Invitrogen SuperScript IV
VILO Master Mix I (Thermo Fisher) in a 20 μL reaction volume. All cDNAs were
diluted 10x with water before using as a template for quantitative real time RT-PCR
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(qPCR). qPCR was performed using ViiA 7 system (Applied Biosystems, Foster City,
CA). Briefly, diluted cDNAs were added to TaqMan universal PCR master mix or SYBR
Green master mix (Applied Biosystems) and run in triplicate. Primer sets are listed in
Table 2. For qPCR analysis of PHD family mRNAs, protocols and primers were used as
previously described (Takeda et al., 2006; Tojo et al., 2015). RNA levels were quantified
using the ΔΔCT method with Gapdh as a reference gene. Transcript levels were
normalized to their respective levels in sham or vehicle controls and expressed as foldchanges.
White matter sparing (WMS)
WMS was evaluated as described previously (Magnuson et al., 2005; Ohri et al.,
2011). Six weeks post-SCI, mice were anesthetized with avertin, followed by
thoracotomy and transcardial perfusion with ice-cold PBS and 4% paraformaldehyde
(PFA). Spinal cords were dissected and submerged in 4% PFA overnight at 4°C. They
were then transferred to 30% sucrose for at least 7 days at 4°C, blocked in Tissue
Freezing Media (Cat # 72592, Electron Microscopy Science, Hatfield, PA) and stored at 20°C. Spinal cords were serially cut (20 µm) in transverse sections spanning 5 mm rostral
and caudal to the injury epicenter, and were stained for myelin using iron eriochrome
cyanine (EC) with an alkali differentiator (Stefanovic et al., 2015). Images were captured
using a Nikon Eclipse Ti inverted microscope (Nikon Instruments Inc., Melville NY),
and white matter was traced using Nikon Elements software. The epicenter of each injury
was identified visually based on the section with the least amount of spared white matter.
Data were normalized to spared white matter in corresponding non-injured sections. All
imaging and analyses were performed blinded to ensure unbiased quantification.
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ODD-luciferase assay
The biological activity of AQ used in animal studies was confirmed on cultured
SH-SY5Y cells using the HIF-1α oxygen degradation domain (ODD)-luciferase reporter
assay (Fig. 10) as previously described (Karuppagounder et al., 2016; Smirnova et al.,
2010).
Statistical analysis
All qPCR or image analysis data (WMS) were analyzed using the non-parametric
Mann-Whitney test (u-test, single sided). Repeated-measures ANOVA (RM-ANOVA)
followed by Tukey post hoc tests were used for analyzing BMS locomotor recovery data.
A priori power calculations were performed for analysis of locomotor recovery. Power
analysis based on BBB/BMS variance in published rodent SCI studies with standard
deviations between 1.5-2.3 shows that the ability to detect a significant difference of 10%
in BMS with at least 90% power in a sample size of 8/group. Hence, all locomotor
recovery assessments were adequately powered. Data are reported as mean ± SD.
Statistical analyses were performed using SPSS, version 25 (IBM).
Results
At 3 days post-SCI, there were similar declines in neuron-specific enolase
(Nse/Eno2) mRNA and increases in astrocyte-specific mRNAs (Gfap, Glul) in vehicleand AQ-treated animals suggesting no effects of AQ on either cell type (Fig. 7a).
However, there were increased OL-specific transcripts (Olig2, Mbp), along with
decreased mRNAs of Atf4, Chop, and the ATF4/CHOP target gene Trib3 in AQ-treated
animals (Fig. 7b). Moreover, Map2 mRNA, which is expressed mainly in neurons, but
also detected in OLs (LoPresti et al., 1995), was increased. These results suggest reduced
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acute loss of OLs and attenuated activation of the ATF4-CHOP pathway. However, as
expression of the ER stress-associated ATF4/CHOP targets Gadd34/Ppp1r15a and
Slc7a11 was unaffected, the anti-ATF4 effects of AQ appear to be target gene-specific.
Finally, AQ treatment did not modify ERSR-associated induction of Grp78 and Xbp1
mRNAs suggesting no general attenuation of the ERSR.
To determine the effects of AQ treatment on chronic locomotor recovery, mice
received vehicle or 30 mg/kg AQ immediately after injury and then daily for 7 days.
Hindlimb function was evaluated using the BMS for 6 weeks post-SCI. Comparison of
BMS scores between vehicle- and AQ-treated mice revealed no significant differences
(Fig. 7c). Consistent with no AQ effects on locomotor recovery, a similar extent of white
matter sparing was detected in AQ- and vehicle-treated groups (Fig. 7d, e). These data
show that despite transient improvement in OL survival acutely after contusive SCI,
pharmacological inhibition of PHDs using AQ did not increase chronic white matter
sparing or locomotor recovery.
To determine if the genetic deletion of the PHDs in OLs affects outcome after
SCI, we used OL-specific Plp-creERT2+/+:Egln1/2/3fl/fl mice to conditionally remove all 3
PHD isoenzymes in OLs following treatment with tamoxifen. Fourteen days after the
completion of tamoxifen or vehicle treatment, we confirmed that tamoxifen treatment
resulted in lower Phd/Egln mRNA levels in uninjured spinal cords of PlpcreERT2+/+:Egln1/2/3fl/fl mice (Fig. 8a). Consistent downregulation of Phd/Egln transcripts
ranged from 23 to 25% of control values. These findings suggest that (i) gene deletion
efficiency was similar for each isoform and (ii) the deletion occurred in most PLPpositive, mature OLs as their estimated spinal cord content is 20-25% (Dawson et al.,
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2003; Sathyamurthy et al., 2018; Valerio-Gomes et al., 2018) and at least the maximally
expressed Phd2/Egln2 appears to be ubiquitously present in all spinal cord cells (Lein et
al., 2007). In addition, Phd/Egln mRNAs were downregulated by 25-32% in the OL-rich
tissue of the optic nerve (Fig. 8a), but not the OL-lacking liver of tamoxifen-treated PlpcreERT2+/+:Egln1/2/3fl/fl mice (Fig. 11). The OL-specific loss of Phd/Egln genes was
biologically relevant as the established HIF target genes Vegf and Epo were upregulated,
including 27% increase of Vegf or 37-39% increases of Vegf and Epo transcripts in the
spinal cord or the optic nerve, respectively. Such upregulation is expected as a result of
reduced negative regulation of HIF due to PHD deficiency (Karuppagounder et al., 2016;
Ramakrishnan et al., 2014). The lesser response in the spinal cord than the optic nerve is
likely caused by high basal level spinal neuron expression of Epo and Vegf mRNAs (Lein
et al., 2007) which can potentially dilute the OL induction of those genes after Phd/Egln
deletion. Thus, our data suggest OL-specific knockout of PHD1/2/3 isoforms.
At 72 h after SCI, tamoxifen- and vehicle-treated Plp-creERT2+/+:Egln1/2/3fl/fl mice
had similar neural cell mRNA levels, suggesting unaffected acute loss of neurons and
OLs (Fig. 8b). No effects on the expression of Atf4, Chop, Gadd34 or Grp78 mRNAs
were observed (Fig. 8c). Moreover, comparison of 6-week BMS scores for tamoxifenand vehicle-treated Plp-creERT2+/+:Egln1/2/3fl/fl mice revealed no significant differences in
locomotor recovery (Fig. 8d). Likewise, no differences in chronic hindlimb locomotor
recovery were observed when tamoxifen-induced OL-PHD knockouts were compared to
WT mice that received identical tamoxifen treatment (Fig. 8d). Therefore, OL-selective
deletion of HIF-PHD does not affect SCI-associated acute OL loss, ATF4-CHOP
signaling or chronic locomotor recovery.
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Discussion
Adaptaquin (AQ), a hydroxyquinoline-based inhibitor of PHDs, abrogates ATF4CHOP-dependent neuronal death and improves functional outcomes in mouse models of
ICH and Parkinson’s disease (Aime et al., 2020; Karuppagounder et al., 2016). While
these studies implicate PHDs in ATF4-CHOP-mediated neuronal death, their
involvement in OL death and white matter damage after SCI remains unknown. Acutely
after SCI, the pro-apoptotic, ERSR-activated transcription factors ATF4 and CHOP are
upregulated in neurons and OLs (Ohri et al., 2013; Ohri et al., 2012; Ohri et al., 2011;
Penas et al., 2007; Valenzuela et al., 2012). Our previous study showed improved
behavioral outcome after thoracic contusive SCI in Chop-/- mice that was associated with
increased WMS and attenuated acute loss of OLs (Ohri et al., 2011). Likewise,
pharmacological interventions targeting proteostasis attenuated SCI-associated activation
of ATF4-CHOP while improving functional recovery and WMS (Ohri et al., 2013).
Therefore, we hypothesized that pharmacological and/or genetic suppression of ATF4CHOP signaling after thoracic contusive SCI would similarly restore proteostasis and
prevent chronic OL loss, leading to increased spared white matter and improved
functional outcomes. However, AQ-mediated attenuation of acute OL loss and ATF4CHOP signaling did not improve chronic locomotor recovery or WMS. Importantly,
although AQ reduced Atf4, Chop, and Trib3 mRNA levels, there was no effect on three
other ERSR transcripts, Gadd34, Grp78, and Xbp1 (Fig. 7b). In previous studies, where
increased acute OL/OPC mRNA levels were accompanied by increases in chronic
locomotor recovery, there was reduced activation of not only Atf4 and Chop, but also
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other ERSR transcripts (Myers et al., 2019; Ohri et al., 2018; Ohri et al., 2013; Ohri et al.,
2011; Saraswat Ohri et al., 2020). It is likely that AQ inhibits ATF4-CHOP signaling that
is distinct from their involvement in the ERSR and therefore limits the effects of AQ’s
effects on SCI outcome. Indeed, in the ICH model, AQ was proposed to inhibit the
ATF4-mediated iron-dependent ferroptosis, but not the cytotoxic ER stress
(Karuppagounder et al., 2016; Ratan, 2020). Hence, our AQ studies suggest that although
PHDs contribute to ATF4-CHOP signaling in the contused spinal cord, the cytotoxic
ERSR is the dominant signaling pathway that drives chronic white matter damage and
functional deficits (Ohri et al., 2020b; Ohri et al., 2011). This interpretation is further
supported by results from SCI mice with OL/OPC-specific PHD deletion (Fig. 8). OLs
are uniquely sensitive to injury-induced ERSR because of their high protein translation
requirements (D'Antonio et al., 2009; Lin et al., 2009; Ohri et al., 2011; Pennuto et al.,
2008; Southwood et al., 2002). However, no effects on thoracic contusive SCI-associated
increases of ATF4 and CHOP signaling were observed in the OL-specific Phd/Egln1,2,3-/mice. Likewise, acute OL loss and locomotor recovery were unaffected.
These observations are in contrast to those from various CNS injury models with
primary effects on the grey matter (Aime et al., 2020; Li et al., 2019a; Li et al., 2016;
Neitemeier et al., 2016; Niatsetskaya et al., 2010). Those data suggest that PHD
inhibition might improve functional outcomes in lumbar or cervical models of SCI,
where neuronal death is paramount to loss of function (Hadi et al., 2000; Magnuson et al.,
1999; Nishida et al., 2015). The differences in the effects of AQ on ICH and thoracic
contusive SCI highlight the complexities of the proteostasis network (Labbadia et al.,
2015). Following CNS trauma, multiple proteostasis signaling pathways are differentially
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activated by distinct pathophysiological stimuli. Depending on the extent and duration of
those stimuli, the various pro-homeostatic and pro-apoptotic signals differentially
summate. Moreover, there are both overlapping and diverse aspects of the respective
arms of proteostasis signaling (Adamson et al., 2016; Lee et al., 2003; Pakos-Zebrucka et
al., 2016; Shoulders et al., 2013). Unfortunately, there is currently no consensus on how
best to globally target proteostasis effectors for treating CNS trauma. While it is likely to
be therapeutically beneficial, it will have to be empirically determined for each type of
injury.
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Figure 7. After SCI, AQ attenuates the acute loss of OL lineage mRNAs, moderately
reduces acute ATF4 and CHOP activation, but does not improve chronic functional
locomotor recovery. (a) neural cell-specific and (b) ISR/ERSR and ATF4-regulated
gene mRNA levels 72 hours-post SCI. Transcript levels (normalized to Gapdh) are
expressed as fold change sham controls. Data in (a, b) are the mean ± SD (n = 8, *p<0.05;
**p<0.01; ns, p>0.05, u-test). (c) BMS analysis of hindlimb locomotion revealed no
significant differences in hindlimb locomotor recovery between vehicle (Veh)- (n=6) and
AQ-treated 30 mg/kg (n=7) mice (repeated measure two-way ANOVA showed
significant effects of time after injury /F5,21 = 12.34; p<0.001/ but no significant effects of
treatment /F1,59 = 0.03; p>0.05/ or the interaction between time after injury and treatment
/F5,21= 0.97, p>0.05/; see Table 3 for raw BMS data). (d) Representative images of the
injury epicenter stained with EC to identify myelin (6 weeks post-SCI) (e) Quantitative
analysis of EC-stained sections through the injury epicenter shows similar extent of
spared white matter. Data are the mean ± SD (n=4, p>0.05, u-test).
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Figure 8. Effects of HIF-PHDs deletion in OL lineage cells after SCI. (a) Tamoxifen
(Tam)-treated Plp-creERT2+/+:Egln1/2/3fl/fl mice (n=10, M:F=4:6) show reduced
Phd1/Egln1, Phd2/Egln2, and Phd3/Egln3 mRNAs in the spinal cord (controls received
vehicle /Veh/, n=9, M:F=4:5). Similarly, Tamoxifen (Tam)-treated PlpcreERT2+/+:Egln1/2/3fl/fl mice (n=4, M:F=2:2) show reduced Phd1/Egln1, Phd2/Egln2, and
Phd3/Egln3 in the optic nerve (controls received vehicle /Veh/, n=3, M:F=2:1).
Confirming biological relevance of the OL-specific PHD1/2/3 deficiency, established
HIF target genes including Vegf or Vegf and Epo were upregulated in OL-containing
spinal cord and optic nerve, respectively. (b) At 72 h after injury, SCI-associated declines
of neuronal- or OL mRNAs are unaffected by Tam-mediated OL-selective deletion of
PHD1/2/3. (c) Likewise, Tam-mediated knockout of OL-PHD1/2/3 did not attenuate
SCI-associated induction of ERSR transcripts including Atf4 and Chop. Transcript levels
(normalized to Gapdh) are expressed as fold changes of Veh control (a) or sham Plp60

creERT2+/+:Egln1/2/3fl/fl controls (b,c). Data (b,c) are the mean ± SD (n=4, M:F=2:2
*p<0.05; ns, p>0.05, u-test). (d) BMS analysis of hindlimb locomotion revealed no
significant differences in recovery between Veh- (n=8, M:F=2:6), Tam-treated PlpcreERT2+/+:Egln1/2/3fl/fl mice (n=12, M:F=5:7), and Tam-treated WT C57BL/6 mice
(n=10, M:F=4:6). When comparing Veh- and Tam-treated Plp-creERT2+/+:Egln1/2/3fl/fl
mice, repeated measure two-way ANOVA showed significant effects of time after injury
(F5,56, = 11.89, p<0.001), but no significant effects of Tam treatment (F2,95 = 2.6, p>0.05),
or the interaction between the time after injury and Tam treatment (F10,56= 0.99, p>0.05);
see Supplementary S3Table for raw BMS data.
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Figure 9. 1H NMR spectrum for the AQ batch used in the current SCI study.
1

H NMR (DMSO-d6 , 500 MHz) δ 9.84 (s, 1H), 8.84 (dd, 1H), 8.2-8.4 (m, 1H), 7.66 (d,

1H), 7.54 (dd, 1H), 7.3-7.5 (m, 6H), 6.8-6.9 (m, 2H), 6.4-6.5 (m, 2H) matches the spectra
of AQ as previously described (Thinnes et al., 2015). Data were recorded on a Varian
Unity Inova 500 MHz and chemical shifts are reported in ppm using the solvent as an
internal standard (DMSO-d6 at 2.5 ppm).
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Figure 10. Validation of biological activity for the AQ batch (AQ /KY/) used in the
current SCI study. SH-SY5Y ODD-Luc cells were treated with increasing
concentrations of AQ (0.1 µM-10 µM) for 3 h. ODD-luciferase activity was determined
by luminometry. AQ inhibits HIF prolyl hydroxylase activity and stabilize luciferase
fused to the oxygen degradation domain (ODD).
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Figure 11. Effects of OL-specific HIF-PHDs deletion in the OL-lacking liver tissue.
Tamoxifen (Tam)-treated Plp-creERT2+/+:Egln1/2/3fl/fl mice (n=4, M:F=2:2) show no
changes in Phd1/Egln1, Phd2/Egln2, Phd3/Egln3 , Epo, and Vegf mRNAs (controls
received vehicle /Veh/, n=3, M:F=2:1)

64

Table 1. Experimental design.
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Table 2. List of qPCR primers.

66

Table 3. Raw BMS score data for individual mice.
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CHAPTER 3
THE TRANSCRIPTOMIC LANDSCAPE OF OLIGODENDROCYTES RESPONSES
TO SCI – SIGNATURES OF CELL DEATH

Introduction
The pathogenesis of spinal cord injury (SCI) results in temporal components that
include primary and secondary injuries as well as post-injury remodeling and plasticity
(Norenberg et al., 2004; Rowland et al., 2008). In thoracic contusive SCI, functional
deficits are primarily driven by white matter (WM) damage (Magnuson et al., 2005;
Magnuson et al., 1999). Acute loss of axons and oligodendrocyte (OL) death are major
contributors to the injury-induced white matter damage (Pukos et al., 2019)and is likely
caused by a combination of cytotoxic events that contribute to the secondary injury
cascade. Increased levels of glutamate (Xu et al., 2004), proinflammatory cytokine
interleukin-1α (IL-1α), tumor necrosis factor-α (TNFα) (Donnelly et al., 2008), and
proNGF (Beattie et al., 2002b) after SCI have been reported to mediate OL death. Recent
studies demonstrate the involvement of the ERSR in OLs as a major cause of secondary
injury induced death after SCI (Myers et al., 2019; Ohri et al., 2013; Ohri et al., 2011;
Valenzuela et al., 2012).The ERSR employs extensive translational regulation and
transcriptional changes with several of its effector mechanisms controlled by master
transcription factors (TFs) such as ATF4, CHOP, XBP1, and ATF6 (Boyce et al., 2006).
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Manipulation of the ERSR-associated translational regulation through eIF2α and
the ERSR-regulated transcription factor CHOP decreases white matter loss and improves
locomotor outcome of SCI (Myers et al., 2019; Ohri et al., 2013; Ohri et al., 2011;
Valenzuela et al., 2012). Aside from these characterized mechanisms, very little is known
about transcriptional and translational events that regulate time-dependent OL responses
in SCI.
Previous transcriptomic studies using homogenized fragments of whole spinal
cord that contain heterogeneous cell populations limit cell-specific interpretation of gene
expression and confound mechanistic insight on OL-specific injury responses (Chen et
al., 2013a; Shi et al., 2017). Furthermore, post-transcriptional regulation of gene
expression by cells under stress is overlooked. RiboTag technology can overcome these
limitations and obtain cell-specific information from complex tissues (Sanz et al., 2009).
Notably, RiboTag showed that despite widely believed negative effects of astrocytic scar
on post-SCI regeneration/structural plasticity, astrocytes upregulate of many genes that
are conducive to axonal growth (Anderson et al., 2016). Another study that utilized
RiboTag identified CD36 as a regulator of macrophage lipid metabolism to drive a postSCI switch from inflammation to lipid catabolism (Zhu et al., 2017). Interestingly,
deleting CD36 was previously shown to increase locomotor recovery after SCI in the
context of alleviating ERSR, inflammation, and microvascular dysfunction (Myers et al.,
2014). Hence, RiboTag is a powerful method that can not only be used to obtain insight
to reveal novel functions or pathways, but also to integrate various mechanisms reported
from previous literature and build a more complete understanding of SCI pathogenesis.
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Here, we utilized RiboTag technology to obtain OL-specific mRNAs from
PlpCreER:Rpl22HA mice and compared translational gene expression changes at 2 (peak of
OL cell death, acute), 10 (delayed OL cell death/remyelination, subacute), and 42
(chronic phase) dpi to identify translatomic responses that may contribute to OL cell
death. Our data show that at 2 days dpi, OLs upregulate genes that may induce oxidative
stress (Chac1, Steap3), inhibit survival signaling kinases (Spred3, Spry4, Parvb), and
contribute directly to death (Runx1). Pro-survival genes upregulated included Sphk1,
Aldh18a1, Gdnf. These data represent the first study to use the RiboTag approach in
studying the OL-specific translational profile after SCI and defines cellular mechanisms
that are activated so that therapeutic strategies can be better target response after SCI.
Materials and Methods
Animals
All animal procedures were approved by the University of Louisville Institutional
Animal Care and Use Committee and the Institutional Biosafety Committee, in
accordance with guidelines from the Public Health Service Policy on Humane Care and
Use of Laboratory Animals, Guide for the Care and Use of Laboratory Animals (Institute
of Laboratory Animal Resources, National Research Council, 1996), and strictly adhered
to NIH guidelines on use of experimental animals. Plp-creERT2 (The Jackson Laboratory,
Plp-cre-B6.Cg-Tg (Plp1-Cre/ERT)3Pop/J; Stock No: 005975) and Rpl22(HA)fl/fl (The
Jackson Laboratory, B6J.129(Cg)-Rpl22tm1.1Psam/SjJ); Stock No: 029977) mice were
crossed to generate experimental subjects (Plp-CreERT2+/wt :Rpl22(HA)fl/wt). Those mice
were treated with tamoxifen to induce expression of Rpl22(HA) primarily in CNS
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myelinating OLs. Controls included female Plp-CreERT2+/wt :Rpl22(HA)fl/wt that were
treated with vehicle.
Spinal cord injury
Prior to surgery, 10 week old female mice Plp-CreERT2+/wt:Rpl22(HA)fl/wt were
anesthetized using an intraperitoneal injection of 0.4 mg/g body weight Avertin (2,2,2tribromoethanol in 0.02 ml of 1.25% 2-methyl-2-butanol in saline, Sigma-Aldrich, St.
Louis, MO). The back of the mice was shaved and disinfected using a 4% chlorohexidine
solution. Lacri-Lube ophthalmic ointment (Allergen, Madison, NJ) was used to prevent
drying of the eyes. A dorsal laminectomy was done at the T9 vertebrae and positioned
under the Infinite Horizons (IH) Impactor as previously described (Ohri et al., 2011;
Scheff et al., 2003). A moderate contusion injury (50 kdyn force/400–600 μm
displacement) was delivered and mice were immediately placed onto a temperaturecontrolled 37°C heating pad until sternal time. Mice were administered buprenorphine
twice daily for the following 2 days. Gentamycin (50 mg/kg; Boehringer Ingelheim,
Ridgefield, CT) was administered subcutaneously to reduce infection. Controls included
sham animals that received T9 laminectomy only. All surgeries were performed without
knowledge of group assignment or genotype.
Drug treatments
Tamoxifen was dissolved in corn oil (Sigma, C8267) at 20 mg/mL and
administered intraperitoneally (1 mg/day) beginning 35 days prior to SCI and continuing
for 8 consecutive days as previously described (Saraswat Ohri et al., 2018a).
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RNA Isolation and high throughput sequencing
The RiboTag protocol for immunoprecipitation of RNA was followed (Sanz et al.,
2019; Sanz et al., 2009). Briefly, frozen tissues from SCI and naïve animals (5 mm
spanning the SCI epicenter) at 2, 10, and 42 day post-SCI (2 animals were pooled
together to produce one biological replicate, n=3 per time point injured, n=1 per time
point naïve) were homogenized with a pre-chilled Dounce homogenizer in cold
homogenization buffer on ice [50 mM Tris (Sigma), pH 7.5, 100 mM KCl (Sigma), 12
mM MgCl2 (Sigma), 1% Nonidet P-40 (Sigma), 200 U/mL RNAsin (Promega, catalog
#N2115), 1 mM DTT (Sigma-Aldrich), proteinase inhibitors (Roche), 1 mg/mL heparin
(Sigma-Aldrich), 0.1 mg/mL cyclohexamide (Sigma-Aldrich)]. Sample homogenates
were then centrifuged at 10,000xg for 10 minutes at 4 °C. Monoclonal mouse anti-HA
antibody (HA.11 Clone 16B12, Biolegend) was added to the supernatant (1000 ml), and
the mixture was incubated for 4 h in a 4 °C cold room. Prewashed protein A/G magnetic
beads (Pierce) in homogenizing buffer were added to mixture and further incubated at 4
°C overnight with rotation. The following day, samples were placed in a rack containing
magnets pre-chilled on ice to remove supernatants. Magnetized beads were washed 3
times using a high salt buffer (50 mM Tris, pH 7.5, 300 mM KCl, 12 mM MgCl2, 1%
Nonidet P-40, 1 mM DTT, 100 g/mL cycloheximide). Input and immunoprecipitated
mRNA was purified by using RNeasy Mini, RNA isolation kit (Qiagen, 74104 ) and
Arcturus PicoPure RNA Isolation Kit (Applied Biosystems, LSKIT0204) according to
manufacturer’s protocol, respectively. RNA was quantified with a NanoDrop 1,000
spectrophotometer (Thermo Scientific), the Qubit Fluorometer (Thermo Scientific), and
RNA integrity was assessed by a Bioanalyzer (Agilent Technologies). Libraries were
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prepared using the Universal Plus mRNA-Seq (NuGEN Cat# 0508) and consisted of Poly
(A) selection, RNA fragmentation, cDNA synthesis, cDNA purification, end repair,
adaptor ligation, strand selection, strand selection purification, library amplification, and
library purification. Sequencing was performed on the University of Louisville Center for
Genetics and Molecular Medicine’s (CGeMM) Illumina NextSeq 500 using the NextSeq
500/550 75 cycle High Output Kit v2.5 (20024906). These procedures were performed at
the University of Louisville Genomics Core Facility while analysis was performed by the
Kentucky Biomedical Research Infrastructure Network Bioinformatics Core.
Total RNA was extracted from spinal cord tissue at the injury epicenter (5 mm
segment spanning the injury epicenter) using Trizol (Invitrogen) according to the
manufacturer’s guidelines. RNA was quantified by ultraviolet spectroscopy
(NanoDrop2000, Thermo Scientific, Waltham, MA).
RNA-seq data analysis
RNA-seq data analysis RNA sequencing produced ~960,000,000 reads across the
24 samples (Table 6). The sequence read quality was assessed using FastQC v.0.10.127,
which indicated that quality was considered to be good so that no sequence trimming was
necessary. The sequences were then directly aligned to the Mus musculus reference
genome assembly using the STAR aligner v.2.628. Raw read counts were obtained from
the STAR aligned bam format files using HTSeq version 0.10.0. The raw counts were
normalized using the Relative Log Expression (RLE) method and then filtered to exclude
genes with fewer than 10 counts across the samples. UCSC Genome Browser tracks were
created to easily explore expression across the tested sites. A principal component
analysis (PCA) was performed using the plotPCA function in DESeq2. Differential
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expression was performed using DESeq2, which computes expected gene counts and
log2 fold changes based on a negative binomial regression model. This study design
included two independent variables of interest, group (IN, IP) and dpi (naïve, 2dpi, 10dpi,
42dpi). Group and dpi were expected to interact with each other across many genes.
Therefore, an interaction term (group x dpi) was added to the DESeq2 negative binomial
regression model to identify genes for which IP vs IN changed over time. There were 12
animals across 24 samples with each animal sampled once for IP and once for IN. To
identify genes with a group-specific effect (IP vs IN) at one or more time points (2x4
interactions), the full regression model was compared to a reduced model using a
likelihood ratio test.
Quantitive real-time PCR
To validate the OL specific immunopurfied mRNAs prior to RNA sequencing,
cDNA synthesis was performed with random hexamers using 50-100 ng of total RNA
using the Invitrogen SuperScript IV VILO Master Mix I (Thermo Fisher) in a 20 μL
reaction volume. qPCR was performed using ViiA 7 system (Applied Biosystems, Foster
City, CA). Briefly, cDNAs were added to Custom TaqMan Gene Expression Array Cards
(Thermo Fisher, 4342249) Taqman Fast Advanced Master Mix (Thermo Fisher,
4444557). Primer sets are listed Table 4. RNA levels were quantified using the ΔΔCT
method with Gapdh as a reference gene. IPs were normalized to their respective inputs
and expressed as fold changes (enrichment).
Western Blot Analyses
Protein lysates were prepared from 5 mm contused spinal cord tissue isolated
from sham and injury epicenter of WT mice at 2, 10, and 42 days post-injury (dpi) in
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protein lysis solution (20 mM Tris, pH-6.8, 137 mM NaCl, 25 mM ß-glycerophosphate, 2
mM NaPPi, 2 mM EDTA, 1 mM Na3VO4, 1% Triton X-100, 10% glycerol, protease
inhibitor, 0.5 mM DTT, 1 mM PMSF). The BCA kit (Pierce) was used to quantify the
protein lysates. Equal concentrations of proteins were separated on SDS-PAGE gels and
transferred to PVDF membrane (Amersham Hybond) and probed with RUNX1 (sc522308, Santa Cruz Biotechnology, 1/1000, Santa Cruz, CA), GDNF (sc-13147, Santa
Cruz Biotechnology, 1/1000, Santa Cruz, CA), PARVB (sc-374581, Santa Cruz
Biotechnology, 1/1000, Santa Cruz, CA), and GAPDH (Chemicon, 1/5000, Temecula,
CA) antibodies.
Histology
Mice were anesthetized with avertin, followed by thoracotomy and transcardial
perfusion with ice-cold PBS for 5 minutes and 4% paraformaldehyde (PFA). Spinal cords
were dissected and submerged in 4% PFA overnight at 4°C, then transferred to 30%
sucrose for at least 7 days at 4°C. Tissue was blocked in Tissue Freezing Media (Cat #
72592, Electron Microscopy Science, Hatfield, PA) and stored at -20°C. Spinal cords
were cryosectioned (20 µm) at -22°C in transverse sections.
Results
Isolation of OL-specific mRNA
The strategy we utilized to isolate mRNA specifically from OLs is outlined in Fig.
12a. To validate the OL-specific expression of HA labeling in PlpCreER:Rpl22HA mice, we
performed immunohistochemistry and quantitative RT-PCR (qPCR) on uninjured spinal
cord isolated from PlpCreER:Rpl22HA mice treated with tamoxifen (Tam) or vehicle (Veh).
In Tam-treated animals, double immunofluorescence showed that co-localization of the
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mature OL marker CC1 with HA was ~60% (Fig. 12b,c). Conversely, very little HA
expression was detected in Veh-treated animals (~5%). We performed
immunoprecipitation (IP) isolations in accordance to the RiboTag procedure with a few
modifications. To optimize OL-specific IP mRNA yields, we homogenized spinal cord
tissues in varying volumes of supplemented homogenizing buffer and established that a
0.05% weight:volume ratio produced the highest and most consistent yields (Fig. 13,
Table 5). We then utilized qPCR to confirm enrichment (IP-HA RNA/Input RNA) of OLspecific mRNAs (Mbp, Plp1, Mog, Mag, Sox10) and de-enrichment of astrocyte
(Aldh1l1, Hgf), neuron (Reln, Snap25), and microglia (Cd68, Tmem19) mRNAs (Fig.
12d). These data validate that OL-specific RNAs can be isolated from the spinal cord in
PlpCreER:Rpl22HA mice using the RiboTag approach.
RNA-Seq of OL-specific mRNA after SCI
A moderate T9 contusion SCI was performed on PlpCreER:Rpl22HA mice treated
with tamoxifen. Spinal cords were isolated at 2 (peak of OL death, acute), 10 (sub-acute),
and 42 (chronic phase) dpi. A 5 mm segment of the epicenter was homogenized, followed
by immunoprecipitation of RNA associated HA-labeled ribosome complexes using antiHA antibody. RNA extraction was performed and sequenced. We obtained >37 million
pair-end reads that aligned >97% with the mouse reference genome for every individual
sample (Table 6). Principal component analysis (PCA) was performed and showed
sufficient separation among groups across all time points (Fig. 14a). PC1 accounts for
70% of the variance which is attributed to the difference between the total RNA samples
and the OL-specific RNA samples, while PC2 accounts for 19% of the variance across
due to differences between naïve and post-injury samples. Similarly, pairwise comparison
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between IP and input (IN) at all time points show that OL-specific genes are enriched,
while astrocyte, neuron, and microglia genes are de-enriched in IP samples. (Fig. 14b).
Additionally, comparison of our naïve uninjured IP-HA mRNA data set to a previously
published transcriptomic data set that focused specifically on neural cells of the cerebral
cortex (Zhang et al. 2014), indicates that the IP mRNAs are predominately isolated from
mature OLs and to a lesser extent from newly formed OLs (Fig. 14c). These results
demonstrate effective RiboTag isolation of OL-enriched mRNAs from the spinal cord.
Differential gene expression using DESeq2 was obtained. Importantly, we
normalized IP-HA samples with their respective IN samples to reduce background noise
and potential contamination of RNA from non-OL-specific cells that may produce falsely
detected differently expressed genes (DEGs) as commonly reported from RiboTag
affinity purification isolations (Gregory et al., 2020; Haimon et al., 2018; Jambusaria et
al., 2020; Kang et al., 2018). When IN-normalized OL gene expression was analyzed
using the interaction function of DESeq2, a total of 3,757 differentially expressed genes
(2,015 upregulated, 1,742 downregulated) were identified as having a significant
interaction in the 2x4 (group x dpi, i.e. a significant OL gene expression change over the
entire time course of analysis) interaction term model as determined by q-value cutoff ≤
0.05 with log2FC > 0. A 2x2 (group x dpi, i.e. a significant OL gene expression change
over an individual time point of analysis, q-value cutoff ≤ 0.05 with log2FC > 1)
interaction was then used to identify individual genes that were upregulated at a given
individual time point. In summation, only genes that were significant across all time, and
a particular chosen individual time point were identified. Gene ontology (GO) enrichment
of input normalized IP-HA DEGs identified from the previous filtering steps show OL
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DEGs enriched in annotated functions associated with bioenergetic metabolism across all
time points (Fig. 15a). Conversely, GO analyses of input injury versus input naïve show
shows a strong enrichment of biological processes that are related to inflammation or
immune-associated responses after SCI which are not observed in the input normalized
IP-HA injury samples further suggesting that our data set is OL-specific across all time
points.
To evaluate how these genes change at different stages after injury, we used Kmeans clustering to sort the 3,757 DEGs into 23 clusters according to significant
upregulation (assigned a value of 1), significant downregulation (assigned a value of -1)
or no significant change (assigned a value of 0) at 2, 10, and 42 dpi (Fig. 16a). The total
number of genes associated with each cluster ranged from 947 to 1 (Table 7). Clusters
that contain fewer numbers of genes were likely to not reach the threshold required for
many biological processes and therefore received a limited set of annotations (Fig 17,
18). Therefore, we combined smaller clusters with larger clusters of similar patterns as
defined by upregulated (U), downregulated (D), or no change (N) when compared to
naïve animals. For instance Clusters 2 contained DEGs that are downregulated at 2 and
10 dpi, but upregulated or no change at 42 dpi when compared to control naïve uninjured
animals, and hence assigned D/D/N (Table 7). Similarly, clusters 4, 15, and 17 follow a
similar trajectory as time passes, namely downregulation at 2 dpi then gradual up
regulation. Clusters 5, 9, 12, and 19 were combined as they were classified as U at 2 dpi,
U/D/N at 10 dpi, and D/N at 42 dpi. GO enrichment (q-value cutoff ≤ 0.05 and |log2FC|
> 1, dpi 2 IP-HA vs naive) was performed on the combined clusters classified (2, 4, 15,
17) and (5,9,12,19) (Fig. 16b,c). Consistent with secondary injury induced damage after
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SCI and OL function, amino-acid biosynthesis, regulation of neuron death, cell junction
organization, regulation of membrane potential, and synaptic transmission processes were
some of the most enriched. We then identified genes associated with the regulation of
neuron death and extract a limited set of genes (Fig 16b). Therefore, we manually filtered
the upregulated DEGs to establish a list of 98 candidate gene list according to these
criterion: 1) log2FC >1; q<0.05 for input normalized IP-HA injury versus input
normalized IP-HA naïve 2) >2 fold (q≤0.05) at 2 dpi when input normalized IP-HA
injury was compared to input normalized IP-HA naïve at 42 dpi, and therefore likely to
represent acute OL response that include regulation of the death and/or survival 3)
log2FC >1; q<0.05 for IP-HA injury verses IP-HA naïve to avoid false detection of
scenarios where variations in input levels lead to apparent changes in expression (Fig
19a). We utilized PUBMED to classify candidate genes as either pro-survival or prodeath (Fig. 19b). Similarly, we repeated the process for acutely downregulated genes and
establish a list of 38 (>-2 fold at 2 dpi when compared to naïve or 42 dpi, q≤0.05).
However, the majorities of genes identified were associated with synaptic functions and
likely represented OL-specific transcriptional responses to neuron loss (Fig. 20). In total,
136 genes (98 upregulated, 38 downregulated) were identified using these criteria. Given
that MAPK signaling pathways are involved in both pro-survival and pro-death responses
after SCI (Genovese et al., 2008), we identified the sprouty related EVH1 domain
containing 3 (Spred3) and sprouty RTK signaling antagonist 4 (Spry4) as inhibitors of
MAPK-associated pro-survival pathways. Similarly, activation of RUNX family
transcription factor 1 (RUNX1) was identified as a response to DNA-damage that by
interaction with p53 is able initiate cell death (Satoh et al., 2012). Additionally we
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identified six-transmembrane epithelial antigen of prostate (Steap3) and parvin beta
(Parvb) as potential contributors to oxidative stress and the inhibition of the pro-survival
Integrin pathway, respectively. Pro-survival genes included Sphingosine-1-p Sphk1 and
glial cell line-derived neurotrophic Gdnf possesses diverse processes that regulate several
molecular events underlying cellular homeostasis and viability (Maceyka et al., 2012;
Wilkins et al., 2003). In mouse models of Huntington’s and Parkinson’s, stimulation of
SPHK1 using K6PC-5, pramipexole, or fingolimod proves to be neuroprotective by
reducing toxic aggregate protein and stimulating Akt kinase (Di Pardo et al., 2019; Motyl
et al., 2018). Another target that was significantly induced after SCI nearly ~20 fold is
aldehyde dehydrogenase 18 family member A1 (Aldh18a1) which encodes a protein
(P5C) that catalyzes the reduction of glutamate to delta1-pyrroline-5-carboxylate, a
critical step in the de novo biosynthesis of proline, ornithine and arginine. Importantly,
proline mediates anti-oxidant defenses and overexpression of this enzyme was shown to
be protective against oxidative stress (Krishnan et al., 2008).
Up-Regulation of potential death/survival regulating genes
To confirm these changes in total protein expression in the spinal cord 2 dpi,
western blot analysis showed ~3 (a 55kDA isoform) to 13.8 (a - 28 kDA isoform) fold
increase in RUNX1 protein levels (Fig. 19c) and ~7.5 fold increase in GDNF protein
levels (Fig. 19d) of sham controls. These changes have a correlation with log2FC values
of ~11.5 for Gdnf and 5.8 for Runx1 obtained from dpi 2 IP-HA versus dpi 2 IP-naïve
samples. For Runx1, the demonstrated upregulation may come from both OL and non-OL
cells, as Ribotag data indicated that non-OL cells are the predominant source of Runx1
mRNA at dpi 2 (IP/IN dpi 2, ~.62 fold, q<0.05). For GDNF, the change is likely
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mediated by OLs as Gdnf mRNA is enriched in IP samples at dpi 2 (IP/IN, ~4.37 fold,
q<0.05).
Discussion
OL death and white matter damage contribute to functional deficits after
traumatic SCI, but OL specific-mechanisms that are activated after SCI remain largely
unknown. Although previous transcriptomic studies provide systematic knowledge about
global transcriptional responses after SCI (Chen et al., 2013a; Shi et al., 2017), a major
challenge has been identifying OL-specific responses apart from responses that occur in
other cell populations in at the injury epicenter. Using RiboTag to profile the OL-specific
translatome, our data indicate that OLs are enriched in upregulated genes that are
associated with pro-survival signaling pathways and cell death. We identified Steap3,
Chac1, Spry4, Spred3, Parvb, and Runx1 as potential candidates that directly contribute
to cell death and oxidative stress or inactivate survival pathways after SCI. Potential prosurvival genes included Sphk1, Aldh18a1, and Gdnf.
Although, RiboTag is an extremely powerful tool to recover and examine cell
type specific translatomes from complex tissues, a technical challenge is to maximize
recovery of cell-specific mRNA from myelin rich tissues. The large quantities of myelin
debris, inherent in spinal cord tissue, that is generated during the homogenizing process
can aggregate with polysomes and subsequently settle with the pellet after centrifugation
to significantly reduce isolation yields (Fig. 13, Table 5). There were negligible RNA
yields when following the standard RiboTag isolation protocol. We systematically
modified individual components of the isolation protocol to optimize conditions relevant
to our model. Adjusting antibody concentration, antibody incubation duration, and tissue
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amount slightly increased recovery but also increased non-specific RNA binding.
However, adjusting the volume of the homogenizing buffer greatly improved our yields.
We reasoned that a larger volume permits for polysomes to more freely diffuse in
solution and kinetically avoid interactions with myelin contaminants. Decreasing the
percent weight to volume ratio to 0.5% improved recovery OL-specific mRNA by ~10
fold, and may be considered for polysome isolation from tissues rich in myelin without a
Percoll debris removal step (Whittemore et al., 1993) which may introduce unwanted
isolation bias.
Another technical challenge is to avoid contamination from other cells. For
instance, since macrophages begin to infiltrate and accumulate within the epicenter
acutely, Cd68, specific to macrophages, was highly expressed in our initial raw data set
of IP-HA samples despite having a ~20 fold depletion (IP/IN, data not shown) using
RiboTag immunopurification. Therefore, we normalized our IP-HA samples with their
respective IN samples and utilized an additional interaction term to identify genes that
have a changing relationship between IP and IN across time points (i.e. identifying
mRNAs whose input-normalized expression in OL IP samples changes, see Materials and
Methods). This process filters out genes that do not have significant temporal interactions
as determined by our selection criteria, and also excludes potential contaminate genes
such as CD14 (macrophage), CD44 (neutrophil), CDH5, and VWF (endothelial). Despite
this filtering process some T-lymphocyte genes including CD52, CD81, and H2-T23
were still detected as significantly changing their OL expression (data not shown).
However, given the absence of classical T-cell markers such as CD2, CD3, CD4, CD28,
and CTLA-4, wild scale T-lymphocyte contamination is highly unlikely. Furthermore, as
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proliferating astrocytes comprise of a substantial amount of cells at the injury epicenter,
the lack of Gfap, Aldh1l1, Apod, Mt1, and Lgals3bp, all of which are highly translated in
astrocytes, further supports a notion that our filtered data represent OLs without a major
contamination by other cell types. It is possible that CD52 and CD81 are expressed, as
OLs have recently been shown to upregulate antigen processing/presentation genes (H2K1, H2-D1, H2-T23) and participate in immunomodulation in MS (Falcao et al., 2018;
Kirby et al., 2020). Therefore, to account for potential contamination we used a filtering
criterion to exclude a significant portion of genes during quantitative data analysis and
show that processes involved in myelin synthesis (Fig. 15a) are enriched acutely after
SCI confirming that our data set is OL-specific.
Our goal was to define responses by mature OLs after SCI. Therefore the
inducible Plp-Cre mouse line was selected to label those OLs and exclude OPCs. While
Plp is expressed by OPCs, only a few single OPCs were CreERT2-positive in this mouse
system (Doerflinger et al. 2002). The majority of HA expression is restricted to CC1+
cells following tamoxifen treatment (Fig. 12 a). When comparing OL-specific IP data to a
previously published neural cell transcriptome (Zhang et al., 2014), we observe very
strong correlation (0.96-1) with myelinating OLs (Schober et al., 2018) (Fig. 14c). In
contrast, they weakly correlate with OPC (0.28-0.39), neurons (0.3-0.33), and astrocyte
(0.23-0.33) equally (Patrick et al. 2018). After SCI, OPCs immediately being to
proliferate and differentiate into new OLs within 3 days (Hesp et al., 2015; McTigue et
al., 2001; Zai et al., 2005). Our data do not show processes involving OPC proliferation
enriched at 2 DPI (Fig. 15a). Therefore, the majority of our dataset is represented by
more mature OLs after SCI.
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Gene ontology performed on combined cluster sets revealed several processes
upregulated including amino acid biosynthetic process (Bcat1, Bcat2, Asns, Aldh18a1,
Pycr1) and regulation of neuron death (Hrk), while downregulated processes were
associated with synaptic function processes (Fig. 16c). Recent studies report induction of
the ERSR can lead to increased ATF4 transcription/translation that results in the
upregulation of genes involved in amino acid synthesis in OLs after SCI (Myers et al.,
2019; Ohri et al., 2013; Ohri et al., 2011; Valenzuela et al., 2012). This is consistent with
our finding of upregulated amino acid biosynthesis genes (Bcat1, Bcat2, Asns, Aldh18a1,
Pycr1), all of which are ATF4-target genes. Additionally, previous work has shown that
Hrk activation contributes to OL apoptosis in the contused spinal cord (Yin et al., 2005).
Taken together, the confirmation of these findings gave us confidence that our OLspecific data accuracy reflects the acute pathology of SCI.
There were no obvious OL-intrinsic cell death mechanisms uncovered by gene
ontology (Fig. 16,17,18). Thus, we manually filtered our data set to account for
biologically relevant processes that occur after SCI such as peak of OL-death and
characterized every individual gene as either pro-survival or pro-death (Fig. 19a). We
decided to first focus our efforts on our upregulated data set which contained more prodeath/survival genes, and as the majority of genes identified in the downregulated dataset
using the same approach were related to OL-specific synaptic functions. Several OLspecific intrinsic pro-death genes (Spry4, Spred3, Parvb) that emerged from the
upregulated dataset were ones that inactivated survival pathways. Others (Runx1, Chac1,
Steap3) found were likely to directly contribute to cell death, while pro-survival genes
included Sphk1, Aldh18a1, and Gdnf. With the exception of Gdnf, none of these genes
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have reported roles in OLs. For instance, previous reports demonstrate that the MAPK
signaling pathway and its stress activated protein kinases mediate secondary injury on a
global scale after SCI (Genovese et al., 2008; Stirling et al., 2008), but OL-specific
molecular mechanisms have never before been studied. Our finding may suggest that
Spred3 and Spry4 can modulate the MAPK, so that extrinsic survival signals are subdued
while pro-apoptotic stress activated pathways are amplified (pro-death Runx1
downstream of MAPK) and drive OLs to cell death. Additionally, OLs have long known
been known to be uniquely sensitive to SCI-induced oxidative death due to their high iron
content and metabolic requirements (Thorburne et al., 1996). The upregulation of Chac1,
Runx1, and Steap3 identified in our data set may contribute to this process and
compliments that finding, but also introduces potential new OL-specific cellular targets.
Conversely, OL-intrinsic pro-survival mechanisms (Aldh18a1, Gdnf, Sphk1) that can
reduce oxidative stress and/or prevent cell death may be stimulated to increase oxidative
stress tolerance. Importantly, western blot analysis confirms increased total protein levels
of GDNF and RUNX1 and further validates our RiboTag approach (Fig. 19c,d).
However, because total homogenate lysates were used for western blot analysis, changes
in protein levels include those from other cell types. Therefore, a more sensitive
quantitative method with single cell resolution such as immunohistochemistry (protein
quantification) or RNAscope (RNA quantification) is required for definitive validation of
our data set. OL survival depends on extrinsic signals such as neurotrophic factors
supplied by axons (Barres et al., 1993, 1999). After SCI, neurons and OLs begin to die
immediately. Neuron loss tapers off at 2 dpi, while OLs death continues nearly 2 week
post-injury (Pukos et al., 2019). In the context of SCI, this area of OL death is
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understudied and OL-intrinsic mechanisms that occur after oligo-axonal synapse loss are
unknown. Genes identified in our downregulated data set is the first report of OL-specific
synapse-related transcriptional changes that occur when oligo-axonal junction are
disrupted and can provide mechanistic insight about axon loss induced OL death after
SCI. Collectively, our RiboTag data accurately reflect previously reported
pathophysiological processes that are associated with SCI-induced death, and therefore
can be used to find relevant OL-specific cell death/cell survival regulators. Furthermore,
these data can serve as a guide to integrate seemingly unrelated cytotoxic events and
provide a broad mechanistic understanding of OL-specific responses to SCI.
SCI is a multifaceted injury with shifting time-dependent components that include
various signaling mechanisms and cellular interactions that ultimately result in the loss of
white matter. The extent of spared white matter, in part determined by OL cell death, is a
large determinant of functional recovery. This study is the first to provide a
comprehensive description of in vivo translational gene expression changes that occur in
OL-specific responses to SCI over acute, subacute, and chronic time points. Our data
reveal the identity of multiple molecular signaling pathways and genes associated with
cellular death that occur at 2 dpi. How manipulation of these pathways and genes affect
spared white matter, OL survival, and functional recovery after SCI will have to be
empirically determined in future studies.
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Figure 12. Isolation and validation of OL-specific mRNAs from PlpCreER:Rpl22HA
mice. (a) Experimental design to isolate oligodendrocyte-specific RNAs from spinal cord
of PlpCreER:Rpl22HA mice. (b) Representative images of T9 thoracic level spinal cords of
PlpCreER:Rpl22HA mice treated with tamoxifen showed abundant immunostaining for HA
co-localized with mature oligodendrocyte marker CC1/APC, while vehicle treated
animals show few HA+/CC1+. (d) Quantitative analysis of immunostaining for HA and
mature oligodendrocyte marker CC1/APC at T9 shows significant increases in
HA+/CC1+ co-localization when compared to vehicle treatment. Data are the mean ± SD
(n=4, p>0.05, u-test). (d) qPCR comparison of IP-HA RNA samples vs. input RNA
samples of spinal cord isolated from injured PlpCreER:Rpl22HA mice (naïve, 2, 10, 42dpi)
treated with tamoxifen mice showed enrichment of oligodendrocyte (Mbp, Plp1, Mog,
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and Sox10) mRNA and de-enrichment of astrocyte (Aldh1l1, Hgf), neuronal (Reln,
Snap25), and microglial (Cd68,Tmem119) mRNA.
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Figure 13. Optimizing isolation of OL-specific mRNAs from PlpCreER:Rpl22HA mice.
Varying amounts of supplemented homogenizing buffer volumes with respect to tissue
mass were used in the tissue dissociation and isolation process to optimize recovery of
IP-HA RNA yields. As myelin debris can associate with polysomes to form a component
of pellet during centrifugation, larger volumes of homogenizing buffer (smaller % weight
to volume ratio) can be used to obtain higher IP-HA RNA yields. While increasing
volumes increases IP-HA RNA yields, volumes that are too large reduce input RNA
recovery yields and inefficiently utilizes valuable reagents.
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Figure 14. OLs at naïve, 2, 10, and 42 dpi display distinct clustering and different
expression of highly enriched genes. (a) Principal component analysis of all genes in
IP-HA and input (n=3 biologic replicates per condition) (b) Volcano plots indicate OLspecific translatome genes are significantly separated from differentially expressed genes
(c) Correlation matrix comparing differentially expressed genes obtained from HA-IP
normalized to input to reference dataset that focused specifically on neural cells of the
cerebral cortex (Zhang et al. 2014). Heatmap showing Spearman’s Rho correlation
coefficient (r), indicating very strong correlation (0.96-1) with myelinating OLs and
weakly correlating with OPC (0.28-0.39), neurons (0.3-0.33), and astrocyte (0.23-0.33)
suggesting that our samples are most likely representative of myelinating OLs.
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Figure 15. GO analysis of enrichment of genes. (a) GO analysis of input normalized
IP-HA injury as determined by the following filtering steps: 1) q <0.05 in 2x4 interaction
2) logFC>1, q<0.05 in 2x2 interaction for the acute 2 dpi, subacute 10 dpi, and chronic
42 dpi time points, shows enrichment of biological processes related to bioenergetics (b)
GO analyses of input injury versus input naïve (pairwise comparison log2FC>1) show
enrichment of biological processes that are related to immune responses at acute 2 dpi,
subacute 10 dpi, and chronic 42 dpi time points after SCI suggesting that our IP-HA
samples are OL-specific.
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Figure 16. OL-specific translatome changes after SCI. (a) Heat map representing kmeans clustering by IP-HA injury versus IP-HA naïve from genes established by DESeq2
group by dpi (2x4) interaction analysis (3,757 genes out of 17,186 detected into 23
clusters) as defined by group (IP-HA, IN) and dpi (naïve, dpi) and significant interaction
(q≤0.05, fold change≥0) (b) GO enrichment of genes upregulated acutely at 2 dpi in
combined cluster 5,9,12, and 19. Top processes enriched are associated with ISR stress
activation (alpha-amino acid biosynthetic process), regulation of neuron death process
contain only a few genes, some of which have been previously implicated in mediating
cell death after SCI (c) GO enrichment analysis of downregulated genes in cluster 4, 2,
15, and 17 show processes involved in synaptic transmission which may reflect loss of
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oligo-axonal synapses, clusters were filtered using the following cut off: |Log2FC |≥1,
q≤0.05.

Figure 17. GO analysis of acute down regulated clusters. GO enrichment analysis of
individual cluster 1, 3, and 4 with patterns D/D/D, D/N/D, and D/N/N was performed (qvalue cutoff ≤ 0.05 and |log2FC| > 1, dpi 2 IP-HA vs naive) individually and demostrated
enrichment of biological processes associated with synaptic transmission.
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Figure 18. GO analysis of acutely upregulated clusters. GO enrichment analysis of
individual cluster 11, 12, and 19 was performed (q-value cutoff ≤ 0.05 and |log2FC| > 1,
dpi 2 IP-HA vs naive) and show limited processes are enriched and suggests grouping
similar behaving clusters. Cluster 11, 12 and 19 are U/N/D, U/N/N, and U/U/N
respectively.
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Figure 19. Filtering steps performed to sort differentially expressed genes. (a)
Manually filtered upregulated DEGs established a 98 candidate gene list >2 fold,
q≤0.05at 2 dpi when compared to 42 dpi to detect acute responses OLs undergo that
contribute to death. (136 total genes identified using criterion, 38 downregulated not
shown, majority of genes were associated with synaptic function) (b) Log2FC expression
changes of (injury IP-HA/naïve IP-HA of select pro-death and pro-survival gene
identified in (a). (c,d) Western blot analysis reveals increased levels of RUNX1 and
GDNF proteins. Untrimmed western blot images are shown in Fig. 21 and 22. RUNX1
western blot densitometry quantification was done on n=3 sham, n=3 2 dpi, one sample
from 2 dpi was excluded because of high background. GDNF western blot densitometry
quantification was done on all samples shown (n=3 sham, n=4 2dpi). Data are mean ± SD
(*p < 0.05; ns, p > 0.05, student t-test.

95

Figure 20. GO analysis of downregulated genes identified through manual filter.
Analysis was conducted using <-2 fold, q≤0.05at 2 dpi when compared to 42 dpi to detect
acute downregulated responses. A limited set of functional processes were obtain and
justifies our approach with starting our analysis with upregulated genes first.

96

Figure 21. The untrimmed image of the western blot image shown in Fig. 19c.
Location of the molecular weight markers is marked. There are bands where the expected
size of the detected targets are (mouse RUNX1, 28 kDa isoform, 55 kDa isoform, ~80
kDa uncharacterized band, GAPDH 35.8 kD).
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Figure 22. The untrimmed image of the western blot image shown in Fig. 19d.
Location of the molecular weight markers is marked. There are bands where the expected
size of the detected targets is (mouse GDNF, 24 kDa, GAPDH 35.8 kD).

98

Table 4. List of qPCR primers
Gene

Assay ID (ThermoFisher Scientific TaqMan Assay)

Mbp

Mm01266402_m1

Plp1

Mm01297209_m1

Mog

Mm00447827_g1

Cldn11

Mm00500914_m1

Mobp

Mm02745649_m1

Opalin

Mm00463365_m1

Mag

Mm01176050_g1

Fa2h

Mm00626259_m1

Gjb1

Mm01950058_s1

Ermn

Mm01331072_m1

18S

Hs03003631_g1

Gjc2

Mm00519131_s1

Klk6

Mm00478322_m1

Sox10

Mm01300162_m1

Aldh1l1

Mm03048949_m1

Hgf

Mm01135185_m1

Reln

Mm00465200_m1

Snap25

Mm01276446_m1

Lhx5

Mm00521778_m1

Osm

Mm01193966_m1
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Cd68

Mm03047343_m1

Tmem19

Mm00504986_m1

Ppia

Mm02342430_g1

Ywhaz

Mm05674356_s1

Mbp

Mm01266402_m1
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Table 5. RiboTag isolation yields and conditions

Spinal

Weight

HB

Input

IP-HA

HA

Incubation

qPCR

qPCR

cord

(mg)

Volume

RNA

RNA

Antibody

time (h)

Validation

Validation

Length

(% w/v

yield

yield

(uL)

Input

IP-HA

(mm)

ratio)

(ng/uL)

(ng/uL)

Enrichment

5

3.3

2

2.2

x

4

24

Y

x

x

5

3.2

2

3.5

x

4

24

Y

x

x

5

3.9

2

2.3

0.2

4

48

Y

x

x

5

3.8

2

4.5

0.6

4

48

Y

x

x

5

4.2

2

3.8

4.2

8

24

Y

Y

x

5

3.8

2

2.6

5.2

8

24

Y

Y

x

10

7.5

2

6.1

1.2

4

24

Y

x

x

10

8.1

2

5.1

x

4

24

Y

x

x

5

4.9

0.07

1.2

6.2

4

24

Y

Y

x

5

4.6

0.5

5.3

4.5

4

24

Y

Y

Y

5

3.6

1

4.6

2.2

4

24

Y

Y

Y

5

5.1

1.5

5.5

5.1

4

24

Y

Y

x

5

3.5

2

4.5

1.1

4

24

Y

x

x

5

4.4

3.5

4.3

0.2

4

24

Y

x

x

5

4.2

.5

3.7

x

4 (IgG)

24

Y

X

x
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Table 6. Summary of initial sequence analysis
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Table 7. Patterns and number of genes contained in the 23 proposed clusters.
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CHAPTER 4
GENERAL DISCUSSION
Review of findings
As discoveries and technological limitations advance, our knowledge about spinal
cord injury (SCI) also evolves to delineate more detailed pathways and mechanisms
involved. The research in this dissertation is in part based on the discovery of additional
pathways that contribute to the activation of downstream effectors involved in mediating
the endoplasmic reticulum stress response (ERSR). The remainder of this research is
focused on identifying and defining novel pathways that contribute to the neurological
impairment after SCI. This section will provide a review of work conducted, touch upon
future work, and finally highlight the clinical implications.
My journey began with the goal of identifying cytotoxic mechanisms that initiate
death after SCI. Various cytotoxic events including hypoxia, bioenergetics failure,
oxidative stress, endoplasmic reticulum (ER) stress, and hemorrhage occur at different
time points with varying duration of insult to differentially contribute to secondary injury
induced cell death (Pukos et al., 2019). Apoptosis, necrosis, and autophagy induced cell
death have been characterized in secondary injury. Recently, a newly characterized form
of iron-dependent cell death named ferroptosis (Dixon et al., 2012), showed involvement
in an intracerebral hemorrhage (ICH) injury model (Karuppagounder et al., 2016). The
Ratan Lab proposed a mechanism whereby the upregulation of select ATF4-target genes
contributes to ferroptosis, and that inhibiting hypoxia-inducible factor prolyl hydroxylase
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(HIF-PHD) suppresses the ATF4/CHOP signaling cascade to inhibit ferroptotic
cell death (Karuppagounder et al., 2016; Ratan, 2020). Interestingly, our previous work
showed that mediators of the ERSR including ATF4/CHOP are upregulated in neurons
and oligodendrocytes (OLs), and that CHOP serves as an ERSR specific pro-apoptotic
transcription factor after SCI (Ohri et al., 2011). In the same study, Chop null mice
showed improved behavioral outcome after thoracic contusive SCI associated with
increased WMS and attenuated acute loss of OLs. We therefore investigated the role of
HIF-PHDs in ATF4-CHOP activation and white matter loss after SCI. We hypothesized
that pharmacological and/or genetic suppression of ATF4-CHOP signaling after thoracic
contusive SCI would similarly restore proteostasis and prevent chronic OL loss, leading
to increased spared white matter and improved functional outcomes. First, we showed in
an acute study that SCI animals treated with AQ for 3 days had lower mRNA levels of
Atf4, Chop, and Trib3, but there were no effect on three other ERSR transcripts, Gadd34,
Grp78, and Xbp1. Clearly, AQ had a biological effect, so we wanted to examine if there
were any long term functional changes and treated SCI animals with AQ for 7 days in a
chronic locomotor study. There were no differences in WMS or BMS locomotor
outcomes at week 6. We then determined the effects of genetically deleting the HIFPHDs in OLs by using OL-specific Plp-creERT2+/+:Egln1/2/3fl/fl mice. Tamoxifen
treatment resulted in the downregulation of Phd/Egln transcripts in both OL-rich tissues
of the spinal cord and optic nerve, but not in OL-lacking liver of tamoxifen-treated PlpcreERT2+/+:Egln1/2/3fl/fl mice. At 72 h after SCI, tamoxifen- and vehicle-treated PlpcreERT2+/+:Egln1/2/3fl/fl mice had similar neural cell mRNA levels, indicating no effect on
the acute loss of neurons and OLs. Furthermore, there were no effects on the expression
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of Atf4, Chop, Gadd34 or Grp78 mRNAs. Consistent with those findings (Ohri et al.,
2021), there were no significant differences in locomotor recovery between 6-week BMS
scores for tamoxifen- and vehicle-treated Plp-creERT2+/+:Egln1/2/3fl/fl mice.
The work in Chapter 2 provides evidence that HIF-PHDs may not be suitable
targets to improve outcomes in traumatic CNS pathologies that involve acute white
matter injury like SCI. Our study was the first to evaluate the involvement of HIF-PHDs
in ATF4/CHOP signaling after SCI and that pharmacological inhibition of HIF-PHDs
using AQ has no effect on spared white matter or locomotor recovery. One possibility of
these negative findings is that AQ inhibits the ATF4-CHOP signaling that is distinct from
their involvement in ERSR. Indeed, in the ICH model, AQ was proposed to inhibit the
ATF4-mediated iron-dependent ferroptosis but not the cytotoxic ERSR (Karuppagounder
et al., 2016; Ratan, 2020). ER stress may be a downstream event in ferroptosis that occurs
as result of oxidative ER damage (Dixon et al., 2014; Lee et al., 2018) and ER stress
(thapsigargin and tunicamycin) induced ATF4 activation appears to be capable of
preventing ferroptosis (Hayano et al., 2016; Lange et al., 2008; Lewerenz). This is
consistent with our unpublished results which indicate that OPCs pretreated with
tunicamycin first, and then with hemin (ferroptosis inducer) show no synergistic effects
in cell viability when compared to tunicamycin treatment alone. Furthermore, Hong et al.
demonstrated activation of the ERSR and its mediators including CHOP after treatment
with the ferroptosis inducers artesunate (ART) and erastin (Hong et al., 2017). It is well
established that CHOP induces several pro-apoptotic proteins such as p53 upregulated
modulator (PUMA), ER oxidoreductin-1α (ERO1α), growth arrest and DNA damage–
inducible protein (GADD34), BIM (Bcl-2-like protein 11), and NOXA (BH3-only
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apoptosis protein) (Hu et al., 2018). However, ART only induces PUMA expression, and
not NOXA or BIM (Hong et al., 2017). ART-induced PUMA expression does not result
in apoptosis (Hong et al., 2017). Taken together, this is consistent with our suggestion
that the ISR and ERSR are predominantly the activators of ATF4 after SCI.
Apoptosis rather than ferroptosis may be primary cell death mechanism in neurotraumachallenged OLs after SCI. Sensitivity to ferroptosis is associated with several biological
processes involving amino acid, iron and polyunsaturated fatty acid (Dixon et al., 2012).
Hence, various cell types have different susceptibility to ferroptosis inducing stress. For
instance, glutathione depletion can induce ferroptotic death in embryonic cortical
neurons, neuroblasts, OLs, and astrocytes (Ratan, 2020). However, primary neurons and
immature OLs are more sensitive to ferroptosis. Mature OLs have increased expression
of solute carrier family 7 member 11 (SLC7A11), a cystine/glutamate transporter,
making them more tolerant to ferroptosis (Hoshino et al., 2020). The difference in
sensitivity may account for the lack of recovery in our SCI model where damage is
primarily due to white matter loss associated with mature OL death when compared to
the ICH model where neuronal loss is the key driver of impairment. Indeed, in animals
treated with systemic iron chelator, deferasirox, there was improved gray matter sparing,
attenuated neuron loss, but no effects on white matter sparing or OL numbers post injury
(Sauerbeck et al., 2013). Additional work could investigate the protective effects of
adaptaquin in models of cervical contusion injury or subarachnoid hemorrhage where
neuronal death is paramount to loss of function (Magnuson et al., 2005; Magnuson et al.,
1999; Sabri et al., 2008).
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Finally, Chapter 3 identified transcriptional and translational gene expression
changes that regulate OPC/OL responses at different time points after SCI by using
RiboTag technology and RNA-sequencing. As expected, the isolated mRNA fraction was
enriched for myelin basic protein/proteolipid protein (Mbp/Plp, OLs, ~5-fold) and
depleted for hepatocyte growth factor (Hgf, astrocyte), synaptosomal-associated protein
(Snap25, neuron), and cluster of differentiation 68 (Cd68, microglia). Finally, we
sequenced mRNA from OLs in the epicenter of the injury at 0, 2, 10, and 42 dpi. We
identified 98 genes that were upregulated >2 fold in OLs at 2 dpi that when compared to
42 dpi and defined their potential roles according to their functions as currently defined in
the literature. Genes that induce oxidative stress (Chac1, Steap3), inhibit MAP kinase
(Spred3, Spry4), and inhibit the AKT pathway (Parvb) were highly upregulated. Our
working hypothesis is that OLs upregulate genes that may increase oxidative stress and
inactivate survival pathways that may collectively contribute to cell death after SCI. This
study will be one of the most comprehensive descriptions of OL-specific gene expression
after SCI to be reported.
Although RiboTag is an extremely powerful tool to recover and examine cell type
specific translatomes from complex tissues, there are limitations to the scope of this study
and technical limitations inherent to the RiboTag technology. For instance, our focus was
on defining responses by myelinating OLs during SCI. Therefore, we selected the
inducible Plp-Cre mouse line to label myelinating cells and exclude OPC responses,
including proliferation and differentiation, which have been documented to be extremely
active acutely after injury (Hesp et al., 2015; McTigue et al., 2001; Zai et. al., 2005).
Indeed, our data do not show proliferation-associated processes at 2 dpi. Hence, this
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study is the first description of myelinating OL-specific translational profile after SCI.
Although OPC responses are likely excluded, so too are newly formed OLs. For the first
two weeks after SCI, OPCs begin to markedly proliferate and differentiate into mature
myelinating OLs (Hesp et al., 2015). They begin to myelinate by week 3 acutely, and
remarkably they maintain this chronically (Hesp et al., 2015). However, the exact
functional implications of this remyelination after SCI are unclear and the identity of the
axons they myelinate are unknown (Hesp et al., 2015). When OPC differentiation is
blocked, the subsequent myelination response is also inhibited. However, despite no new
myelin being formed, there was no decease in motor function behavior (Duncan et al.,
2018). This suggests that the endogenous remyelination response is not sufficient to
improve recovery. Importantly, given that more than more than half of the OLs were
newly formed, we could evaluate this response using our mouse model by starting
tamoxifen induction after SCI. Another technical issue to consider is the lack of IP-IgG
controls utilized in this study. Studies utilizing the RiboTag system have shown that IPIgG can immunoprecipitate nonspecific RNAs that contribute to background noise and
confound the later analyses (Haimon et al., 2018). However, this issue can be rectified by
utilizing stringent selection criteria given that IP-HA specific genes are detected are
significantly higher than that of IP-IgG genes (Haimon et al., 2018; Sanz et al., 2019).
Nonetheless, genes can be unintentionally eliminated by criteria selection as background
noise. Moreover, there is well documented contamination of RNAs (from total pool of
RNA, target cell specific and non-specific) that can associate with HA-labeled ribosomes
during the isolation and antibody incubation period (Gregory et al., 2020; Haimon et al.,
2018; Jambusaria et al., 2020; Kang et al., 2018; Scheckel et al., 2020). Such potential
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contamination can at least in part be removed by normalizing to input RNAs and filtering
by relative enrichment as demonstrated in this study. While the immunopurification
process likely excludes mRNAs that are translationally regulated at the initiation complex
formation step, ribosomes that remain attached to mRNAs in cases where protein
synthesis or elongation is depressed or stalled due to regulation (Haimon et al., 2018;
Sanz et al., 2019) may still be precipitated. Such scenario would inaccurately reflect
translatomic gene expression changes and lead to discrepancies between the translatome
and the proteome. Finally, when the OL-specific IP mRNAs are normalized to the IN to
obtain enrichment, genes that are also transcriptionally upregulated or downregulated by
surrounding cells and tissues may be minimized by the normalization procedure and
therefore subsequently eliminated by the selection criteria process (Haimon et al., 2018).
A common technique is to perform downstream gene analyses by only comparing IPmRNA without normalization with the assumption that all mRNAs that are obtained
through immunopurification process are target cell specific (Itoh et al., 2018; Voskuhl et
al., 2019). Using IPs only can avoid apparent enrichment of genes that would be
otherwise be detected when IPs are normalized to IN (caused by a reduction of such
transcripts in total input mRNAs due to cellular death of non-target cells) is avoided. To
address this issue, we examined the use of both IPs that are normalized to the IN and IP
only when considering differentially expressed genes between naïve and SCI.
Specifically, we used IP normalized to IN and changes with their interactions across our
time as defined by q ≤ 0.05 and |log2FC|≥ 0 to obtain DEGs. Genes defined by this initial
criterion were then subjected to k-mean clustering using fold change values obtained
from IP only. Consequently, changes that are minimized because of the normalization
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process are detected when compared to IPs only, while contamination issues that maybe
overlooked when using IPs only are detected.
We focused on genes that were implicated in pro-death pathways that have not
characterized in OLs after SCI and therefore represent only a small fraction of overall
genes identified. One such gene identified that may contribute to OL cell death was sixtransmembrane epithelial antigen of the prostate 3 (STEAP3) which functions to reduce
Fe3+ to Fe2+ (Li et al., 2020). Importantly, Fe2+ is highly reactive and forms reactive
oxygen species through the Fenton reaction (Lloyd et al., 1997). Increased expression of
STEAP3 can increase levels of Fe2+ that may lead to the generation of more oxidative
damage. For instance, Giacci et al. used nanoscale secondary ion mass spectrometry
(NanoSIMS) to quantify oxidative damage after optic nerve transection and show that
increases in DNA, protein, and lipid damage occurred in both OPCs and mature OLs at 3
dpi, followed by a decline of OLs at day 7 (Giacci et al. 2018). STEAP3 is upregulated
and further increases cellular death when p53 is activated in breast cancer and leukemia
cells (Lespagnol et al., 2008), while knockdown results in inhibition of apoptosis
(Ohgami et al., 2005). Moreover, aside from general increases of oxidation, it can interact
with NIX (comprised of BCL2 and adenovirus E1B 19-kDa interacting protein 3 and
BNIP3-lL), members of the BH3-only apoptotic family of proteins, and therefore further
intensify the apoptotic effects of STEAP3 (Zhang et al., 2012a). Additionally, STEAP3
interacts with Myt1 kinase which is a regulator of cyclin-dependent kinase activity
(Lespagnol et al., 2008). Collectively, these studies suggest that STEAP3 may be directly
involved in apoptosis and cell-cycle progression. A natural next step would be to study
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the effects of manipulating STEAP3 whether through overexpression or knockdown on
survival or proliferation in cultured rat OPCs and ultimately in vivo after injury.
Another group of genes inhibit either the MAP kinase (Spred3, Spry4), or AKT
(Parvb) pathways. The mitogen-activated protein kinase (MAPK) and protein kinase B
(Akt) pathways serve as a connection that bridges extracellular signals to intracellular
responses and mediate the responses that results in cell survival, proliferation,
differentiation, and death. Extracellular signal-regulated kinase (ERK) is one component
of the MAPK family that can be activated in response to several extracellular ligands
through G protein coupled receptors, tyrosine kinase receptor, and the protein kinase C
(PKC) (Bhat et al., 1996; Bhat et al., 2007; Guo et al., 2007). The Akt pathway is in part
regulated by integrin-linked kinase (ILK) and can be activated by signals including
integrins, cytokine receptors, B and T cell receptors, receptor tyrosine kinases (RTKs),
and G protein-coupled receptors (GPCRs). ILK-mediated phosphorylation of Akt
increases proliferation and survival of cells, while inhibition of ILK inhibits PKB/Akt
activation and induces apoptosis (Edwards et al., 2005; Persad et al., 2000; White et al.,
2001). Furthermore, ERK and Akt are pro‐survival by mediating the cellular growth
factors and blocking apoptosis (Bellacosa et al., 1995; Bellacosa et al., 2005; Duronio,
2008; Fresno Vara et al., 2004). The sprouty family of proteins (Spry4, Spred3) acts as
negative regulators of ERK activation (Casci et al., 1999; Hacohen et al., 1998; Reich et
al., 1999), but have no inhibitory effect on either the JNK or p38 MAPK pathways
(Yusoff et al., 2002). Moreover, the sprouty and spred proteins suppress ERK activation
induced by fibroblast growth factor (FGF), platelet‐derived growth factor (PDGF),
vascular endothelial cell growth factor (VEGF), nerve growth factor (NGF), and glial cell
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line-derived neurotrophic factor (GDNF), all of which play pro-survival roles in the CNS
(Bansal et al., 1997; Cohen et al., 1996; Hu et al., 2008; Wilkins et al., 2003). Finally, βparvin (PARVB) binds to the integrin-linked kinase (ILK) to inhibit its kinase activity
(Mongroo et al., 2004). Expression of PARVB in MDA-MB-231 cells inhibited ILK
kinase activity, cell growth and in vitro matrigel invasion (Mongroo et al., 2004).
Importantly, these genes have never before been implicated to have a role in OLs after
SCI. Upregulated Spred3, Spry4, and ParvB levels may collectively act to modulate the
MAPK and Akt pathways, so that extrinsic survival signals are subdued while proapoptotic stress activated pathways are unaffected, collectively resulting in OL death.
Given that MAPK and Akt function largely through tyrosine kinase mediated
phosphorylation, one possible intervention is the use of phosphatase inhibitors to acutely
stimulate pro-survival pathways (Dewang et al., 2005; Heneberg, 2009). Another possible
approach to facilitate OL survival is to inhibit the pro-death pathways. Because these
cellular mechanisms are widely used in all cells, emphasis should be on pro-proliferating
and pro-myelinating responses. Therefore, in the case of phosphatase inhibition, it might
be possible that in trying to prevent death of existing myelinating cells, we also stimulate
OL function to increase myelination given that ERK MAPK signaling is required to
increase myelin thickness (Ishii et al., 2012), but inhibits OPC to OL differentiation (Suo
et al., 2019). Similar, inhibitors of JNK or p38 may initially prevent OL death, but halt
the differentiation of OPCs into OLs (Bhat et al., 2007). What effect this has on overall
functional recovery and spared white matter remains unknown and potential a future
direction. Additionally, future work could also include studying genes involved in OPC
cell proliferation, differentiation, and myelination after SCI. For instance, a Cre mouse
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under the control of the PDGFRα promoter (Duncan et al. 2018) which is expressed
earlier in the OL lineage (Pringle et al., 1992) may be used to specifically study OPC
proliferation, differentiation, and new myelination events after SCI. Finally, our current
mouse model can be used to define OL responses in various other traumatic CNS injuries
such as stroke, TBI or ICH. Defining elements that are common to multiple injury models
may narrow down and help identify mechanisms that can be targeted to reduce white
matter damage and/or stimulate its repair.
Potential Clinical Implications
The oldest medical journal known to exist from ancient Egyptian times described
SCI as “an ailment not to be treated” (Whiteneck et al., 2009). Tremendous advances in
technology have accelerated knowledge about pathophysiological mechanisms
underlying SCI, but there are currently still no effective treatments acutely. This is in part
due to our lack of understanding of acute and chronic events that occur at the cellular
level of the injury. Until such progress has been made, we are still very far from being
able to develop clinically effective therapies that can treat SCI. In neurotrauma, the goal
of neuroprotective strategies is to minimize the secondary damage and therefore preserve
functional tissue. Neuroprotective strategies that target an individual component of
secondary injury- induced cellular death like excitotoxicity (Hawryluk et al., 2008) using
gacyclidine (a NMDA receptor antagonist) or nimodipine (a Ca2+ channel blocker) allow
other secondary injury associated mechanism to still progress. Importantly, both of these
failed to demonstrate chronic improvements in motor function (Pointillart et al., 2000).
As mentioned in Chapter 1, SCI involves several different cytotoxic mediators of
death which raises 3 important considerations for neuroprotective strategies: 1. the
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identification of cell-specific molecular mechanisms that contribute to death after SCI; 2.
the selection of adaptive/maladaptive mechanisms to target; 3. the potential consequences
target manipulation. Given that the amount of spared white matter after contusive
thoracic SCI largely determines the extent of functional recovery (Basso et al., 1995;
Blight, 1983a, 1983b; Blight et al., 1986; Bresnahan et al., 1987; Bresnahan et al. 1976;
Kelley et al., 2014; Kim et al., 2010; Loy et al., 2007), treatments for SCI should protect
OLs as they play a critical role in the formation and maintenance of white matter. The
identification of OL-specific mechanisms that occurs over the duration of SCI is perhaps
the most challenging, yet the most informative and critical step forward toward clinical
significance. Therefore in Chapter 3, we used RiboTag to obtain OL-specific gene
expression and identified candidate mechanisms that are activated post SCI that may
contribute to cell death or survival.
The regenerative potential of any neuroprotective strategies will likely depend on
the severity of injury, and also, its mechanism of action. Additionally, the extent of
neurological recovery that is achievable using neuroprotective therapy is unknown. For
instance, strategies can be selected to enhance survival and/or reduce death, but until we
can make some substantial progress bridging the gap in knowledge about preclinical SCI
studies and clinical injury trajectory and treatment, we can only speculate about such
approaches. For faster clinical translation, repurposed FDA approved pharmacological
agents will have the most potential to reach the largest amount of people the quickest.
However, despite all these uncertainties, it is evident that as time progresses post SCI and
numerous cytotoxic stressors begin to accumulate, it likely becomes an increasingly
difficult task to prevent death, until it reaches a point where it becomes impossible. There
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is a brief time frame that begins immediately after SCI when OLs activate responses that
help them contemplate between pro-survival and pro-death. Therefore, neuroprotective
interventions should coincide with this time frame and be administered quickly, as there
is likely a rapidly closing therapeutic window that maximizes cellular protection.
Neuroprotective treatments outside of this window will likely not be functionally
beneficial. Arguably, some mechanisms may be better to target than others. Of all the
options for neuroprotection, this simplest and most logical solution would be to inhibit
mechanisms that contribute to cell death or cell death directly. However, there are nearly
~22 different types of cellular death to choose from (Galluzzi et al., 2018) and just as
many different cytotoxic stressors that occur after SCI (Pukos et al. 2019). Data from
Chapter 3 suggest OLs launch a robust cellular and molecular response to SCI by 2 dpi.
How they respond likely depends on the combination of extrinsic, intrinsic, and
environmental factors. Because many of these pathways and mechanisms that lead to
death are deliberately redundant, it is effortless for the cell to find an alternative way to
die if one pathway is targeted and may perhaps be a reason why there hasn’t been any
clinical success which this approach (Hawryluk et al., 2008). This however could be
viewed as strength as it gives us the opportunity to identify and target mechanisms or
stressors that are common in mediating death, and therefore have broad widespread
implications. In the case of secondary injury induced death, oxidative stress damages
DNA, lipids, proteins, and mitochondria. Research described in the Chapter 3 identified
upregulated genes that can contribute to oxidative stress (Steap3) and reduce anti-oxidant
(Chac1) levels within the cell. Targeting these proteins using pharmacological inhibitors
would likely alleviate overall oxidative stress. A potential side effect of STEAP3 is the
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inhibition of myelin synthesis since Fe2+ is required for enzymatic activity. RUNX1 (a
transcription factor) is another attractive therapeutic target as manipulating this single
mechanism leads to extensive transcriptional and translation regulation of multiple
signaling molecules in a pathway. However, such broad changes may also have extensive
side effects given the wide scale of changes.
Despite fundamental differences in our model and underlying pathogenesis, the
cancer field in many regards faced similar hurdles that parallel the SCI neuroprotection
field. Thus, there are several key points we can learn from our colleagues who has had
remarkable success with manipulating cell death and survival (Baudino, 2015). For
instance, the combination of two or more chemotherapy agents is a hallmark of cancer
therapy and demonstrates a clear advantage over mono-therapy because of additive and
synergistic effects when targeting key mechanisms (Bayat Mokhtari et al., 2017). A clear
advantage over mono-therapy is that lower therapeutically relevant dosages can be used
to combat off target effects and reduce drug toxicity. A common example is the use of
CHOP (cyclophosphamide, hydroxydaunorubicin, oncovin, and prednisone), not be
confused with the pro-apoptotic ERSR effector CHOP, which individually function
through different mechanisms when treating lymphoma (Lenz et al., 2005). Therefore,
similar to inducing death in malignant cells, a combinatorial approach may perhaps be
needed to block various different cytotoxic events and reduce cellular death. In the
context of SCI, dual therapy is utilized in strategies that involve enhancing
neuroplasticity, such as combining physical therapy with epidural stimulation, but less
prevalent in neuroprotection (Harkema et al., 2011). A 2004 study from Mary Bunge’s
lab combined a neuroprotective strategy with cell therapy and showed greater motor
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improvement in groups with combined treatment when compared to mono-therapy
(Pearse et al., 2004). Taken together, the combinatorial approach has been used with
different treatment modalities in SCI, yet it is underutilized in the neuroprotective field.
Therefore, aside from identifying different mechanisms that may be targeted, a more
focused effort should be made on combining different treatments that have demonstrated
effectiveness with mono-therapy in animal models, and assess their potential synergistic
effects such as combinations of minocycline, gacyclidine, and nimodipine. However, if
we consider the same principle where the goal is to block death instead of inducing it as
in cancer, such strategies may still be insufficient to restore cellular homeostasis or
functionality, and therefore not likely to address the chronic neurological disabilities
associated with SCI. Inhibiting cell death mechanisms can prolong the therapeutic
window of intervention, but will inevitably lead to death if intrinsic survival mechanisms
are not enough to compensate and restore function to overcome secondary injury induced
stress. Importantly, this represents another opening for therapeutic intervention where it
would be advantageous to manipulate pro-survival mechanisms identified in Chapter 3
and enhance or facilitate endogenous responses that restore homeostasis. For instance,
molecular activation of Sphk1 can lead to Akt signaling-induced proliferation of non-post
mitotic cells, enhance survival, and directly inhibit apoptosis (Guan et al., 2011;
Kapitonov et al., 2009)
As extensively described in Chapter 2, HIF-PHDs are one seemingly perfect
target: 1. there are multiple molecular inhibitors currently developed for HIF-PHDs
(Joharapurkar et al., 2018) 2. HIF-PHD can target a downstream transcription factor,
ATF4, which acts as a downstream effector for several different stress responses
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including the ERSR and ISR (Karuppagounder et al., 2016). By manipulating ATF4 there
is a potential to not only reduce cell death but also enhance endogenous survival
mechanisms that may aim to restore stress-induced aberrant OL behavior (Harding et al.,
2000). 3. HIF-PHD inhibition can lead to HIF1α (transcription factor) induction which
activates genes involved in angiogenesis, vessel dilatation, and apoptosis inhibition
(Ziello et al., 2007). 4. HIF-PHD inhibitors have a protective effect by reducing damage
in animal models of intracerebral hemorrhage and hypoxia-ischemia (Karuppagounder et
al., 2016; Li et al., 2019a). 5. Currently HIF-PHD inhibitors (FG-4592, GSK1278863,
Molidustat and Vadadustat) are being tested in 27 clinical trials involving anemia. In
summation, with one pharmacological agent, HIF-PHD inhibition modulates two
transcriptional pathways that are heavily involved in mediating endogenous
survival/death and therefore likely to restore homeostasis. Furthermore, the majority of
literature shows an overwhelming positive role of PHD inhibition, although there have
been some reports linking aberrant HIF activation and PHD knockdown to cancer
(Semenza, 2010). However, adaptaquin had no effect on WMS or BMS locomotor
outcomes after thoracic SCI suggesting that mechanisms of grey matter damage are
different from those of white matter damage. Our results show that adaptaquin
moderately lowered acute induction of Atf4/Chop mRNAs but this was insufficient to
provide enough protection against white matter pathologies. These data suggest that PHD
inhibition may improve functional outcomes in lumbar or cervical models of SCI and
subarachnoid hemorrhage (SAH), where neuronal death is paramount to loss of function
(Hadi et al., 2000; Magnuson et al., 1999; Nishida et al., 2015). Importantly, despite the
lack of effect in thoracic SCI, adaptaquin’s multiple potential clinical implications in
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various diseases does provide hope that our approach of targeting mechanisms that are
central to multiple stress responses may one day be successful in SCI.
The journey to developing a treatment for acute SCI is a long and arduous.
Although there is an urgent need to develop clinically relevant translatable therapies, we
are severely lacking a fundamental understanding of events that occur at the cellular level
after SCI. However, despite these limitations, we are now better equipped than ever
before to observe these events and further use a systematic approach that is mechanism
driven to identify potential therapeutics.
Conclusion
Traumatic SCI is a complex pathology characterized by the loss of gray and white
matter that results in permanent neurological impairment. Although research on SCI has
been ongoing for over a century (Allen, 1911), the underlying pathophysiology of SCI is
still not well understood and therefore hampers our ability to develop clinically
meaningful treatments. Currently, there is no treatment for acute SCI that offer consistent
neuroprotection. However, rapid advances in technology, neurobiological knowledge,
preclinical animal models, and transgenic animals have equipped us with unprecedented
new tools to examine and discover events occurring at the cellular level after SCI that
may serve as novel targets for neuroprotective strategies. The work in this dissertation
was enabled by such progresses, and represents a small but necessary step forward in
advancing the field of SCI research. Here, we showed that the pharmacological agent,
adaptaquin, which offers neuroprotection in several models of CNS injury, and functions
by inhibiting a newly characterized type of cell death, ferroptosis, is ineffective in
protecting against white matter loss and improving locomotor outcome after SCI. Next
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we generated one of the most comprehensive descriptions of OL-specific translational
gene expression after SCI. Taken together, we are increasing our fundamental knowledge
of SCI mechanisms at remarkable pace, but more work is still needed to identify and fully
comprehend the complex cascade of events that occur after SCI before we are able to
translate these findings into clinical applications for humans. However, the work
presented here sets the contextual framework for others to build up and generate new
hypotheses that can be tested in a more sophisticated manner as technology improves to
ultimately develop a treatment for SCI.

121

REFERENCES

Adamson, B., Norman, T. M., Jost, M., Cho, M. Y., Nunez, J. K., Chen, Y., . . .
Weissman, J. S. (2016). A Multiplexed Single-Cell CRISPR Screening Platform
Enables Systematic Dissection of the Unfolded Protein Response. Cell, 167(7),
1867-1882 e1821. doi:10.1016/j.cell.2016.11.048
Ahuja, C. S., Wilson, J. R., Nori, S., Kotter, M. R. N., Druschel, C., Curt, A., & Fehlings,
M. G. (2017). Traumatic spinal cord injury. Nat Rev Dis Primers, 3, 17018.
doi:10.1038/nrdp.2017.18
Aime, P., Karuppagounder, S. S., Rao, A., Chen, Y., Burke, R. E., Ratan, R. R., &
Greene, L. A. (2020). The drug adaptaquin blocks ATF4/CHOP-dependent prodeath Trib3 induction and protects in cellular and mouse models of Parkinson's
disease. Neurobiol Dis, 136, 104725. doi:10.1016/j.nbd.2019.104725
Allen, A. R. (1911). SURGERY OF EXPERIMENTAL LESION OF SPINAL CORD
EQUIVALENT TO CRUSH INJURY OF FRACTURE DISLOCATION OF
SPINAL COLUMN: A PRELIMINARY REPORT. Journal of the American
Medical Association, LVII(11), 878-880.
doi:10.1001/jama.1911.04260090100008 %J Journal of the American Medical
Association
Almad, A., Sahinkaya, F. R., & McTigue, D. M. (2011). Oligodendrocyte fate after spinal
cord injury. Neurotherapeutics, 8(2), 262-273. doi:10.1007/s13311-011-0033-5
Anderson, M. A., Burda, J. E., Ren, Y., Ao, Y., O'Shea, T. M., Kawaguchi, R., . . .
Sofroniew, M. V. (2016). Astrocyte scar formation aids central nervous system
axon regeneration. Nature, 532(7598), 195-200. doi:10.1038/nature17623
Anthes, D. L., Theriault, E., & Tator, C. H. (1996). Ultrastructural evidence for arteriolar
vasospasm after spinal cord trauma. Neurosurgery, 39(4), 804-814.
doi:10.1097/00006123-199610000-00032
Ashby, M. C., & Tepikin, A. V. (2001). ER calcium and the functions of intracellular
organelles. Semin Cell Dev Biol, 12(1), 11-17. doi:10.1006/scdb.2000.0212
Bansal, R., & Pfeiffer, S. E. (1997). FGF-2 converts mature oligodendrocytes to a novel
phenotype. J Neurosci Res, 50(2), 215-228. doi:10.1002/(SICI)10974547(19971015)50:2<215::AID-JNR10>3.0.CO;2-7
Barres, B. A., & Raff, M. C. (1993). Proliferation of oligodendrocyte precursor cells
depends on electrical activity in axons. Nature, 361(6409), 258-260.
doi:10.1038/361258a0
Barres, B. A., & Raff, M. C. (1999). Axonal control of oligodendrocyte development. J
Cell Biol, 147(6), 1123-1128. doi:10.1083/jcb.147.6.1123
Basso, D. M., Fisher, L. C., Anderson, A. J., Jakeman, L. B., McTigue, D. M., &
Popovich, P. G. (2006). Basso Mouse Scale for locomotion detects differences in

122

recovery after spinal cord injury in five common mouse strains. J Neurotrauma, 23(5),
635-659. doi:10.1089/neu.2006.23.635
Baudino, T. A. (2015). Targeted Cancer Therapy: The Next Generation of Cancer
Treatment. Curr Drug Discov Technol, 12(1), 3-20.
doi:10.2174/1570163812666150602144310
Baumann, N., & Pham-Dinh, D. (2001). Biology of oligodendrocyte and myelin in the
mammalian central nervous system. Physiol Rev, 81(2), 871-927.
doi:10.1152/physrev.2001.81.2.871
Bayat Mokhtari, R., Homayouni, T. S., Baluch, N., Morgatskaya, E., Kumar, S., Das, B.,
& Yeger, H. (2017). Combination therapy in combating cancer. Oncotarget,
8(23), 38022-38043. doi:10.18632/oncotarget.16723
Beattie, E. C., Stellwagen, D., Morishita, W., Bresnahan, J. C., Ha, B. K., Von Zastrow,
M., . . . Malenka, R. C. (2002a). Control of synaptic strength by glial TNFalpha.
Science, 295(5563), 2282-2285. doi:10.1126/science.1067859
Beattie, M. S. (2004). Inflammation and apoptosis: linked therapeutic targets in spinal
cord injury. Trends Mol Med, 10(12), 580-583.
doi:10.1016/j.molmed.2004.10.006
Beattie, M. S., Harrington, A. W., Lee, R., Kim, J. Y., Boyce, S. L., Longo, F. M., . . .
Yoon, S. O. (2002b). ProNGF induces p75-mediated death of oligodendrocytes
following spinal cord injury. Neuron, 36(3), 375-386. doi:10.1016/s08966273(02)01005-x
Beattie, M. S., Hermann, G. E., Rogers, R. C., & Bresnahan, J. C. (2002c). Cell death in
models of spinal cord injury. Prog Brain Res, 137, 37-47. doi:10.1016/s00796123(02)37006-7
Beattie, M. S., Li, Q., & Bresnahan, J. C. (2000). Cell death and plasticity after
experimental spinal cord injury. Prog Brain Res, 128, 9-21. doi:10.1016/S00796123(00)28003-5
Bellacosa, A., de Feo, D., Godwin, A. K., Bell, D. W., Cheng, J. Q., Altomare, D. A., . . .
Testa, J. R. (1995). Molecular alterations of the AKT2 oncogene in ovarian and
breast carcinomas. Int J Cancer, 64(4), 280-285. doi:10.1002/ijc.2910640412
Bellacosa, A., Kumar, C. C., Di Cristofano, A., & Testa, J. R. (2005). Activation of AKT
kinases in cancer: implications for therapeutic targeting. Adv Cancer Res, 94, 2986. doi:10.1016/S0065-230X(05)94002-5
Benton, R. L., & Hagg, T. (2011). Vascular Pathology as a Potential Therapeutic Target
in SCI. Transl Stroke Res, 2(4), 556-574. doi:10.1007/s12975-011-0128-7
Bergsbaken, T., Fink, S. L., & Cookson, B. T. (2009). Pyroptosis: host cell death and
inflammation. Nat Rev Microbiol, 7(2), 99-109. doi:10.1038/nrmicro2070
Bhat, N. R., & Zhang, P. (1996). Activation of mitogen-activated protein kinases in
oligodendrocytes. J Neurochem, 66(5), 1986-1994. doi:10.1046/j.14714159.1996.66051986.x
Bhat, N. R., Zhang, P., & Mohanty, S. B. (2007). p38 MAP kinase regulation of
oligodendrocyte differentiation with CREB as a potential target. Neurochem Res,
32(2), 293-302. doi:10.1007/s11064-006-9274-9
Blais, J. D., Filipenko, V., Bi, M., Harding, H. P., Ron, D., Koumenis, C., . . . Bell, J. C.
(2004). Activating transcription factor 4 is translationally regulated by hypoxic

123

stress. Mol Cell Biol, 24(17), 7469-7482. doi:10.1128/MCB.24.17.74697482.2004
Boyce, M., & Yuan, J. (2006). Cellular response to endoplasmic reticulum stress: a
matter of life or death. Cell Death Differ, 13(3), 363-373.
doi:10.1038/sj.cdd.4401817
Boyd, A., Zhang, H., & Williams, A. (2013). Insufficient OPC migration into
demyelinated lesions is a cause of poor remyelination in MS and mouse models.
Acta Neuropathol, 125(6), 841-859. doi:10.1007/s00401-013-1112-y
Bradl, M., & Lassmann, H. (2010). Oligodendrocytes: biology and pathology. Acta
Neuropathol, 119(1), 37-53. doi:10.1007/s00401-009-0601-5
Brown, M., Strudwick, N., Suwara, M., Sutcliffe, L. K., Mihai, A. D., Ali, A. A., . . .
Schroder, M. (2016). An initial phase of JNK activation inhibits cell death early in
the endoplasmic reticulum stress response. J Cell Sci, 129(12), 2317-2328.
doi:10.1242/jcs.179127
Caprariello, A. V., Mangla, S., Miller, R. H., & Selkirk, S. M. (2012). Apoptosis of
oligodendrocytes in the central nervous system results in rapid focal
demyelination. Ann Neurol, 72(3), 395-405. doi:10.1002/ana.23606
Carroll, M., Dyer, J., & Sossin, W. S. (2006). Serotonin increases phosphorylation of
synaptic 4EBP through TOR, but eukaryotic initiation factor 4E levels do not
limit somatic cap-dependent translation in aplysia neurons. Mol Cell Biol, 26(22),
8586-8598. doi:10.1128/MCB.00955-06
Casci, T., Vinos, J., & Freeman, M. (1999). Sprouty, an intracellular inhibitor of Ras
signaling. Cell, 96(5), 655-665. doi:10.1016/s0092-8674(00)80576-0
Casha, S., Yu, W. R., & Fehlings, M. G. (2005). FAS deficiency reduces apoptosis,
spares axons and improves function after spinal cord injury. Exp Neurol, 196(2),
390-400. doi:10.1016/j.expneurol.2005.08.020
Chen, A., Muzzio, I. A., Malleret, G., Bartsch, D., Verbitsky, M., Pavlidis, P., . . .
Kandel, E. R. (2003). Inducible enhancement of memory storage and synaptic
plasticity in transgenic mice expressing an inhibitor of ATF4 (CREB-2) and
C/EBP proteins. Neuron, 39(4), 655-669. doi:10.1016/s0896-6273(03)00501-4
Chen, J. J. (2014). Translational control by heme-regulated eIF2alpha kinase during
erythropoiesis. Curr Opin Hematol, 21(3), 172-178.
doi:10.1097/MOH.0000000000000030
Chen, K., Deng, S., Lu, H., Zheng, Y., Yang, G., Kim, D., . . . Wu, J. Q. (2013a). RNAseq characterization of spinal cord injury transcriptome in acute/subacute phases:
a resource for understanding the pathology at the systems level. PLoS One, 8(8),
e72567. doi:10.1371/journal.pone.0072567
Chen, Y., & Brandizzi, F. (2013b). IRE1: ER stress sensor and cell fate executor. Trends
Cell Biol, 23(11), 547-555. doi:10.1016/j.tcb.2013.06.005
Chipuk, J. E., Bouchier-Hayes, L., & Green, D. R. (2006). Mitochondrial outer
membrane permeabilization during apoptosis: the innocent bystander scenario.
Cell Death Differ, 13(8), 1396-1402. doi:10.1038/sj.cdd.4401963
Choy, M. S., Yusoff, P., Lee, I. C., Newton, J. C., Goh, C. W., Page, R., . . . Peti, W.
(2015). Structural and Functional Analysis of the GADD34:PP1 eIF2alpha
Phosphatase. Cell Rep, 11(12), 1885-1891. doi:10.1016/j.celrep.2015.05.043

124

Clemens, M. J. (2004). Targets and mechanisms for the regulation of translation in
malignant transformation. Oncogene, 23(18), 3180-3188.
doi:10.1038/sj.onc.1207544
Cohen, R. I., Marmur, R., Norton, W. T., Mehler, M. F., & Kessler, J. A. (1996). Nerve
growth factor and neurotrophin-3 differentially regulate the proliferation and
survival of developing rat brain oligodendrocytes. J Neurosci, 16(20), 6433-6442.
Coleman, M. L., Sahai, E. A., Yeo, M., Bosch, M., Dewar, A., & Olson, M. F. (2001).
Membrane blebbing during apoptosis results from caspase-mediated activation of
ROCK I. Nat Cell Biol, 3(4), 339-345. doi:10.1038/35070009
Connor, J. R., & Menzies, S. L. (1996). Relationship of iron to oligodendrocytes and
myelination. Glia, 17(2), 83-93. doi:10.1002/(SICI)10981136(199606)17:2<83::AID-GLIA1>3.0.CO;2-7
Corona, C., Pasini, S., Liu, J., Amar, F., Greene, L. A., & Shelanski, M. L. (2018).
Activating Transcription Factor 4 (ATF4) Regulates Neuronal Activity by
Controlling GABABR Trafficking. J Neurosci, 38(27), 6102-6113.
doi:10.1523/JNEUROSCI.3350-17.2018
Costa-Mattioli, M., & Walter, P. (2020). The integrated stress response: From mechanism
to disease. Science, 368(6489). doi:10.1126/science.aat5314
Craig, E. A. (1985). The heat shock response. CRC Crit Rev Biochem, 18(3), 239-280.
doi:10.3109/10409238509085135
Crowe, M. J., Bresnahan, J. C., Shuman, S. L., Masters, J. N., & Beattie, M. S. (1997).
Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys.
Nat Med, 3(1), 73-76. doi:10.1038/nm0197-73
Cudrici, C., Niculescu, T., Niculescu, F., Shin, M. L., & Rus, H. (2006). Oligodendrocyte
cell death in pathogenesis of multiple sclerosis: Protection of oligodendrocytes
from apoptosis by complement. J Rehabil Res Dev, 43(1), 123-132.
doi:10.1682/jrrd.2004.08.0111
Cummins, E. P., Berra, E., Comerford, K. M., Ginouves, A., Fitzgerald, K. T.,
Seeballuck, F., . . . Taylor, C. T. (2006). Prolyl hydroxylase-1 negatively regulates
IkappaB kinase-beta, giving insight into hypoxia-induced NFkappaB activity.
Proc Natl Acad Sci U S A, 103(48), 18154-18159. doi:10.1073/pnas.0602235103
D'Antonio, M., Feltri, M. L., & Wrabetz, L. (2009). Myelin under stress. J Neurosci Res,
87(15), 3241-3249. doi:10.1002/jnr.22066
D'Arcy, M. S. (2019). Cell death: a review of the major forms of apoptosis, necrosis and
autophagy. Cell Biol Int, 43(6), 582-592. doi:10.1002/cbin.11137
D'Ignazio, L., & Rocha, S. (2016). Hypoxia Induced NF-kappaB. Cells, 5(1).
doi:10.3390/cells5010010
Dara, L., Ji, C., & Kaplowitz, N. (2011). The contribution of endoplasmic reticulum
stress to liver diseases. Hepatology, 53(5), 1752-1763. doi:10.1002/hep.24279
Dawson, M. R., Polito, A., Levine, J. M., & Reynolds, R. (2003). NG2-expressing glial
progenitor cells: an abundant and widespread population of cycling cells in the
adult rat CNS. Mol Cell Neurosci, 24(2), 476-488. doi:10.1016/s10447431(03)00210-0
de Bont, C. M., Boelens, W. C., & Pruijn, G. J. M. (2019). NETosis, complement, and
coagulation: a triangular relationship. Cell Mol Immunol, 16(1), 19-27.
doi:10.1038/s41423-018-0024-0
125

de Rivero Vaccari, J. P., Bastien, D., Yurcisin, G., Pineau, I., Dietrich, W. D., De
Koninck, Y., . . . Lacroix, S. (2012). P2X4 receptors influence inflammasome
activation after spinal cord injury. J Neurosci, 32(9), 3058-3066.
doi:10.1523/JNEUROSCI.4930-11.2012
Desai, M. K., Mastrangelo, M. A., Ryan, D. A., Sudol, K. L., Narrow, W. C., & Bowers,
W. J. (2010). Early oligodendrocyte/myelin pathology in Alzheimer's disease
mice constitutes a novel therapeutic target. Am J Pathol, 177(3), 1422-1435.
doi:10.2353/ajpath.2010.100087
Dewang, P. M., Hsu, N. M., Peng, S. Z., & Li, W. R. (2005). Protein tyrosine
phosphatases and their inhibitors. Curr Med Chem, 12(1), 1-22.
doi:10.2174/0929867053363504
Dixon, S. J., Lemberg, K. M., Lamprecht, M. R., Skouta, R., Zaitsev, E. M., Gleason, C.
E., . . . Stockwell, B. R. (2012). Ferroptosis: an iron-dependent form of
nonapoptotic cell death. Cell, 149(5), 1060-1072. doi:10.1016/j.cell.2012.03.042
Dixon, S. J., Patel, D. N., Welsch, M., Skouta, R., Lee, E. D., Hayano, M., . . . Stockwell,
B. R. (2014). Pharmacological inhibition of cystine-glutamate exchange induces
endoplasmic reticulum stress and ferroptosis. Elife, 3, e02523.
doi:10.7554/eLife.02523
Doerflinger, N. H., Macklin, W. B., & Popko, B. (2003). Inducible site-specific
recombination in myelinating cells. Genesis, 35(1), 63-72.
doi:10.1002/gene.10154
Dong, H., Fazzaro, A., Xiang, C., Korsmeyer, S. J., Jacquin, M. F., & McDonald, J. W.
(2003). Enhanced oligodendrocyte survival after spinal cord injury in Baxdeficient mice and mice with delayed Wallerian degeneration. J Neurosci, 23(25),
8682-8691.
Donnelly, D. J., & Popovich, P. G. (2008). Inflammation and its role in neuroprotection,
axonal regeneration and functional recovery after spinal cord injury. Exp Neurol,
209(2), 378-388. doi:10.1016/j.expneurol.2007.06.009
Ducker, T. B., Kindt, G. W., & Kempf, L. G. (1971). Pathological findings in acute
experimental spinal cord trauma. J Neurosurg, 35(6), 700-708.
doi:10.3171/jns.1971.35.6.0700
Dumont, R. J., Okonkwo, D. O., Verma, S., Hurlbert, R. J., Boulos, P. T., Ellegala, D. B.,
& Dumont, A. S. (2001). Acute spinal cord injury, part I: pathophysiologic
mechanisms. Clin Neuropharmacol, 24(5), 254-264. doi:10.1097/00002826200109000-00002
Duncan, I. D., & Radcliff, A. B. (2016). Inherited and acquired disorders of myelin: The
underlying myelin pathology. Exp Neurol, 283(Pt B), 452-475.
doi:10.1016/j.expneurol.2016.04.002
Duronio, V. (2008). The life of a cell: apoptosis regulation by the PI3K/PKB pathway.
Biochem J, 415(3), 333-344. doi:10.1042/BJ20081056
Edwards, L. A., Thiessen, B., Dragowska, W. H., Daynard, T., Bally, M. B., & Dedhar,
S. (2005). Inhibition of ILK in PTEN-mutant human glioblastomas inhibits
PKB/Akt activation, induces apoptosis, and delays tumor growth. Oncogene,
24(22), 3596-3605. doi:10.1038/sj.onc.1208427
Elmore, S. (2007). Apoptosis: a review of programmed cell death. Toxicol Pathol, 35(4),
495-516. doi:10.1080/01926230701320337
126

Emery, E., Aldana, P., Bunge, M. B., Puckett, W., Srinivasan, A., Keane, R. W., . . .
Levi, A. D. (1998). Apoptosis after traumatic human spinal cord injury. J
Neurosurg, 89(6), 911-920. doi:10.3171/jns.1998.89.6.0911
Evans, C., Hardin, J., & Stoebel, D. M. (2018). Selecting between-sample RNA-Seq
normalization methods from the perspective of their assumptions. Brief
Bioinform, 19(5), 776-792. doi:10.1093/bib/bbx008
Eyers, P. A., Keeshan, K., & Kannan, N. (2017). Tribbles in the 21st Century: The
Evolving Roles of Tribbles Pseudokinases in Biology and Disease. Trends Cell
Biol, 27(4), 284-298. doi:10.1016/j.tcb.2016.11.002
Falcao, A. M., van Bruggen, D., Marques, S., Meijer, M., Jakel, S., Agirre, E., . . .
Castelo-Branco, G. (2018). Disease-specific oligodendrocyte lineage cells arise in
multiple sclerosis. Nat Med, 24(12), 1837-1844. doi:10.1038/s41591-018-0236-y
Fassbender, J. M., Whittemore, S. R., & Hagg, T. (2011). Targeting microvasculature for
neuroprotection after SCI. Neurotherapeutics, 8(2), 240-251. doi:10.1007/s13311011-0029-1
Fong, G. H., & Takeda, K. (2008). Role and regulation of prolyl hydroxylase domain
proteins. Cell Death Differ, 15(4), 635-641. doi:10.1038/cdd.2008.10
Frank, D., & Vince, J. E. (2019). Pyroptosis versus necroptosis: similarities, differences,
and crosstalk. Cell Death Differ, 26(1), 99-114. doi:10.1038/s41418-018-0212-6
Fresno Vara, J. A., Casado, E., de Castro, J., Cejas, P., Belda-Iniesta, C., & GonzalezBaron, M. (2004). PI3K/Akt signalling pathway and cancer. Cancer Treat Rev,
30(2), 193-204. doi:10.1016/j.ctrv.2003.07.007
Fukutoku, T., Kumagai, G., Fujita, T., Sasaki, A., Wada, K., Liu, X., . . . Ishibashi, Y.
(2020). Sex-Related Differences in Anxiety and Functional Recovery after Spinal
Cord Injury in Mice. J Neurotrauma, 37(21), 2235-2243.
doi:10.1089/neu.2019.6929
Fuss, B., Afshari, F. S., Colello, R. J., & Macklin, W. B. (2001). Normal CNS
myelination in transgenic mice overexpressing MHC class I H-2L(d) in
oligodendrocytes. Mol Cell Neurosci, 18(2), 221-234.
doi:10.1006/mcne.2001.1011
Galehdar, Z., Swan, P., Fuerth, B., Callaghan, S. M., Park, D. S., & Cregan, S. P. (2010).
Neuronal apoptosis induced by endoplasmic reticulum stress is regulated by
ATF4-CHOP-mediated induction of the Bcl-2 homology 3-only member PUMA.
J Neurosci, 30(50), 16938-16948. doi:10.1523/JNEUROSCI.1598-10.2010
Gallo, V., Zhou, J. M., McBain, C. J., Wright, P., Knutson, P. L., & Armstrong, R. C.
(1996). Oligodendrocyte progenitor cell proliferation and lineage progression are
regulated by glutamate receptor-mediated K+ channel block. J Neurosci, 16(8),
2659-2670.
Galluzzi, L., Vitale, I., Aaronson, S. A., Abrams, J. M., Adam, D., Agostinis, P., . . .
Kroemer, G. (2018). Molecular mechanisms of cell death: recommendations of
the Nomenclature Committee on Cell Death 2018. Cell Death Differ, 25(3), 486541. doi:10.1038/s41418-017-0012-4
Gardner, B. M., Pincus, D., Gotthardt, K., Gallagher, C. M., & Walter, P. (2013).
Endoplasmic reticulum stress sensing in the unfolded protein response. Cold
Spring Harb Perspect Biol, 5(3), a013169. doi:10.1101/cshperspect.a013169

127

Gencic, S., Abuelo, D., Ambler, M., & Hudson, L. D. (1989). Pelizaeus-Merzbacher
disease: an X-linked neurologic disorder of myelin metabolism with a novel
mutation in the gene encoding proteolipid protein. Am J Hum Genet, 45(3), 435442.
Genovese, T., Esposito, E., Mazzon, E., Muia, C., Di Paola, R., Meli, R., . . . Cuzzocrea,
S. (2008). Evidence for the role of mitogen-activated protein kinase signaling
pathways in the development of spinal cord injury. J Pharmacol Exp Ther,
325(1), 100-114. doi:10.1124/jpet.107.131060
Genuth, N. R., & Barna, M. (2018). The Discovery of Ribosome Heterogeneity and Its
Implications for Gene Regulation and Organismal Life. Mol Cell, 71(3), 364-374.
doi:10.1016/j.molcel.2018.07.018
German, O. L., Miranda, G. E., Abrahan, C. E., & Rotstein, N. P. (2006). Ceramide is a
mediator of apoptosis in retina photoreceptors. Invest Ophthalmol Vis Sci, 47(4),
1658-1668. doi:10.1167/iovs.05-1310
Ghasemi, N., Razavi, S., & Nikzad, E. (2017). Multiple Sclerosis: Pathogenesis,
Symptoms, Diagnoses and Cell-Based Therapy. Cell J, 19(1), 1-10.
doi:10.22074/cellj.2016.4867
Glick, D., Barth, S., & Macleod, K. F. (2010). Autophagy: cellular and molecular
mechanisms. J Pathol, 221(1), 3-12. doi:10.1002/path.2697
Goldman, S. A., & Kuypers, N. J. (2015). How to make an oligodendrocyte.
Development, 142(23), 3983-3995. doi:10.1242/dev.126409
Gregory, J. A., Hoelzli, E., Abdelaal, R., Braine, C., Cuevas, M., Halpern, M., . . .
Phatnani, H. (2020). Cell Type-Specific In Vitro Gene Expression Profiling of
Stem Cell-Derived Neural Models. Cells, 9(6). doi:10.3390/cells9061406
Guan, H., Song, L., Cai, J., Huang, Y., Wu, J., Yuan, J., . . . Li, M. (2011). Sphingosine
kinase 1 regulates the Akt/FOXO3a/Bim pathway and contributes to apoptosis
resistance in glioma cells. PLoS One, 6(5), e19946.
doi:10.1371/journal.pone.0019946
Gudz, T. I., Schneider, T. E., Haas, T. A., & Macklin, W. B. (2002). Myelin proteolipid
protein forms a complex with integrins and may participate in integrin receptor
signaling in oligodendrocytes. J Neurosci, 22(17), 7398-7407.
Guo, G., & Bhat, N. R. (2007). p38alpha MAP kinase mediates hypoxia-induced motor
neuron cell death: a potential target of minocycline's neuroprotective action.
Neurochem Res, 32(12), 2160-2166. doi:10.1007/s11064-007-9408-8
Hacohen, N., Kramer, S., Sutherland, D., Hiromi, Y., & Krasnow, M. A. (1998). sprouty
encodes a novel antagonist of FGF signaling that patterns apical branching of the
Drosophila airways. Cell, 92(2), 253-263. doi:10.1016/s0092-8674(00)80919-8
Hadi, B., Zhang, Y. P., Burke, D. A., Shields, C. B., & Magnuson, D. S. (2000). Lasting
paraplegia caused by loss of lumbar spinal cord interneurons in rats: no direct
correlation with motor neuron loss. J Neurosurg, 93(2 Suppl), 266-275.
doi:10.3171/spi.2000.93.2.0266
Haimon, Z., Volaski, A., Orthgiess, J., Boura-Halfon, S., Varol, D., Shemer, A., . . . Jung,
S. (2018). Re-evaluating microglia expression profiles using RiboTag and cell
isolation strategies. Nat Immunol, 19(6), 636-644. doi:10.1038/s41590-018-01106

128

Han, J., Back, S. H., Hur, J., Lin, Y. H., Gildersleeve, R., Shan, J., . . . Kaufman, R. J.
(2013). ER-stress-induced transcriptional regulation increases protein synthesis
leading to cell death. Nat Cell Biol, 15(5), 481-490. doi:10.1038/ncb2738
Harding, H. P., Novoa, I., Zhang, Y., Zeng, H., Wek, R., Schapira, M., & Ron, D. (2000).
Regulated translation initiation controls stress-induced gene expression in
mammalian cells. Mol Cell, 6(5), 1099-1108. doi:10.1016/s1097-2765(00)001088
Harding, H. P., Zhang, Y., Zeng, H., Novoa, I., Lu, P. D., Calfon, M., . . . Ron, D. (2003).
An integrated stress response regulates amino acid metabolism and resistance to
oxidative stress. Mol Cell, 11(3), 619-633. doi:10.1016/s1097-2765(03)00105-9
Harkema, S., Gerasimenko, Y., Hodes, J., Burdick, J., Angeli, C., Chen, Y., . . . Edgerton,
V. R. (2011). Effect of epidural stimulation of the lumbosacral spinal cord on
voluntary movement, standing, and assisted stepping after motor complete
paraplegia: a case study. Lancet, 377(9781), 1938-1947. doi:10.1016/S01406736(11)60547-3
Hartl, F. U., Bracher, A., & Hayer-Hartl, M. (2011). Molecular chaperones in protein
folding and proteostasis. Nature, 475(7356), 324-332. doi:10.1038/nature10317
Hausmann, O. N. (2003). Post-traumatic inflammation following spinal cord injury.
Spinal Cord, 41(7), 369-378. doi:10.1038/sj.sc.3101483
Hawryluk, G. W., Rowland, J., Kwon, B. K., & Fehlings, M. G. (2008). Protection and
repair of the injured spinal cord: a review of completed, ongoing, and planned
clinical trials for acute spinal cord injury. Neurosurg Focus, 25(5), E14.
doi:10.3171/FOC.2008.25.11.E14
Head, S. R., Komori, H. K., LaMere, S. A., Whisenant, T., Van Nieuwerburgh, F.,
Salomon, D. R., & Ordoukhanian, P. (2014). Library construction for nextgeneration sequencing: overviews and challenges. Biotechniques, 56(2), 61-64,
66, 68, passim. doi:10.2144/000114133
Heiman, M., Kulicke, R., Fenster, R. J., Greengard, P., & Heintz, N. (2014). Cell typespecific mRNA purification by translating ribosome affinity purification (TRAP).
Nat Protoc, 9(6), 1282-1291. doi:10.1038/nprot.2014.085
Heneberg, P. (2009). Use of protein tyrosine phosphatase inhibitors as promising targeted
therapeutic drugs. Curr Med Chem, 16(6), 706-733.
doi:10.2174/092986709787458407
Heo, J. H., Lee, S. T., Kon, C., Park, H. J., Shim, J. Y., & Kim, M. (2009). White matter
hyperintensities and cognitive dysfunction in Alzheimer disease. J Geriatr
Psychiatry Neurol, 22(3), 207-212. doi:10.1177/0891988709335800
Hershey, J. W., Sonenberg, N., & Mathews, M. B. (2012). Principles of translational
control: an overview. Cold Spring Harb Perspect Biol, 4(12).
doi:10.1101/cshperspect.a011528
Hesp, Z. C., Goldstein, E. Z., Miranda, C. J., Kaspar, B. K., & McTigue, D. M. (2015).
Chronic oligodendrogenesis and remyelination after spinal cord injury in mice
and rats. J Neurosci, 35(3), 1274-1290. doi:10.1523/JNEUROSCI.2568-14.2015
Hetz, C. (2012). The unfolded protein response: controlling cell fate decisions under ER
stress and beyond. Nat Rev Mol Cell Biol, 13(2), 89-102. doi:10.1038/nrm3270
Hoffman-Zacharska, D., Mierzewska, H., Szczepanik, E., Poznanski, J., Mazurczak, T.,
Jakubiuk-Tomaszuk, A., . . . Bal, J. (2013). The spectrum of PLP1 gene mutations
129

in patients with the classical form of the Pelizaeus-Merzbacher disease. Med
Wieku Rozwoj, 17(4), 293-300.
Holcik, M., Sonenberg, N., & Korneluk, R. G. (2000). Internal ribosome initiation of
translation and the control of cell death. Trends Genet, 16(10), 469-473.
doi:10.1016/s0168-9525(00)02106-5
Holz, M. K., Ballif, B. A., Gygi, S. P., & Blenis, J. (2005). mTOR and S6K1 mediate
assembly of the translation preinitiation complex through dynamic protein
interchange and ordered phosphorylation events. Cell, 123(4), 569-580.
doi:10.1016/j.cell.2005.10.024
Hong, S. H., Lee, D. H., Lee, Y. S., Jo, M. J., Jeong, Y. A., Kwon, W. T., . . . Lee, Y. J.
(2017). Molecular crosstalk between ferroptosis and apoptosis: emerging role of
ER stress-induced p53-independent PUMA expression. Oncotarget, 8(70),
115164-115178. doi:10.18632/oncotarget.23046
Hoshino, T., Yamakado, H., Takahashi, R., & Matsuzawa, S. I. (2020). Susceptibility to
erastin-induced ferroptosis decreases during maturation in a human
oligodendrocyte cell line. FEBS Open Bio, 10(9), 1758-1764. doi:10.1002/22115463.12923
Hu, A. M., Li, J. J., Sun, W., Yang, D. G., Yang, M. L., Du, L. J., . . . Gao, L. J. (2015).
Myelotomy reduces spinal cord edema and inhibits aquaporin-4 and aquaporin-9
expression in rats with spinal cord injury. Spinal Cord, 53(2), 98-102.
doi:10.1038/sc.2014.209
Hu, H., Tian, M., Ding, C., & Yu, S. (2018). The C/EBP Homologous Protein (CHOP)
Transcription Factor Functions in Endoplasmic Reticulum Stress-Induced
Apoptosis and Microbial Infection. Front Immunol, 9, 3083.
doi:10.3389/fimmu.2018.03083
Hu, J. G., Fu, S. L., Wang, Y. X., Li, Y., Jiang, X. Y., Wang, X. F., . . . Xu, X. M. (2008).
Platelet-derived growth factor-AA mediates oligodendrocyte lineage
differentiation through activation of extracellular signal-regulated kinase
signaling pathway. Neuroscience, 151(1), 138-147.
doi:10.1016/j.neuroscience.2007.10.050
Inohara, N., Ding, L., Chen, S., & Nunez, G. (1997). harakiri, a novel regulator of cell
death, encodes a protein that activates apoptosis and interacts selectively with
survival-promoting proteins Bcl-2 and Bcl-X(L). EMBO J, 16(7), 1686-1694.
doi:10.1093/emboj/16.7.1686
Inoue, K. (2017). Cellular Pathology of Pelizaeus-Merzbacher Disease Involving
Chaperones Associated with Endoplasmic Reticulum Stress. Front Mol Biosci, 4,
7. doi:10.3389/fmolb.2017.00007
Ishii, A., Fyffe-Maricich, S. L., Furusho, M., Miller, R. H., & Bansal, R. (2012).
ERK1/ERK2 MAPK signaling is required to increase myelin thickness
independent of oligodendrocyte differentiation and initiation of myelination. J
Neurosci, 32(26), 8855-8864. doi:10.1523/JNEUROSCI.0137-12.2012
Itoh, N., Itoh, Y., Tassoni, A., Ren, E., Kaito, M., Ohno, A., . . . Voskuhl, R. R. (2018).
Cell-specific and region-specific transcriptomics in the multiple sclerosis model:
Focus on astrocytes. Proc Natl Acad Sci U S A, 115(2), E302-E309.
doi:10.1073/pnas.1716032115

130

Jambusaria, A., Hong, Z., Zhang, L., Srivastava, S., Jana, A., Toth, P. T., . . . Rehman, J.
(2020). Endothelial heterogeneity across distinct vascular beds during
homeostasis and inflammation. Elife, 9. doi:10.7554/eLife.51413
Jia, Z., Zhu, H., Li, J., Wang, X., Misra, H., & Li, Y. (2012). Oxidative stress in spinal
cord injury and antioxidant-based intervention. Spinal Cord, 50(4), 264-274.
doi:10.1038/sc.2011.111
Joharapurkar, A. A., Pandya, V. B., Patel, V. J., Desai, R. C., & Jain, M. R. (2018).
Prolyl Hydroxylase Inhibitors: A Breakthrough in the Therapy of Anemia
Associated with Chronic Diseases. J Med Chem, 61(16), 6964-6982.
doi:10.1021/acs.jmedchem.7b01686
Johnson, G. G., White, M. C., & Grimaldi, M. (2011). Stressed to death: targeting
endoplasmic reticulum stress response induced apoptosis in gliomas. Curr Pharm
Des, 17(3), 284-292. doi:10.2174/138161211795049660
Jurewicz, A., Matysiak, M., Tybor, K., Kilianek, L., Raine, C. S., & Selmaj, K. (2005).
Tumour necrosis factor-induced death of adult human oligodendrocytes is
mediated by apoptosis inducing factor. Brain, 128(Pt 11), 2675-2688.
doi:10.1093/brain/awh627
Kang, S. S., Ebbert, M. T. W., Baker, K. E., Cook, C., Wang, X., Sens, J. P., . . . Fryer, J.
D. (2018). Microglial translational profiling reveals a convergent APOE pathway
from aging, amyloid, and tau. J Exp Med, 215(9), 2235-2245.
doi:10.1084/jem.20180653
Kanno, H., Ozawa, H., Tateda, S., Yahata, K., & Itoi, E. (2015). Upregulation of the
receptor-interacting protein 3 expression and involvement in neural tissue damage
after spinal cord injury in mice. BMC Neurosci, 16, 62. doi:10.1186/s12868-0150204-0
Kapitonov, D., Allegood, J. C., Mitchell, C., Hait, N. C., Almenara, J. A., Adams, J. K., .
. . Spiegel, S. (2009). Targeting sphingosine kinase 1 inhibits Akt signaling,
induces apoptosis, and suppresses growth of human glioblastoma cells and
xenografts. Cancer Res, 69(17), 6915-6923. doi:10.1158/0008-5472.CAN-090664
Karuppagounder, S. S., Alim, I., Khim, S. J., Bourassa, M. W., Sleiman, S. F., John, R., .
. . Ratan, R. R. (2016). Therapeutic targeting of oxygen-sensing prolyl
hydroxylases abrogates ATF4-dependent neuronal death and improves outcomes
after brain hemorrhage in several rodent models. Sci Transl Med, 8(328),
328ra329. doi:10.1126/scitranslmed.aac6008
King, H. A., & Gerber, A. P. (2016). Translatome profiling: methods for genome-scale
analysis of mRNA translation. Brief Funct Genomics, 15(1), 22-31.
doi:10.1093/bfgp/elu045
Kirby, L., & Castelo-Branco, G. (2020). Crossing boundaries: Interplay between the
immune system and oligodendrocyte lineage cells. Semin Cell Dev Biol.
doi:10.1016/j.semcdb.2020.10.013
Koditz, J., Nesper, J., Wottawa, M., Stiehl, D. P., Camenisch, G., Franke, C., . . .
Katschinski, D. M. (2007). Oxygen-dependent ATF-4 stability is mediated by the
PHD3 oxygen sensor. Blood, 110(10), 3610-3617. doi:10.1182/blood-2007-06094441

131

Koskenkorva-Frank, T. S., Weiss, G., Koppenol, W. H., & Burckhardt, S. (2013). The
complex interplay of iron metabolism, reactive oxygen species, and reactive
nitrogen species: insights into the potential of various iron therapies to induce
oxidative and nitrosative stress. Free Radic Biol Med, 65, 1174-1194.
doi:10.1016/j.freeradbiomed.2013.09.001
Kukurba, K. R., & Montgomery, S. B. (2015). RNA Sequencing and Analysis. Cold
Spring Harb Protoc, 2015(11), 951-969. doi:10.1101/pdb.top084970
Kumar, H., Choi, H., Jo, M. J., Joshi, H. P., Muttigi, M., Bonanomi, D., . . . Han, I.
(2018). Neutrophil elastase inhibition effectively rescued angiopoietin-1 decrease
and inhibits glial scar after spinal cord injury. Acta Neuropathol Commun, 6(1),
73. doi:10.1186/s40478-018-0576-3
Kurtishi, A., Rosen, B., Patil, K. S., Alves, G. W., & Moller, S. G. (2019). Cellular
Proteostasis in Neurodegeneration. Mol Neurobiol, 56(5), 3676-3689.
doi:10.1007/s12035-018-1334-z
Labbadia, J., & Morimoto, R. I. (2015). The biology of proteostasis in aging and disease.
Annu Rev Biochem, 84, 435-464. doi:10.1146/annurev-biochem-060614-033955
Lackner, D. H., Beilharz, T. H., Marguerat, S., Mata, J., Watt, S., Schubert, F., . . .
Bahler, J. (2007). A network of multiple regulatory layers shapes gene expression
in fission yeast. Mol Cell, 26(1), 145-155. doi:10.1016/j.molcel.2007.03.002
Lee, A. H., Iwakoshi, N. N., & Glimcher, L. H. (2003). XBP-1 regulates a subset of
endoplasmic reticulum resident chaperone genes in the unfolded protein response.
Mol Cell Biol, 23(21), 7448-7459. doi:10.1128/mcb.23.21.7448-7459.2003
Lee, J. T., Xu, J., Lee, J. M., Ku, G., Han, X., Yang, D. I., . . . Hsu, C. Y. (2004).
Amyloid-beta peptide induces oligodendrocyte death by activating the neutral
sphingomyelinase-ceramide pathway. J Cell Biol, 164(1), 123-131.
doi:10.1083/jcb.200307017
Lee, K., Tirasophon, W., Shen, X., Michalak, M., Prywes, R., Okada, T., . . . Kaufman,
R. J. (2002). IRE1-mediated unconventional mRNA splicing and S2P-mediated
ATF6 cleavage merge to regulate XBP1 in signaling the unfolded protein
response. Genes Dev, 16(4), 452-466. doi:10.1101/gad.964702
Lee, Y. S., Lee, D. H., Choudry, H. A., Bartlett, D. L., & Lee, Y. J. (2018). FerroptosisInduced Endoplasmic Reticulum Stress: Cross-talk between Ferroptosis and
Apoptosis. Mol Cancer Res, 16(7), 1073-1076. doi:10.1158/1541-7786.MCR-180055
Lein, E. S., Hawrylycz, M. J., Ao, N., Ayres, M., Bensinger, A., Bernard, A., . . . Jones,
A. R. (2007). Genome-wide atlas of gene expression in the adult mouse brain.
Nature, 445(7124), 168-176. doi:10.1038/nature05453
Lenz, G., Dreyling, M., Hoster, E., Wormann, B., Duhrsen, U., Metzner, B., . . .
Hiddemann, W. (2005). Immunochemotherapy with rituximab and
cyclophosphamide, doxorubicin, vincristine, and prednisone significantly
improves response and time to treatment failure, but not long-term outcome in
patients with previously untreated mantle cell lymphoma: results of a prospective
randomized trial of the German Low Grade Lymphoma Study Group (GLSG). J
Clin Oncol, 23(9), 1984-1992. doi:10.1200/JCO.2005.08.133
Lespagnol, A., Duflaut, D., Beekman, C., Blanc, L., Fiucci, G., Marine, J. C., . . .
Telerman, A. (2008). Exosome secretion, including the DNA damage-induced
132

p53-dependent secretory pathway, is severely compromised in TSAP6/Steap3null mice. Cell Death Differ, 15(11), 1723-1733. doi:10.1038/cdd.2008.104
Li, K., Li, T., Wang, Y., Xu, Y., Zhang, S., Culmsee, C., . . . Zhu, C. (2019a). Sex
differences in neonatal mouse brain injury after hypoxia-ischemia and adaptaquin
treatment. J Neurochem, 150(6), 759-775. doi:10.1111/jnc.14790
Li, L., Saliba, P., Reischl, S., Marti, H. H., & Kunze, R. (2016). Neuronal deficiency of
HIF prolyl 4-hydroxylase 2 in mice improves ischemic stroke recovery in an HIF
dependent manner. Neurobiol Dis, 91, 221-235. doi:10.1016/j.nbd.2016.03.018
Li, P. L., Liu, H., Chen, G. P., Li, L., Shi, H. J., Nie, H. Y., . . . Zhu, L. (2020). STEAP3
(Six-Transmembrane Epithelial Antigen of Prostate 3) Inhibits Pathological
Cardiac Hypertrophy. Hypertension, 76(4), 1219-1230.
doi:10.1161/HYPERTENSIONAHA.120.14752
Li, Y., Chen, Y., Li, X., Wu, J., Pan, J. Y., Cai, R. X., . . . Wang, X. D. (2019b). RNA
sequencing screening of differentially expressed genes after spinal cord injury.
Neural Regen Res, 14(9), 1583-1593. doi:10.4103/1673-5374.255994
Li, Y., Guo, Y., Tang, J., Jiang, J., & Chen, Z. (2014). New insights into the roles of
CHOP-induced apoptosis in ER stress. Acta Biochim Biophys Sin (Shanghai),
46(8), 629-640. doi:10.1093/abbs/gmu048
Lin, J. H., Walter, P., & Yen, T. S. (2008). Endoplasmic reticulum stress in disease
pathogenesis. Annu Rev Pathol, 3, 399-425.
doi:10.1146/annurev.pathmechdis.3.121806.151434
Lin, W., & Popko, B. (2009). Endoplasmic reticulum stress in disorders of myelinating
cells. Nat Neurosci, 12(4), 379-385. doi:10.1038/nn.2273
Lipinski, M. M., Wu, J., Faden, A. I., & Sarkar, C. (2015). Function and Mechanisms of
Autophagy in Brain and Spinal Cord Trauma. Antioxid Redox Signal, 23(6), 565577. doi:10.1089/ars.2015.6306
Liu, S., Li, Y., Choi, H. M. C., Sarkar, C., Koh, E. Y., Wu, J., & Lipinski, M. M. (2018).
Lysosomal damage after spinal cord injury causes accumulation of RIPK1 and
RIPK3 proteins and potentiation of necroptosis. Cell Death Dis, 9(5), 476.
doi:10.1038/s41419-018-0469-1
Lloyd, R. V., Hanna, P. M., & Mason, R. P. (1997). The origin of the hydroxyl radical
oxygen in the Fenton reaction. Free Radic Biol Med, 22(5), 885-888.
doi:10.1016/s0891-5849(96)00432-7
LoPresti, P., Szuchet, S., Papasozomenos, S. C., Zinkowski, R. P., & Binder, L. I. (1995).
Functional implications for the microtubule-associated protein tau: localization in
oligodendrocytes. Proc Natl Acad Sci U S A, 92(22), 10369-10373.
doi:10.1073/pnas.92.22.10369
Lottes, E. N., & Cox, D. N. (2020). Homeostatic Roles of the Proteostasis Network in
Dendrites. Front Cell Neurosci, 14, 264. doi:10.3389/fncel.2020.00264
Lucchinetti, C., Bruck, W., Parisi, J., Scheithauer, B., Rodriguez, M., & Lassmann, H.
(2000). Heterogeneity of multiple sclerosis lesions: implications for the
pathogenesis of demyelination. Ann Neurol, 47(6), 707-717. doi:10.1002/15318249(200006)47:6<707::aid-ana3>3.0.co;2-q
Luchetti, S., Beck, K. D., Galvan, M. D., Silva, R., Cummings, B. J., & Anderson, A. J.
(2010). Comparison of immunopathology and locomotor recovery in C57BL/6,

133

BUB/BnJ, and NOD-SCID mice after contusion spinal cord injury. J
Neurotrauma, 27(2), 411-421. doi:10.1089/neu.2009.0930
Magnuson, D. S., Lovett, R., Coffee, C., Gray, R., Han, Y., Zhang, Y. P., & Burke, D. A.
(2005). Functional consequences of lumbar spinal cord contusion injuries in the
adult rat. J Neurotrauma, 22(5), 529-543. doi:10.1089/neu.2005.22.529
Magnuson, D. S., Trinder, T. C., Zhang, Y. P., Burke, D., Morassutti, D. J., & Shields, C.
B. (1999). Comparing deficits following excitotoxic and contusion injuries in the
thoracic and lumbar spinal cord of the adult rat. Exp Neurol, 156(1), 191-204.
doi:10.1006/exnr.1999.7016
Mallon, B. S., Shick, H. E., Kidd, G. J., & Macklin, W. B. (2002). Proteolipid promoter
activity distinguishes two populations of NG2-positive cells throughout neonatal
cortical development. J Neurosci, 22(3), 876-885.
Man, S. M., Karki, R., & Kanneganti, T. D. (2017). Molecular mechanisms and functions
of pyroptosis, inflammatory caspases and inflammasomes in infectious diseases.
Immunol Rev, 277(1), 61-75. doi:10.1111/imr.12534
Marciniak, S. J., Yun, C. Y., Oyadomari, S., Novoa, I., Zhang, Y., Jungreis, R., . . . Ron,
D. (2004). CHOP induces death by promoting protein synthesis and oxidation in
the stressed endoplasmic reticulum. Genes Dev, 18(24), 3066-3077.
doi:10.1101/gad.1250704
Matsuyama, D., Watanabe, M., Suyama, K., Kuroiwa, M., & Mochida, J. (2014).
Endoplasmic reticulum stress response in the rat contusive spinal cord injury
model-susceptibility in specific cell types. Spinal Cord, 52(1), 9-16.
doi:10.1038/sc.2013.118
Matute, C., Torre, I., Perez-Cerda, F., Perez-Samartin, A., Alberdi, E., Etxebarria, E., . . .
Domercq, M. (2007). P2X(7) receptor blockade prevents ATP excitotoxicity in
oligodendrocytes and ameliorates experimental autoimmune encephalomyelitis. J
Neurosci, 27(35), 9525-9533. doi:10.1523/JNEUROSCI.0579-07.2007
McCullough, K. D., Martindale, J. L., Klotz, L. O., Aw, T. Y., & Holbrook, N. J. (2001).
Gadd153 sensitizes cells to endoplasmic reticulum stress by down-regulating Bcl2
and perturbing the cellular redox state. Mol Cell Biol, 21(4), 1249-1259.
doi:10.1128/MCB.21.4.1249-1259.2001
McTigue, D. M., Wei, P., & Stokes, B. T. (2001). Proliferation of NG2-positive cells and
altered oligodendrocyte numbers in the contused rat spinal cord. J Neurosci,
21(10), 3392-3400.
Mongroo, P. S., Johnstone, C. N., Naruszewicz, I., Leung-Hagesteijn, C., Sung, R. K.,
Carnio, L., . . . Hannigan, G. E. (2004). Beta-parvin inhibits integrin-linked kinase
signaling and is downregulated in breast cancer. Oncogene, 23(55), 8959-8970.
doi:10.1038/sj.onc.1208112
Morath, D. J., & Mayer-Proschel, M. (2001). Iron modulates the differentiation of a
distinct population of glial precursor cells into oligodendrocytes. Dev Biol,
237(1), 232-243. doi:10.1006/dbio.2001.0352
Morimoto, R. I., Kline, M. P., Bimston, D. N., & Cotto, J. J. (1997). The heat-shock
response: regulation and function of heat-shock proteins and molecular
chaperones. Essays Biochem, 32, 17-29.
Muller, C., Bandemer, J., Vindis, C., Camare, C., Mucher, E., Gueraud, F., . . . NegreSalvayre, A. (2013). Protein disulfide isomerase modification and inhibition
134

contribute to ER stress and apoptosis induced by oxidized low density
lipoproteins. Antioxid Redox Signal, 18(7), 731-742. doi:10.1089/ars.2012.4577
Myers, S. A., Andres, K. R., Hagg, T., & Whittemore, S. R. (2014). CD36 deletion
improves recovery from spinal cord injury. Exp Neurol, 256, 25-38.
doi:10.1016/j.expneurol.2014.03.016
Myers, S. A., Gobejishvili, L., Saraswat Ohri, S., Garrett Wilson, C., Andres, K. R.,
Riegler, A. S., . . . Whittemore, S. R. (2019). Following spinal cord injury,
PDE4B drives an acute, local inflammatory response and a chronic, systemic
response exacerbated by gut dysbiosis and endotoxemia. Neurobiol Dis, 124, 353363. doi:10.1016/j.nbd.2018.12.008
Nakamura, M., Okada, S., Toyama, Y., & Okano, H. (2005). Role of IL-6 in spinal cord
injury in a mouse model. Clin Rev Allergy Immunol, 28(3), 197-204.
doi:10.1385/CRIAI:28:3:197
Nandal, A., Ruiz, J. C., Subramanian, P., Ghimire-Rijal, S., Sinnamon, R. A., Stemmler,
T. L., . . . Philpott, C. C. (2011). Activation of the HIF prolyl hydroxylase by the
iron chaperones PCBP1 and PCBP2. Cell Metab, 14(5), 647-657.
doi:10.1016/j.cmet.2011.08.015
Nasrabady, S. E., Rizvi, B., Goldman, J. E., & Brickman, A. M. (2018). White matter
changes in Alzheimer's disease: a focus on myelin and oligodendrocytes. Acta
Neuropathol Commun, 6(1), 22. doi:10.1186/s40478-018-0515-3
Naughton, M. C., McMahon, J. M., & FitzGerald, U. F. (2016). The role of the unfolded
protein response in myelination. Neural Regen Res, 11(3), 394-395.
doi:10.4103/1673-5374.179036
Neitemeier, S., Dolga, A. M., Honrath, B., Karuppagounder, S. S., Alim, I., Ratan, R. R.,
& Culmsee, C. (2016). Inhibition of HIF-prolyl-4-hydroxylases prevents
mitochondrial impairment and cell death in a model of neuronal oxytosis. Cell
Death Dis, 7, e2214. doi:10.1038/cddis.2016.107
Niatsetskaya, Z., Basso, M., Speer, R. E., McConoughey, S. J., Coppola, G., Ma, T. C., &
Ratan, R. R. (2010). HIF prolyl hydroxylase inhibitors prevent neuronal death
induced by mitochondrial toxins: therapeutic implications for Huntington's
disease and Alzheimer's disease. Antioxid Redox Signal, 12(4), 435-443.
doi:10.1089/ars.2009.2800
Nishida, F., Zanuzzi, C. N., Martinez, A., Barbeito, C. G., & Portiansky, E. L. (2015).
Functional and histopathological changes induced by intraparenchymal injection
of kainic acid in the rat cervical spinal cord. Neurotoxicology, 49, 68-78.
doi:10.1016/j.neuro.2015.05.006
Nobuta, H., Yang, N., Ng, Y. H., Marro, S. G., Sabeur, K., Chavali, M., . . . Wernig, M.
(2019). Oligodendrocyte Death in Pelizaeus-Merzbacher Disease Is Rescued by
Iron Chelation. Cell Stem Cell, 25(4), 531-541 e536.
doi:10.1016/j.stem.2019.09.003
Norenberg, M. D., Smith, J., & Marcillo, A. (2004). The pathology of human spinal cord
injury: defining the problems. J Neurotrauma, 21(4), 429-440.
doi:10.1089/089771504323004575
Novgorodov, S. A., Voltin, J. R., Gooz, M. A., Li, L., Lemasters, J. J., & Gudz, T. I.
(2018). Acid sphingomyelinase promotes mitochondrial dysfunction due to

135

glutamate-induced regulated necrosis. J Lipid Res, 59(2), 312-329.
doi:10.1194/jlr.M080374
O'Shea, T. M., Burda, J. E., & Sofroniew, M. V. (2017). Cell biology of spinal cord
injury and repair. J Clin Invest, 127(9), 3259-3270. doi:10.1172/JCI90608
Oakes, S. A. (2017). Endoplasmic reticulum proteostasis: a key checkpoint in cancer. Am
J Physiol Cell Physiol, 312(2), C93-C102. doi:10.1152/ajpcell.00266.2016
Ohgami, R. S., Campagna, D. R., Greer, E. L., Antiochos, B., McDonald, A., Chen, J., . .
. Fleming, M. D. (2005). Identification of a ferrireductase required for efficient
transferrin-dependent iron uptake in erythroid cells. Nat Genet, 37(11), 12641269. doi:10.1038/ng1658
Ohoka, N., Yoshii, S., Hattori, T., Onozaki, K., & Hayashi, H. (2005). TRB3, a novel ER
stress-inducible gene, is induced via ATF4-CHOP pathway and is involved in cell
death. EMBO J, 24(6), 1243-1255. doi:10.1038/sj.emboj.7600596
Ohri, S., Burke, D. A., Andres, K. R., Hetman, M., & Whittemore, S. R. (2021). Acute
Neural and Proteostasis Messenger Ribonucleic Acid Levels Predict Chronic
Locomotor Recovery after Contusive Spinal Cord Injury. J Neurotrauma, 38(3),
365-372. doi:10.1089/neu.2020.7258
Ohri, S. S., Bankston, A. N., Mullins, S. A., Liu, Y., Andres, K. R., Beare, J. E., . . .
Whittemore, S. R. (2018). Blocking Autophagy in Oligodendrocytes Limits
Functional Recovery after Spinal Cord Injury. J Neurosci, 38(26), 5900-5912.
doi:10.1523/JNEUROSCI.0679-17.2018
Ohri, S. S., Hetman, M., & Whittemore, S. R. (2013). Restoring endoplasmic reticulum
homeostasis improves functional recovery after spinal cord injury. Neurobiol Dis,
58, 29-37. doi:10.1016/j.nbd.2013.04.021
Ohri, S. S., Howard, R. M., Liu, Y., Andres, K. R., Shepard, C. T., Hetman, M., &
Whittemore, S. R. (2020a). Oligodendrocyte-specific deletion of Xbp1
exacerbates the endoplasmic reticulum stress response and restricts locomotor
recovery after thoracic spinal cord injury. Glia, 69(2), 424-435.
doi:10.1002/glia.23907
Ohri, S. S., Howard, R. M., Liu, Y., Andres, K. R., Shephard, C. T., Hetman, M., &
Whittemore, S. R. (2020b). Oligodendrocyte-specific deletion of XBP1
exacerbates the endoplasmic reticulum stress response and restricts locomotor
recovery after thoracic spinal cord injury. Glia. doi:10.1002/glia.23907
Ohri, S. S., Maddie, M. A., Zhang, Y., Shields, C. B., Hetman, M., & Whittemore, S. R.
(2012). Deletion of the pro-apoptotic endoplasmic reticulum stress response
effector CHOP does not result in improved locomotor function after severe
contusive spinal cord injury. J Neurotrauma, 29(3), 579-588.
doi:10.1089/neu.2011.1940
Ohri, S. S., Maddie, M. A., Zhao, Y., Qiu, M. S., Hetman, M., & Whittemore, S. R.
(2011). Attenuating the endoplasmic reticulum stress response improves
functional recovery after spinal cord injury. Glia, 59(10), 1489-1502.
doi:10.1002/glia.21191
Ohri, S. S., Mullins, A., Hetman, M., & Whittemore, S. R. (2014). Inhibition of
GADD34, the stress-inducible regulatory subunit of the endoplasmic reticulum
stress response, does not enhance functional recovery after spinal cord injury.
PLoS One, 9(11), e109703. doi:10.1371/journal.pone.0109703
136

Oyadomari, S., & Mori, M. (2004). Roles of CHOP/GADD153 in endoplasmic reticulum
stress. Cell Death Differ, 11(4), 381-389. doi:10.1038/sj.cdd.4401373
Oyinbo, C. A. (2011). Secondary injury mechanisms in traumatic spinal cord injury: a
nugget of this multiply cascade. Acta Neurobiol Exp (Wars), 71(2), 281-299.
Pakos-Zebrucka, K., Koryga, I., Mnich, K., Ljujic, M., Samali, A., & Gorman, A. M.
(2016). The integrated stress response. EMBO Rep, 17(10), 1374-1395.
doi:10.15252/embr.201642195
Panda, A. C., Martindale, J. L., & Gorospe, M. (2017). Polysome Fractionation to
Analyze mRNA Distribution Profiles. Bio Protoc, 7(3).
doi:10.21769/BioProtoc.2126
Park, E., Velumian, A. A., & Fehlings, M. G. (2004). The role of excitotoxicity in
secondary mechanisms of spinal cord injury: a review with an emphasis on the
implications for white matter degeneration. J Neurotrauma, 21(6), 754-774.
doi:10.1089/0897715041269641
Pearse, D. D., Pereira, F. C., Marcillo, A. E., Bates, M. L., Berrocal, Y. A., Filbin, M. T.,
& Bunge, M. B. (2004). cAMP and Schwann cells promote axonal growth and
functional recovery after spinal cord injury. Nat Med, 10(6), 610-616.
doi:10.1038/nm1056
Peferoen, L., Kipp, M., van der Valk, P., van Noort, J. M., & Amor, S. (2014).
Oligodendrocyte-microglia cross-talk in the central nervous system. Immunology,
141(3), 302-313. doi:10.1111/imm.12163
Penas, C., Guzman, M. S., Verdu, E., Fores, J., Navarro, X., & Casas, C. (2007). Spinal
cord injury induces endoplasmic reticulum stress with different cell-type
dependent response. J Neurochem, 102(4), 1242-1255. doi:10.1111/j.14714159.2007.04671.x
Pennuto, M., Tinelli, E., Malaguti, M., Del Carro, U., D'Antonio, M., Ron, D., . . .
Wrabetz, L. (2008). Ablation of the UPR-mediator CHOP restores motor function
and reduces demyelination in Charcot-Marie-Tooth 1B mice. Neuron, 57(3), 393405. doi:10.1016/j.neuron.2007.12.021
Persad, S., Attwell, S., Gray, V., Delcommenne, M., Troussard, A., Sanghera, J., &
Dedhar, S. (2000). Inhibition of integrin-linked kinase (ILK) suppresses activation
of protein kinase B/Akt and induces cell cycle arrest and apoptosis of PTENmutant prostate cancer cells. Proc Natl Acad Sci U S A, 97(7), 3207-3212.
doi:10.1073/pnas.060579697
Pfeiffer, S. E., Warrington, A. E., & Bansal, R. (1993). The oligodendrocyte and its many
cellular processes. Trends Cell Biol, 3(6), 191-197. doi:10.1016/09628924(93)90213-k
Picard, F., Milhem, H., Loubiere, P., Laurent, B., Cocaign-Bousquet, M., & Girbal, L.
(2012). Bacterial translational regulations: high diversity between all mRNAs and
major role in gene expression. BMC Genomics, 13, 528. doi:10.1186/1471-216413-528
Pihan, P., Carreras-Sureda, A., & Hetz, C. (2017). BCL-2 family: integrating stress
responses at the ER to control cell demise. Cell Death Differ, 24(9), 1478-1487.
doi:10.1038/cdd.2017.82

137

Pitale, P. M., Gorbatyuk, O., & Gorbatyuk, M. (2017). Neurodegeneration: Keeping
ATF4 on a Tight Leash. Front Cell Neurosci, 11, 410.
doi:10.3389/fncel.2017.00410
Pointillart, V., Petitjean, M. E., Wiart, L., Vital, J. M., Lassie, P., Thicoipe, M., &
Dabadie, P. (2000). Pharmacological therapy of spinal cord injury during the
acute phase. Spinal Cord, 38(2), 71-76. doi:10.1038/sj.sc.3100962
Pringle, N. P., Mudhar, H. S., Collarini, E. J., & Richardson, W. D. (1992). PDGF
receptors in the rat CNS: during late neurogenesis, PDGF alpha-receptor
expression appears to be restricted to glial cells of the oligodendrocyte lineage.
Development, 115(2), 535-551.
Pukos, N., Goodus, M. T., Sahinkaya, F. R., & McTigue, D. M. (2019). Myelin status and
oligodendrocyte lineage cells over time after spinal cord injury: What do we know
and what still needs to be unwrapped? Glia, 67(11), 2178-2202.
doi:10.1002/glia.23702
Quiros, P. M., Prado, M. A., Zamboni, N., D'Amico, D., Williams, R. W., Finley, D., . . .
Auwerx, J. (2017). Multi-omics analysis identifies ATF4 as a key regulator of the
mitochondrial stress response in mammals. J Cell Biol, 216(7), 2027-2045.
doi:10.1083/jcb.201702058
Ramakrishnan, S., Anand, V., & Roy, S. (2014). Vascular endothelial growth factor
signaling in hypoxia and inflammation. J Neuroimmune Pharmacol, 9(2), 142160. doi:10.1007/s11481-014-9531-7
Ramanathan, M., Porter, D. F., & Khavari, P. A. (2019). Methods to study RNA-protein
interactions. Nat Methods, 16(3), 225-234. doi:10.1038/s41592-019-0330-1
Ratan, R. R. (2020). The Chemical Biology of Ferroptosis in the Central Nervous
System. Cell Chem Biol, 27(5), 479-498. doi:10.1016/j.chembiol.2020.03.007
Ratcliffe, P. J., O'Rourke, J. F., Maxwell, P. H., & Pugh, C. W. (1998). Oxygen sensing,
hypoxia-inducible factor-1 and the regulation of mammalian gene expression. J
Exp Biol, 201(Pt 8), 1153-1162.
Ravindran, R., Loebbermann, J., Nakaya, H. I., Khan, N., Ma, H., Gama, L., . . .
Pulendran, B. (2016). The amino acid sensor GCN2 controls gut inflammation by
inhibiting inflammasome activation. Nature, 531(7595), 523-527.
doi:10.1038/nature17186
Reich, A., Sapir, A., & Shilo, B. (1999). Sprouty is a general inhibitor of receptor
tyrosine kinase signaling. Development, 126(18), 4139-4147.
Richter, K., Haslbeck, M., & Buchner, J. (2010a). The heat shock response: life on the
verge of death. Mol Cell, 40(2), 253-266. doi:10.1016/j.molcel.2010.10.006
Richter, R., Rorbach, J., Pajak, A., Smith, P. M., Wessels, H. J., Huynen, M. A., . . .
Chrzanowska-Lightowlers, Z. M. (2010b). A functional peptidyl-tRNA hydrolase,
ICT1, has been recruited into the human mitochondrial ribosome. EMBO J, 29(6),
1116-1125. doi:10.1038/emboj.2010.14
Robinson, S. R., Dang, T. N., Dringen, R., & Bishop, G. M. (2009). Hemin toxicity: a
preventable source of brain damage following hemorrhagic stroke. Redox Rep,
14(6), 228-235. doi:10.1179/135100009X12525712409931
Di Pardo, A., Pepe, G., Castaldo, S., Marracino, F., Capocci, L., Amico, E., . . .
Maglione, V. (2019). Stimulation of Sphingosine Kinase 1 (SPHK1) Is Beneficial

138

in a Huntington's Disease Pre-clinical Model. Front Mol Neurosci, 12, 100.
doi:10.3389/fnmol.2019.00100
Genovese, T., Esposito, E., Mazzon, E., Muia, C., Di Paola, R., Meli, R., . . . Cuzzocrea,
S. (2008). Evidence for the role of mitogen-activated protein kinase signaling
pathways in the development of spinal cord injury. J Pharmacol Exp Ther,
325(1), 100-114. doi:10.1124/jpet.107.131060
Krishnan, N., Dickman, M. B., & Becker, D. F. (2008). Proline modulates the
intracellular redox environment and protects mammalian cells against oxidative
stress. Free Radic Biol Med, 44(4), 671-681.
doi:10.1016/j.freeradbiomed.2007.10.054
Maceyka, M., Harikumar, K. B., Milstien, S., & Spiegel, S. (2012). Sphingosine-1phosphate signaling and its role in disease. Trends Cell Biol, 22(1), 50-60.
doi:10.1016/j.tcb.2011.09.003
Motyl, J., Przykaza, L., Boguszewski, P. M., Kosson, P., & Strosznajder, J. B. (2018).
Pramipexole and Fingolimod exert neuroprotection in a mouse model of
Parkinson's disease by activation of sphingosine kinase 1 and Akt kinase.
Neuropharmacology, 135, 139-150. doi:10.1016/j.neuropharm.2018.02.023
Satoh, Y., Matsumura, I., Tanaka, H., Harada, H., Harada, Y., Matsui, K., . . . Kanakura,
Y. (2012). C-terminal mutation of RUNX1 attenuates the DNA-damage repair
response in hematopoietic stem cells. Leukemia, 26(2), 303-311.
doi:10.1038/leu.2011.202
Wilkins, A., Majed, H., Layfield, R., Compston, A., & Chandran, S. (2003).
Oligodendrocytes promote neuronal survival and axonal length by distinct
intracellular mechanisms: a novel role for oligodendrocyte-derived glial cell linederived neurotrophic factor. J Neurosci, 23(12), 4967-4974.
Rojas-Rivera, D., Delvaeye, T., Roelandt, R., Nerinckx, W., Augustyns, K.,
Vandenabeele, P., & Bertrand, M. J. M. (2017). When PERK inhibitors turn out
to be new potent RIPK1 inhibitors: critical issues on the specificity and use of
GSK2606414 and GSK2656157. Cell Death Differ, 24(6), 1100-1110.
doi:10.1038/cdd.2017.58
Rolfe, D. F., & Brown, G. C. (1997). Cellular energy utilization and molecular origin of
standard metabolic rate in mammals. Physiol Rev, 77(3), 731-758.
doi:10.1152/physrev.1997.77.3.731
Ron, D. (2002). Translational control in the endoplasmic reticulum stress response. J Clin
Invest, 110(10), 1383-1388. doi:10.1172/JCI16784
Rowland, T., Hagenbuch, S., Pober, D., & Garrison, A. (2008). Exercise tolerance and
thermoregulatory responses during cycling in boys and men. Med Sci Sports
Exerc, 40(2), 282-287. doi:10.1249/mss.0b013e31815a95a7
Rozpedek, W., Pytel, D., Mucha, B., Leszczynska, H., Diehl, J. A., & Majsterek, I.
(2016). The Role of the PERK/eIF2alpha/ATF4/CHOP Signaling Pathway in
Tumor Progression During Endoplasmic Reticulum Stress. Curr Mol Med, 16(6),
533-544. doi:10.2174/1566524016666160523143937
Sabri, M., Kawashima, A., Ai, J., & Macdonald, R. L. (2008). Neuronal and astrocytic
apoptosis after subarachnoid hemorrhage: a possible cause for poor prognosis.
Brain Res, 1238, 163-171. doi:10.1016/j.brainres.2008.08.031

139

Safra, M., Ben-Hamo, S., Kenyon, C., & Henis-Korenblit, S. (2013). The ire-1 ER stressresponse pathway is required for normal secretory-protein metabolism in C.
elegans. J Cell Sci, 126(Pt 18), 4136-4146. doi:10.1242/jcs.123000
Sahinkaya, F. R., Milich, L. M., & McTigue, D. M. (2014). Changes in NG2 cells and
oligodendrocytes in a new model of intraspinal hemorrhage. Exp Neurol, 255,
113-126. doi:10.1016/j.expneurol.2014.02.025
Salter, M. G., & Fern, R. (2005). NMDA receptors are expressed in developing
oligodendrocyte processes and mediate injury. Nature, 438(7071), 1167-1171.
doi:10.1038/nature04301
Sanz, E., Bean, J. C., Carey, D. P., Quintana, A., & McKnight, G. S. (2019). RiboTag:
Ribosomal Tagging Strategy to Analyze Cell-Type-Specific mRNA Expression In
Vivo. Curr Protoc Neurosci, 88(1), e77. doi:10.1002/cpns.77
Sanz, E., Yang, L., Su, T., Morris, D. R., McKnight, G. S., & Amieux, P. S. (2009). Celltype-specific isolation of ribosome-associated mRNA from complex tissues. Proc
Natl Acad Sci U S A, 106(33), 13939-13944. doi:10.1073/pnas.0907143106
Saraswat Ohri, S., Bankston, A. N., Mullins, S. A., Liu, Y., Andres, K. R., Beare, J. E., . .
. Whittemore, S. R. (2018a). Blocking Autophagy in Oligodendrocytes Limits
Functional Recovery after Spinal Cord Injury. J Neurosci, 38(26), 5900-5912.
doi:10.1523/JNEUROSCI.0679-17.2018
Saraswat Ohri, S., Burke, D. A., Andres, K. R., Hetman, M., & Whittemore, S. R. (2020).
Acute Neural and Proteostasis Messenger Ribonucleic Acid Levels Predict
Chronic Locomotor Recovery after Contusive Spinal Cord Injury. J Neurotrauma.
doi:10.1089/neu.2020.7258
Saraswat Ohri, S., Howard, R. M., Liu, Y., Andres, K. R., Shepard, C. T., Hetman, M., &
Whittemore, S. R. (2021). Oligodendrocyte-specific deletion of Xbp1 exacerbates
the endoplasmic reticulum stress response and restricts locomotor recovery after
thoracic spinal cord injury. Glia, 69(2), 424-435. doi:10.1002/glia.23907
Saraswat Ohri, S., Mullins, A., Hetman, M., & Whittemore, S. R. (2018b). Activating
Transcription Factor-6alpha Deletion Modulates the Endoplasmic Reticulum
Stress Response after Spinal Cord Injury but Does Not Affect Locomotor
Recovery. J Neurotrauma, 35(3), 486-491. doi:10.1089/neu.2015.3993
Sathyamurthy, A., Johnson, K. R., Matson, K. J. E., Dobrott, C. I., Li, L., Ryba, A. R., . .
. Levine, A. J. (2018). Massively Parallel Single Nucleus Transcriptional Profiling
Defines Spinal Cord Neurons and Their Activity during Behavior. Cell Rep,
22(8), 2216-2225. doi:10.1016/j.celrep.2018.02.003
Sato, A., Ohtaki, H., Tsumuraya, T., Song, D., Ohara, K., Asano, M., . . . Shioda, S.
(2012). Interleukin-1 participates in the classical and alternative activation of
microglia/macrophages after spinal cord injury. J Neuroinflammation, 9, 65.
doi:10.1186/1742-2094-9-65
Sauerbeck, A., Schonberg, D. L., Laws, J. L., & McTigue, D. M. (2013). Systemic iron
chelation results in limited functional and histological recovery after traumatic
spinal cord injury in rats. Exp Neurol, 248, 53-61.
doi:10.1016/j.expneurol.2013.05.011
Scheckel, C., Imeri, M., Schwarz, P., & Aguzzi, A. (2020). Ribosomal profiling during
prion disease uncovers progressive translational derangement in glia but not in
neurons. Elife, 9. doi:10.7554/eLife.62911
140

Scheff, S. W., Rabchevsky, A. G., Fugaccia, I., Main, J. A., & Lumpp, J. E., Jr. (2003).
Experimental modeling of spinal cord injury: characterization of a force-defined
injury device. J Neurotrauma, 20(2), 179-193. doi:10.1089/08977150360547099
Schober, P., Boer, C., & Schwarte, L. A. (2018). Correlation Coefficients: Appropriate
Use and Interpretation. Anesth Analg, 126(5), 1763-1768.
doi:10.1213/ANE.0000000000002864
Schott, J., Reitter, S., Philipp, J., Haneke, K., Schafer, H., & Stoecklin, G. (2014).
Translational regulation of specific mRNAs controls feedback inhibition and
survival during macrophage activation. PLoS Genet, 10(6), e1004368.
doi:10.1371/journal.pgen.1004368
Schroder, M., & Kaufman, R. J. (2005). ER stress and the unfolded protein response.
Mutat Res, 569(1-2), 29-63. doi:10.1016/j.mrfmmm.2004.06.056
Schwanhausser, B., Busse, D., Li, N., Dittmar, G., Schuchhardt, J., Wolf, J., . . . Selbach,
M. (2011). Global quantification of mammalian gene expression control. Nature,
473(7347), 337-342. doi:10.1038/nature10098
Semenza, G. L. (2001). HIF-1, O(2), and the 3 PHDs: how animal cells signal hypoxia to
the nucleus. Cell, 107(1), 1-3. doi:10.1016/s0092-8674(01)00518-9
Semenza, G. L. (2007). Hypoxia-inducible factor 1 (HIF-1) pathway. Sci STKE,
2007(407), cm8. doi:10.1126/stke.4072007cm8
Semenza, G. L. (2010). Defining the role of hypoxia-inducible factor 1 in cancer biology
and therapeutics. Oncogene, 29(5), 625-634. doi:10.1038/onc.2009.441
Semenza, G. L. (2012). Hypoxia-inducible factors in physiology and medicine. Cell,
148(3), 399-408. doi:10.1016/j.cell.2012.01.021
Shahbazian, D., Roux, P. P., Mieulet, V., Cohen, M. S., Raught, B., Taunton, J., . . .
Sonenberg, N. (2006). The mTOR/PI3K and MAPK pathways converge on eIF4B
to control its phosphorylation and activity. EMBO J, 25(12), 2781-2791.
doi:10.1038/sj.emboj.7601166
Sharma, H. S., Winkler, T., Stalberg, E., Gordh, T., Alm, P., & Westman, J. (2003).
Topical application of TNF-alpha antiserum attenuates spinal cord trauma
induced edema formation, microvascular permeability disturbances and cell injury
in the rat. Acta Neurochir Suppl, 86, 407-413. doi:10.1007/978-3-7091-06518_85
Shen, M., Schmitt, S., Buac, D., & Dou, Q. P. (2013). Targeting the ubiquitin-proteasome
system for cancer therapy. Expert Opin Ther Targets, 17(9), 1091-1108.
doi:10.1517/14728222.2013.815728
Shenton, D., Smirnova, J. B., Selley, J. N., Carroll, K., Hubbard, S. J., Pavitt, G. D., . . .
Grant, C. M. (2006). Global translational responses to oxidative stress impact
upon multiple levels of protein synthesis. J Biol Chem, 281(39), 29011-29021.
doi:10.1074/jbc.M601545200
Shi, L. L., Zhang, N., Xie, X. M., Chen, Y. J., Wang, R., Shen, L., . . . Lu, H. Z. (2017).
Transcriptome profile of rat genes in injured spinal cord at different stages by
RNA-sequencing. BMC Genomics, 18(1), 173. doi:10.1186/s12864-017-3532-x
Shoulders, M. D., Ryno, L. M., Genereux, J. C., Moresco, J. J., Tu, P. G., Wu, C., . . .
Wiseman, R. L. (2013). Stress-independent activation of XBP1s and/or ATF6
reveals three functionally diverse ER proteostasis environments. Cell Rep, 3(4),
1279-1292. doi:10.1016/j.celrep.2013.03.024
141

Shultz, R. B., & Zhong, Y. (2017). Minocycline targets multiple secondary injury
mechanisms in traumatic spinal cord injury. Neural Regen Res, 12(5), 702-713.
doi:10.4103/1673-5374.206633
Shuman, S. L., Bresnahan, J. C., & Beattie, M. S. (1997). Apoptosis of microglia and
oligodendrocytes after spinal cord contusion in rats. J Neurosci Res, 50(5), 798808. doi:10.1002/(SICI)1097-4547(19971201)50:5<798::AID-JNR16>3.0.CO;2Y
Simons, M., & Nave, K. A. (2015). Oligodendrocytes: Myelination and Axonal Support.
Cold Spring Harb Perspect Biol, 8(1), a020479. doi:10.1101/cshperspect.a020479
Smirnova, N. A., Rakhman, I., Moroz, N., Basso, M., Payappilly, J., Kazakov, S., . . .
Gazaryan, I. G. (2010). Utilization of an in vivo reporter for high throughput
identification of branched small molecule regulators of hypoxic adaptation. Chem
Biol, 17(4), 380-391. doi:10.1016/j.chembiol.2010.03.008
Song, B., Scheuner, D., Ron, D., Pennathur, S., & Kaufman, R. J. (2008). Chop deletion
reduces oxidative stress, improves beta cell function, and promotes cell survival
in multiple mouse models of diabetes. J Clin Invest, 118(10), 3378-3389.
doi:10.1172/JCI34587
Southwood, C. M., Fykkolodziej, B., Maheras, K. J., Garshott, D. M., Estill, M., Fribley,
A. M., & Gow, A. (2016). Overexpression of CHOP in Myelinating Cells Does
Not Confer a Significant Phenotype under Normal or Metabolic Stress
Conditions. J Neurosci, 36(25), 6803-6819. doi:10.1523/JNEUROSCI.111815.2016
Southwood, C. M., Garbern, J., Jiang, W., & Gow, A. (2002). The unfolded protein
response modulates disease severity in Pelizaeus-Merzbacher disease. Neuron,
36(4), 585-596. doi:10.1016/s0896-6273(02)01045-0
Spriggs, K. A., Bushell, M., & Willis, A. E. (2010). Translational regulation of gene
expression during conditions of cell stress. Mol Cell, 40(2), 228-237.
doi:10.1016/j.molcel.2010.09.028
Squair, J. W., Tigchelaar, S., Moon, K. M., Liu, J., Tetzlaff, W., Kwon, B. K., . . .
Skinnider, M. A. (2018). Integrated systems analysis reveals conserved gene
networks underlying response to spinal cord injury. Elife, 7.
doi:10.7554/eLife.39188
Stefanovic, D., Stefanovic, M., & Lalosevic, D. (2015). Use of eriochrome cyanine R in
routine histology and histopathology: is it time to say goodbye to hematoxylin?
Biotech Histochem, 90(6), 461-469. doi:10.3109/10520295.2015.1057765
Stewart, A. N., MacLean, S. M., Stromberg, A. J., Whelan, J. P., Bailey, W. M., Gensel,
J. C., & Wilson, M. E. (2020). Considerations for Studying Sex as a Biological
Variable in Spinal Cord Injury. Front Neurol, 11, 802.
doi:10.3389/fneur.2020.00802
Stirling, D. P., Liu, J., Plunet, W., Steeves, J. D., & Tetzlaff, W. (2008). SB203580, a p38
mitogen-activated protein kinase inhibitor, fails to improve functional outcome
following a moderate spinal cord injury in rat. Neuroscience, 155(1), 128-137.
doi:10.1016/j.neuroscience.2008.05.007
Strowitzki, M. J., Cummins, E. P., & Taylor, C. T. (2019). Protein Hydroxylation by
Hypoxia-Inducible Factor (HIF) Hydroxylases: Unique or Ubiquitous? Cells,
8(5). doi:10.3390/cells8050384
142

Suo, N., Guo, Y. E., He, B., Gu, H., & Xie, X. (2019). Inhibition of MAPK/ERK
pathway promotes oligodendrocytes generation and recovery of demyelinating
diseases. Glia, 67(7), 1320-1332. doi:10.1002/glia.23606
Takeda, K., Ho, V. C., Takeda, H., Duan, L. J., Nagy, A., & Fong, G. H. (2006).
Placental but not heart defects are associated with elevated hypoxia-inducible
factor alpha levels in mice lacking prolyl hydroxylase domain protein 2. Mol Cell
Biol, 26(22), 8336-8346. doi:10.1128/MCB.00425-06
Taylor, E. M., & Morgan, E. H. (1990). Developmental changes in transferrin and iron
uptake by the brain in the rat. Brain Res Dev Brain Res, 55(1), 35-42.
doi:10.1016/0165-3806(90)90103-6
Teske, B. F., Wek, S. A., Bunpo, P., Cundiff, J. K., McClintick, J. N., Anthony, T. G., &
Wek, R. C. (2011). The eIF2 kinase PERK and the integrated stress response
facilitate activation of ATF6 during endoplasmic reticulum stress. Mol Biol Cell,
22(22), 4390-4405. doi:10.1091/mbc.E11-06-0510
Thinnes, C. C., Tumber, A., Yapp, C., Scozzafava, G., Yeh, T., Chan, M. C., . . .
Schofield, C. J. (2015). Betti reaction enables efficient synthesis of 8hydroxyquinoline inhibitors of 2-oxoglutarate oxygenases. Chem Commun
(Camb), 51(84), 15458-15461. doi:10.1039/c5cc06095h
Thorburne, S. K., & Juurlink, B. H. (1996). Low glutathione and high iron govern the
susceptibility of oligodendroglial precursors to oxidative stress. J Neurochem,
67(3), 1014-1022. doi:10.1046/j.1471-4159.1996.67031014.x
Tojo, Y., Sekine, H., Hirano, I., Pan, X., Souma, T., Tsujita, T., . . . Suzuki, N. (2015).
Hypoxia Signaling Cascade for Erythropoietin Production in Hepatocytes. Mol
Cell Biol, 35(15), 2658-2672. doi:10.1128/MCB.00161-15
Ubeda, M., Vallejo, M., & Habener, J. F. (1999). CHOP enhancement of gene
transcription by interactions with Jun/Fos AP-1 complex proteins. Mol Cell Biol,
19(11), 7589-7599. doi:10.1128/mcb.19.11.7589
Ulndreaj, A., Chio, J. C., Ahuja, C. S., & Fehlings, M. G. (2016). Modulating the
immune response in spinal cord injury. Expert Rev Neurother, 16(10), 1127-1129.
doi:10.1080/14737175.2016.1207532
Valenzuela, V., Collyer, E., Armentano, D., Parsons, G. B., Court, F. A., & Hetz, C.
(2012). Activation of the unfolded protein response enhances motor recovery after
spinal cord injury. Cell Death Dis, 3, e272. doi:10.1038/cddis.2012.8
Valerio-Gomes, B., Guimaraes, D. M., Szczupak, D., & Lent, R. (2018). The Absolute
Number of Oligodendrocytes in the Adult Mouse Brain. Front Neuroanat, 12, 90.
doi:10.3389/fnana.2018.00090
Vattem, K. M., & Wek, R. C. (2004). Reinitiation involving upstream ORFs regulates
ATF4 mRNA translation in mammalian cells. Proc Natl Acad Sci U S A, 101(31),
11269-11274. doi:10.1073/pnas.0400541101
Vogel, C., Abreu Rde, S., Ko, D., Le, S. Y., Shapiro, B. A., Burns, S. C., . . . Penalva, L.
O. (2010). Sequence signatures and mRNA concentration can explain two-thirds
of protein abundance variation in a human cell line. Mol Syst Biol, 6, 400.
doi:10.1038/msb.2010.59
von der Haar, T. (2008). A quantitative estimation of the global translational activity in
logarithmically growing yeast cells. BMC Syst Biol, 2, 87. doi:10.1186/17520509-2-87
143

Voskuhl, R. R., Itoh, N., Tassoni, A., Matsukawa, M. A., Ren, E., Tse, V., . . . Itoh, Y.
(2019). Gene expression in oligodendrocytes during remyelination reveals
cholesterol homeostasis as a therapeutic target in multiple sclerosis. Proc Natl
Acad Sci U S A, 116(20), 10130-10139. doi:10.1073/pnas.1821306116
Walker, C. L., Fry, C. M. E., Wang, J., Du, X., Zuzzio, K., Liu, N. K., . . . Xu, X. M.
(2019). Functional and Histological Gender Comparison of Age-Matched Rats
after Moderate Thoracic Contusive Spinal Cord Injury. J Neurotrauma, 36(12),
1974-1984. doi:10.1089/neu.2018.6233
Wallace, M. C., Tator, C. H., & Frazee, P. (1986). Relationship between posttraumatic
ischemia and hemorrhage in the injured rat spinal cord as shown by colloidal
carbon angiography. Neurosurgery, 18(4), 433-439. doi:10.1227/00006123198604000-00007
Wang, M., Wey, S., Zhang, Y., Ye, R., & Lee, A. S. (2009a). Role of the unfolded
protein response regulator GRP78/BiP in development, cancer, and neurological
disorders. Antioxid Redox Signal, 11(9), 2307-2316. doi:10.1089/ARS.2009.2485
Wang, S., Wu, J., Zeng, Y. Z., Wu, S. S., Deng, G. R., Chen, Z. D., & Lin, B. (2017).
Necrostatin-1 Mitigates Endoplasmic Reticulum Stress After Spinal Cord Injury.
Neurochem Res, 42(12), 3548-3558. doi:10.1007/s11064-017-2402-x
Wang, Y., Jiao, J., Zhang, S., Zheng, C., & Wu, M. (2019). RIP3 inhibition protects
locomotion function through ameliorating mitochondrial antioxidative capacity
after spinal cord injury. Biomed Pharmacother, 116, 109019.
doi:10.1016/j.biopha.2019.109019
Wang, Y., Wang, H., Tao, Y., Zhang, S., Wang, J., & Feng, X. (2014). Necroptosis
inhibitor necrostatin-1 promotes cell protection and physiological function in
traumatic spinal cord injury. Neuroscience, 266, 91-101.
doi:10.1016/j.neuroscience.2014.02.007
Wang, Y., Wang, J., Wang, H., Feng, X., Tao, Y., Yang, J., & Cai, J. (2018).
Necrosulfonamide Attenuates Spinal Cord Injury via Necroptosis Inhibition.
World Neurosurg, 114, e1186-e1191. doi:10.1016/j.wneu.2018.03.174
Wang, Z., Gerstein, M., & Snyder, M. (2009b). RNA-Seq: a revolutionary tool for
transcriptomics. Nat Rev Genet, 10(1), 57-63. doi:10.1038/nrg2484
Warden, P., Bamber, N. I., Li, H., Esposito, A., Ahmad, K. A., Hsu, C. Y., & Xu, X. M.
(2001). Delayed glial cell death following wallerian degeneration in white matter
tracts after spinal cord dorsal column cordotomy in adult rats. Exp Neurol, 168(2),
213-224. doi:10.1006/exnr.2000.7622
Warner, J. R. (1999). The economics of ribosome biosynthesis in yeast. Trends Biochem
Sci, 24(11), 437-440. doi:10.1016/s0968-0004(99)01460-7
Wendel, H. G., Silva, R. L., Malina, A., Mills, J. R., Zhu, H., Ueda, T., . . . Lowe, S. W.
(2007). Dissecting eIF4E action in tumorigenesis. Genes Dev, 21(24), 3232-3237.
doi:10.1101/gad.1604407
Whetstone, W. D., Hsu, J. Y., Eisenberg, M., Werb, Z., & Noble-Haeusslein, L. J. (2003).
Blood-spinal cord barrier after spinal cord injury: relation to revascularization and
wound healing. J Neurosci Res, 74(2), 227-239. doi:10.1002/jnr.10759
White, D. E., Cardiff, R. D., Dedhar, S., & Muller, W. J. (2001). Mammary epithelialspecific expression of the integrin-linked kinase (ILK) results in the induction of

144

mammary gland hyperplasias and tumors in transgenic mice. Oncogene, 20(48),
7064-7072. doi:10.1038/sj.onc.1204910
Whiteneck, G., Gassaway, J., Dijkers, M., & Jha, A. (2009). New approach to study the
contents and outcomes of spinal cord injury rehabilitation: the SCIRehab Project.
J Spinal Cord Med, 32(3), 251-259. doi:10.1080/10790268.2009.11760779
Whittemore, S. R., Sanon, H. R., & Wood, P. M. (1993). Concurrent isolation and
characterization of oligodendrocytes, microglia and astrocytes from adult human
spinal cord. Int J Dev Neurosci, 11(6), 755-764. doi:10.1016/07365748(93)90064-k
Wight, P. A., Duchala, C. S., Readhead, C., & Macklin, W. B. (1993). A myelin
proteolipid protein-LacZ fusion protein is developmentally regulated and targeted
to the myelin membrane in transgenic mice. J Cell Biol, 123(2), 443-454.
doi:10.1083/jcb.123.2.443
Wilkins, A., Majed, H., Layfield, R., Compston, A., & Chandran, S. (2003).
Oligodendrocytes promote neuronal survival and axonal length by distinct
intracellular mechanisms: a novel role for oligodendrocyte-derived glial cell linederived neurotrophic factor. J Neurosci, 23(12), 4967-4974.
Wortel, I. M. N., van der Meer, L. T., Kilberg, M. S., & van Leeuwen, F. N. (2017).
Surviving Stress: Modulation of ATF4-Mediated Stress Responses in Normal and
Malignant Cells. Trends Endocrinol Metab, 28(11), 794-806.
doi:10.1016/j.tem.2017.07.003
Xu, G. Y., Hughes, M. G., Ye, Z., Hulsebosch, C. E., & McAdoo, D. J. (2004).
Concentrations of glutamate released following spinal cord injury kill
oligodendrocytes in the spinal cord. Exp Neurol, 187(2), 329-336.
doi:10.1016/j.expneurol.2004.01.029
Xue, Y., Enosi Tuipulotu, D., Tan, W. H., Kay, C., & Man, S. M. (2019). Emerging
Activators and Regulators of Inflammasomes and Pyroptosis. Trends Immunol,
40(11), 1035-1052. doi:10.1016/j.it.2019.09.005
Yang, W. S., Kim, K. J., Gaschler, M. M., Patel, M., Shchepinov, M. S., & Stockwell, B.
R. (2016). Peroxidation of polyunsaturated fatty acids by lipoxygenases drives
ferroptosis. Proc Natl Acad Sci U S A, 113(34), E4966-4975.
doi:10.1073/pnas.1603244113
Yin, K. J., Kim, G. M., Lee, J. M., He, Y. Y., Xu, J., & Hsu, C. Y. (2005). JNK activation
contributes to DP5 induction and apoptosis following traumatic spinal cord injury.
Neurobiol Dis, 20(3), 881-889. doi:10.1016/j.nbd.2005.05.026
Yoneshima, E., Okamoto, K., Sakai, E., Nishishita, K., Yoshida, N., & Tsukuba, T.
(2016). The Transcription Factor EB (TFEB) Regulates Osteoblast Differentiation
Through ATF4/CHOP-Dependent Pathway. J Cell Physiol, 231(6), 1321-1333.
doi:10.1002/jcp.25235
Yuan, Y. M., & He, C. (2013). The glial scar in spinal cord injury and repair. Neurosci
Bull, 29(4), 421-435. doi:10.1007/s12264-013-1358-3
Yune, T. Y., Chang, M. J., Kim, S. J., Lee, Y. B., Shin, S. W., Rhim, H., . . . Oh, T. H.
(2003). Increased production of tumor necrosis factor-alpha induces apoptosis
after traumatic spinal cord injury in rats. J Neurotrauma, 20(2), 207-219.
doi:10.1089/08977150360547116

145

Yusoff, P., Lao, D. H., Ong, S. H., Wong, E. S., Lim, J., Lo, T. L., . . . Guy, G. R. (2002).
Sprouty2 inhibits the Ras/MAP kinase pathway by inhibiting the activation of
Raf. J Biol Chem, 277(5), 3195-3201. doi:10.1074/jbc.M108368200
Zai, L. J., & Wrathall, J. R. (2005). Cell proliferation and replacement following
contusive spinal cord injury. Glia, 50(3), 247-257. doi:10.1002/glia.20176
Zenklusen, D., Larson, D. R., & Singer, R. H. (2008). Single-RNA counting reveals
alternative modes of gene expression in yeast. Nat Struct Mol Biol, 15(12), 12631271. doi:10.1038/nsmb.1514
Zhang, F., Tao, Y., Zhang, Z., Guo, X., An, P., Shen, Y., . . . Wang, F. (2012a).
Metalloreductase Steap3 coordinates the regulation of iron homeostasis and
inflammatory responses. Haematologica, 97(12), 1826-1835.
doi:10.3324/haematol.2012.063974
Zhang, N., Yin, Y., Xu, S. J., Wu, Y. P., & Chen, W. S. (2012b). Inflammation &
apoptosis in spinal cord injury. Indian J Med Res, 135, 287-296.
Zhang, S., Chen, Y., Wang, Y., Zhang, P., Chen, G., & Zhou, Y. (2020). Insights Into
Translatomics in the Nervous System. Front Genet, 11, 599548.
doi:10.3389/fgene.2020.599548
Zhang, S., Macias-Garcia, A., Ulirsch, J. C., Velazquez, J., Butty, V. L., Levine, S. S., . .
. Chen, J. J. (2019). HRI coordinates translation necessary for protein homeostasis
and mitochondrial function in erythropoiesis. Elife, 8. doi:10.7554/eLife.46976
Zhang, X., Chen, X., Liu, Q., Zhang, S., & Hu, W. (2017). Translation repression via
modulation of the cytoplasmic poly(A)-binding protein in the inflammatory
response. Elife, 6. doi:10.7554/eLife.27786
Zhang, Y., Chen, K., Sloan, S. A., Bennett, M. L., Scholze, A. R., O'Keeffe, S., . . . Wu,
J. Q. (2014). An RNA-sequencing transcriptome and splicing database of glia,
neurons, and vascular cells of the cerebral cortex. J Neurosci, 34(36), 1192911947. doi:10.1523/JNEUROSCI.1860-14.2014
Zhu, Y., Lyapichev, K., Lee, D. H., Motti, D., Ferraro, N. M., Zhang, Y., . . . Lee, J. K.
(2017). Macrophage Transcriptional Profile Identifies Lipid Catabolic Pathways
That Can Be Therapeutically Targeted after Spinal Cord Injury. J Neurosci, 37(9),
2362-2376. doi:10.1523/JNEUROSCI.2751-16.2017
Ziello, J. E., Jovin, I. S., & Huang, Y. (2007). Hypoxia-Inducible Factor (HIF)-1
regulatory pathway and its potential for therapeutic intervention in malignancy
and ischemia. Yale J Biol Med, 80(2), 51-60.

146

LIST OF ABBREVIATIONS
ABBREVIATION
AD

Alzheimer's Deisease

AIF

Apoptosis Inducing Factor

AMPA

α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid

AQ

Adaptaquin

ASIA

American Spinal Injury Association

ATF4

Activating Transcription Factor 4

ATF6α

Activating Transcription Factor 6

ATP

Adenosine triphosphate

BDNF

Brain Derived Neurotrophic Factor

BiP

Beclin-1/p62

BMS

Basso Mouse Scale
ChaC Glutathione Specific Gamma-

CHAC1

Glutamylcyclotransferase 1

CHOP

C/EBP Homolougous Protein

CNS

Central Nervous System

Dpi

Days Post Injury

DRG

Dorsal Root Ganglion
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DTI

Diffusion Tensor Imagining

ER

Endoplasmic Reticulum

ERSR

Endoplasmic Reticulum Stress Response

GADD34

Growth-arrest DNA Damage Gene 34

GCN2

General Control Nonderepressible 2

GDNF

Glial Derived Neurotrophic Factor

GO

Gene Ontology

GRP78

78-kDa glucose-regulated protein

HA

Human influenza hemagglutinin

HIF

Hypoxia Inducable Factor

HSF1

Heat Schock Factor 1

HSP

Heat Shock Protein

HSR

Heat Shock Response

ICH

Intracerebral Hemorrhage

IN

Input

IP

Immunoprecipitated

IRE1α

Inositol Requiring Enzyme 1 Alpha

ISR

Intregrated Stress Response

JNK

c-Jun N-terminal kinase

MAPK

Mitogen Activated Protein Kinase

MBP

Myelin Basic Protein

MRI

Magnetic Resonance Imaging

MS

Multiple Sclerosis
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NMDA

N-Methyl-D-aspartic acid

NP

Neuropathic Pain

ODD

Oxygen-dependent degradation

OL

Oligodendrocyte

OPC

Oligodendrocyte Precursor Cell

PARVB

Beta Parvin

PERK

PKR-like ER Kinase

PHD

Prolyl Hydroxylase

PLP

Proteolipid Protein

PMD

Pelizaeus Merzbacher Disease

PP1

Protein Phosphatase 1

RER

Rough Endoplasmic Reticulum

ROS

Reactive Oxygen Species

S1P

Site-1 Protease

SCI

Spinal Cord Injury

SNPs

Single Nucleotide Polymorphisms

SPRED3

Sprouty Related EVH1 Domain Containing 3

SPRY4

Sprouty RTK Signaling Antagonist 4

STEAP3

Six-Transmembrane Epithelial Antigen Of Prostate 3

TNF-α

Tumour Necrosis Factor Alpha

TRAP

Translating Ribosome Affinity Purification

uORFs

Upstream Open Reading Frames

UPR

Unfolded Protein Response
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UPS

Ubiquitin Proteasome System

WMS

White Matter Spared

XBP1

X-Box Binding Protein 1
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